Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),A1BG,Alpha-1B-glycoprotein,20185,128,1.46 [0.52-4.06],0.4700204905173181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AAMDC,Mth938 domain-containing protein,19613,127,0.87 [0.62-1.20],0.3896532163512587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AARSD1,Alanyl-tRNA editing protein Aarsd1,23153,167,0.89 [0.69-1.14],0.3671654926916321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABCA2,ATP-binding cassette sub-family A member 2,19476,122,0.94 [0.57-1.56],0.8235826404790982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABHD14B,Protein ABHD14B,22991,169,1.10 [0.86-1.40],0.4572225830737333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABL1,Tyrosine-protein kinase ABL1,23153,167,1.17 [0.96-1.42],0.1212265505215473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABO,Histo-blood group ABO system transferase,20188,130,1.00 [0.89-1.12],0.9496799703727992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABRAXAS2,BRISC complex subunit Abraxas 2,19476,122,0.88 [0.67-1.15],0.3374303532579483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22716,165,1.15 [0.98-1.35],0.0922966827162315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19814,126,0.96 [0.73-1.25],0.7475857019162971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",20163,130,0.94 [0.78-1.14],0.55588960597948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAN,Aggrecan core protein,23025,168,1.43 [0.87-2.35],0.1567998458850468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE,Angiotensin-converting enzyme,20188,130,0.84 [0.46-1.53],0.5624852206366431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE2,Angiotensin-converting enzyme 2,22843,165,1.09 [0.86-1.39],0.4834478738992676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACHE,Acetylcholinesterase,19710,123,0.93 [0.56-1.55],0.7730265203874693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOT13,Acyl-coenzyme A thioesterase 13,20100,129,1.03 [0.89-1.19],0.7089767544222807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,23267,170,1.13 [0.87-1.46],0.367547990150645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP1,Low molecular weight phosphotyrosine protein phosphatase,19566,122,0.56 [0.36-0.86],0.008111203245585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP5,Tartrate-resistant acid phosphatase type 5,23367,170,1.25 [0.84-1.88],0.2743556288754675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP6,Lysophosphatidic acid phosphatase type 6,23439,170,0.95 [0.78-1.16],0.6157464508795987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRBP,Acrosin-binding protein,20093,131,1.18 [0.80-1.76],0.4069514963841038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRV1,Acrosomal protein SP-10,19566,122,1.16 [1.00-1.36],0.0535919103637011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACSL1,Long-chain-fatty-acid--CoA ligase 1,19476,122,1.14 [0.73-1.79],0.5581843374884792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",22843,165,1.51 [1.19-1.93],0.0007563836814616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN2,Alpha-actinin-2,19476,122,1.34 [1.06-1.70],0.0158458499947668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN4,Alpha-actinin-4,22853,166,1.08 [0.72-1.61],0.7175054267843406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,23021,168,2.85 [1.84-4.42],2.954716898337917e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY1,Aminoacylase-1,23267,170,0.93 [0.75-1.16],0.5269749368595963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19476,122,1.30 [0.96-1.74],0.0848345338044967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACYP1,Acylphosphatase-1,19642,123,0.95 [0.73-1.24],0.7118971147836625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA,Adenosine deaminase,23536,169,1.03 [0.71-1.50],0.8684533268861175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,23148,170,1.75 [1.32-2.32],0.0001047034246439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19566,122,1.95 [1.29-2.94],0.0014291883852101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22843,165,1.60 [1.03-2.48],0.0350156896673296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,23062,169,1.31 [0.91-1.90],0.1468630222729025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,23536,169,0.73 [0.52-1.02],0.0664771063556843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23435,168,1.68 [1.09-2.57],0.018294050693588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,20100,129,1.59 [0.95-2.66],0.0792705228484341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19566,122,1.14 [0.67-1.96],0.6292111516833161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23559,171,0.56 [0.33-0.97],0.0375299038957831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,23153,167,1.23 [0.88-1.72],0.2238746428129925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22843,165,1.09 [0.73-1.62],0.6771528845679384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19566,122,1.01 [0.63-1.64],0.956590462999076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,23327,169,0.70 [0.52-0.94],0.0180324835736335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL2,ADAMTS-like protein 2,20171,128,1.51 [0.97-2.37],0.0708763393370136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL4,ADAMTS-like protein 4,19613,127,0.67 [0.33-1.34],0.2539498779538365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL5,ADAMTS-like protein 5,20163,130,0.86 [0.57-1.32],0.4953129898008039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22716,165,1.18 [0.84-1.65],0.3357002153843003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADD1,Alpha-adducin,19710,123,0.77 [0.60-0.98],0.0366587814821112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRB3,Adhesion G protein-coupled receptor B3,23021,168,1.09 [0.73-1.63],0.682837293584883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRD1,Adhesion G-protein coupled receptor D1,19710,123,1.12 [0.74-1.71],0.5864077431904133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,20100,129,1.64 [1.24-2.19],0.0006066246971014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE2,Adhesion G protein-coupled receptor E2,23346,169,1.67 [1.05-2.65],0.0289218179017223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE5,Adhesion G protein-coupled receptor E5,23448,171,1.45 [0.97-2.19],0.0732557155244747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRF5,Adhesion G protein-coupled receptor F5,20163,130,1.09 [0.58-2.04],0.796815032076377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG1,Adhesion G-protein coupled receptor G1,23153,167,1.13 [0.98-1.30],0.0942319306196953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG2,Adhesion G-protein coupled receptor G2,23267,170,0.76 [0.46-1.24],0.2694232096505964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRV1,Adhesion G-protein coupled receptor V1,19511,122,1.02 [0.80-1.31],0.8577730746459251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH1B,All-trans-retinol dehydrogenase,19710,123,0.98 [0.78-1.23],0.8638331391962222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22843,165,1.06 [0.90-1.26],0.4858718726539212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADIPOQ,Adiponectin,20185,128,1.25 [0.98-1.59],0.0760200599698071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,23465,170,2.05 [1.21-3.46],0.0072522115733971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADRA2A,Alpha-2A adrenergic receptor,19476,122,0.93 [0.71-1.22],0.5885746906231419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFAP1,Actin filament-associated protein 1,19710,123,0.77 [0.61-0.97],0.024967459980613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFM,Afamin,20185,128,0.84 [0.37-1.91],0.6754567026295009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFP,Alpha-fetoprotein,22978,168,0.90 [0.72-1.11],0.3311718005578458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGBL2,Cytosolic carboxypeptidase 2,19511,122,1.23 [1.01-1.48],0.0371366503751556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGER,Advanced glycosylation end product-specific receptor,23193,168,1.19 [0.86-1.65],0.3014428670480873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR2,Anterior gradient protein 2 homolog,22580,161,1.19 [1.04-1.37],0.0145149753405158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR3,Anterior gradient protein 3,22679,165,1.14 [0.91-1.42],0.2518115375220631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,23346,169,1.77 [1.28-2.44],0.0005311400263395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRP,Agouti-related protein,23536,169,1.26 [0.97-1.65],0.0876434234073107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGT,Angiotensinogen,20188,130,1.04 [0.48-2.25],0.9289777225154678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGXT,Serine--pyruvate aminotransferase,23267,170,1.16 [0.98-1.38],0.0870935403868514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHCY,Adenosylhomocysteinase,23267,170,1.00 [0.82-1.22],0.9787663365625732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK,Neuroblast differentiation-associated protein AHNAK,19613,127,1.06 [0.62-1.79],0.834782725691349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK2,Protein AHNAK2,19613,127,1.27 [0.75-2.15],0.3684870199139406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,20093,131,1.17 [0.94-1.46],0.168729544431168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSG,Alpha-2-HS-glycoprotein,20188,130,0.72 [0.39-1.32],0.2825697521636706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSP,Alpha-hemoglobin-stabilizing protein,23235,167,0.91 [0.77-1.07],0.2515115324075227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIDA,"Axin interactor, dorsalization-associated protein",19624,123,1.10 [0.92-1.33],0.3012352832850187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1,Allograft inflammatory factor 1,22716,165,1.22 [0.94-1.58],0.1352933386893193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1L,Allograft inflammatory factor 1-like,19613,127,1.12 [0.85-1.50],0.4197546462343942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23120,167,1.16 [1.02-1.31],0.0243190015069294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK1,Adenylate kinase isoenzyme 1,23267,170,0.89 [0.72-1.11],0.3147821297311915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK2,"Adenylate kinase 2, mitochondrial",20115,129,1.07 [0.91-1.25],0.4195043218768181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKAP12,A-kinase anchor protein 12,19710,123,0.99 [0.42-2.31],0.9765790820702084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B1,Aldo-keto reductase family 1 member B1,22716,165,1.08 [0.90-1.30],0.4247708997068508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B10,Aldo-keto reductase family 1 member B10,19624,123,1.16 [0.91-1.48],0.2405854249648457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1C4,Aldo-keto reductase family 1 member C4,22843,165,1.29 [1.05-1.59],0.0162116540012908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR7L,Aflatoxin B1 aldehyde reductase member 4,19566,122,1.12 [0.88-1.43],0.3597678744472241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT1S1,Proline-rich AKT1 substrate 1,22749,164,1.08 [0.87-1.34],0.473889476047529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT2,RAC-beta serine/threonine-protein kinase,20124,129,0.98 [0.86-1.12],0.821139110802061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT3,RAC-gamma serine/threonine-protein kinase,22610,165,1.00 [0.79-1.28],0.9758977704112912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALCAM,CD166 antigen,23559,171,2.39 [1.24-4.60],0.0092655265526043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH1A1,Retinal dehydrogenase 1,23278,167,0.85 [0.65-1.10],0.2108161857685957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH2,"Aldehyde dehydrogenase, mitochondrial",20093,131,1.19 [0.91-1.54],0.2019504968344428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",23197,169,1.18 [0.99-1.39],0.0638678021483359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",20124,129,1.22 [0.86-1.71],0.2640342584466626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALMS1,Alstrom syndrome protein 1,19814,126,1.00 [0.68-1.49],0.9850592958486744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPI,Intestinal-type alkaline phosphatase,19566,122,0.94 [0.82-1.09],0.4066044039844821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPP,"Alkaline phosphatase, placental type",23153,167,1.11 [0.98-1.25],0.1163216970790824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBN,Ameloblastin,22853,166,1.27 [0.83-1.94],0.2685975528790015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,23430,170,3.45 [1.84-6.47],0.000112472552169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,20171,128,0.67 [0.35-1.26],0.2154505167100119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,22749,164,1.40 [1.18-1.66],0.0001139823940779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO1,Amphoterin-induced protein 1,19624,123,1.30 [0.99-1.71],0.0623891821315095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO2,Amphoterin-induced protein 2,23153,167,1.84 [1.04-3.25],0.0361902133478811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMN,Protein amnionless,22853,166,1.20 [0.90-1.59],0.2065566433212127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOT,Angiomotin,19710,123,0.86 [0.54-1.36],0.5177014948880901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOTL2,Angiomotin-like protein 2,20009,130,1.08 [0.77-1.52],0.6421829207564652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMPD3,AMP deaminase 3,20115,129,0.74 [0.58-0.93],0.0116025362344222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18936,123,0.62 [0.42-0.89],0.0104402937080432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2A,Pancreatic alpha-amylase,22408,167,0.82 [0.62-1.08],0.1544585091047807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2B,Alpha-amylase 2B,21707,165,0.80 [0.60-1.06],0.1268029268040989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANG,Angiogenin,23227,170,1.30 [0.87-1.92],0.1974575723771388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT1,Angiopoietin-1,23173,168,0.98 [0.83-1.15],0.7917923318073572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT2,Angiopoietin-2,23465,170,1.53 [1.08-2.16],0.0155295716925279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL1,Angiopoietin-related protein 1,22902,168,1.32 [0.82-2.12],0.2544598546916442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL2,Angiopoietin-related protein 2,23267,168,1.20 [0.86-1.69],0.2882042532503966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL3,Angiopoietin-related protein 3,23303,170,1.01 [0.69-1.50],0.940955763787887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL4,Angiopoietin-related protein 4,23310,169,1.51 [1.12-2.03],0.0074470338370833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL7,Angiopoietin-related protein 7,23465,170,1.37 [0.96-1.96],0.0819259334607367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANK2,Ankyrin-2,19476,122,0.87 [0.66-1.15],0.3377395955202273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19566,122,1.04 [0.84-1.29],0.7437656887128394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRA2,Ankyrin repeat family A protein 2,19464,125,0.82 [0.59-1.15],0.2466957597757852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRD54,Ankyrin repeat domain-containing protein 54,22716,165,0.94 [0.73-1.20],0.6225970816690429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19613,127,0.61 [0.34-1.09],0.0935283147333178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANPEP,Aminopeptidase N,23341,171,1.66 [1.04-2.66],0.0340041788229702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA1,Annexin A1,19610,122,0.65 [0.42-1.01],0.0565577630079603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA10,Annexin A10,22749,164,1.25 [1.08-1.45],0.0032291942414844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA11,Annexin A11,23198,169,0.98 [0.80-1.20],0.8518491197083119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA2,Annexin A2,19320,124,0.99 [0.78-1.27],0.9436599902080444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA3,Annexin A3,23435,168,1.01 [0.83-1.23],0.9132793371971384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA4,Annexin A4,23166,170,0.97 [0.80-1.17],0.7141018327596232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA5,Annexin A5,22667,164,1.82 [1.21-2.72],0.0036615719343114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC1,Amiloride-sensitive amine oxidase [copper-containing],22853,166,1.16 [0.93-1.43],0.1834836901830413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC3,Membrane primary amine oxidase,23375,171,1.57 [1.00-2.49],0.051911037228507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP1G2,AP-1 complex subunit gamma-like 2,20093,131,0.94 [0.76-1.16],0.5453399084861175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP2B1,AP-2 complex subunit beta,19624,123,0.97 [0.67-1.39],0.8660197911353902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3B1,AP-3 complex subunit beta-1,20100,129,0.98 [0.79-1.22],0.858685376704351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3S2,AP-3 complex subunit sigma-2,20115,129,1.03 [0.73-1.45],0.8866352234826157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,23153,167,1.37 [1.07-1.76],0.0119263704333874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APCS,Serum amyloid P-component,20004,127,0.66 [0.39-1.11],0.1190813124610878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,23402,170,0.99 [0.78-1.24],0.8986122781324835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APLP1,Amyloid-like protein 1,23267,170,0.93 [0.71-1.21],0.5836922371145306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA1,Apolipoprotein A-I,20185,128,0.41 [0.20-0.84],0.0146799122979701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA2,Apolipoprotein A-II,20188,130,1.19 [0.86-1.66],0.2971163087188359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA4,Apolipoprotein A-IV,20185,128,0.78 [0.47-1.30],0.3384204453506492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOB,Apolipoprotein B-100,20188,130,0.81 [0.39-1.67],0.5665825551319255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOBR,Apolipoprotein B receptor,19613,127,1.09 [0.73-1.62],0.6890050141686126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOC1,Apolipoprotein C-I,20152,127,0.61 [0.39-0.97],0.0354688716086974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOD,Apolipoprotein D,19303,123,0.62 [0.37-1.05],0.0736444386667314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOE,Apolipoprotein E,20185,128,0.90 [0.68-1.20],0.4890336016932498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOF,Apolipoprotein F,20188,130,0.46 [0.28-0.75],0.0019759329086898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOH,Beta-2-glycoprotein 1,23278,167,1.28 [0.90-1.82],0.1661255521635849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOL1,Apolipoprotein L1,20188,130,1.10 [0.82-1.47],0.5209738956132326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOM,Apolipoprotein M,23341,171,0.73 [0.46-1.15],0.1715068104519158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APP,Amyloid-beta precursor protein,23241,167,1.05 [0.86-1.29],0.6296552541249696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APPL2,DCC-interacting protein 13-beta,19710,123,0.94 [0.81-1.09],0.4123895358056932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APRT,Adenine phosphoribosyltransferase,23018,169,1.13 [0.84-1.52],0.4109760807855548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARAF,Serine/threonine-protein kinase A-Raf,19814,126,0.92 [0.71-1.20],0.556214747028449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,23153,167,2.17 [1.64-2.88],5.994672424983498e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARF6,ADP-ribosylation factor 6,20100,129,0.96 [0.82-1.12],0.5823555323411871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARFIP1,Arfaptin-1,20124,129,0.94 [0.74-1.21],0.6462570690967415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,23102,167,0.64 [0.49-0.83],0.0008758340244771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG2,"Arginase-2, mitochondrial",20093,131,1.01 [0.68-1.52],0.9481491206270378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP1,Rho GTPase-activating protein 1,22716,165,0.95 [0.70-1.28],0.7308236158304691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP25,Rho GTPase-activating protein 25,22716,165,1.02 [0.81-1.28],0.8627158514192381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP30,Rho GTPase-activating protein 30,19814,126,1.22 [0.84-1.77],0.2880859672276805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP45,Rho GTPase-activating protein 45,19710,123,0.88 [0.71-1.09],0.2585044741602761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP5,Rho GTPase-activating protein 5,19464,125,0.89 [0.69-1.14],0.3400224661282235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF1,Rho guanine nucleotide exchange factor 1,20115,129,0.94 [0.78-1.13],0.5067625641992448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF10,Rho guanine nucleotide exchange factor 10,20124,129,0.96 [0.80-1.15],0.6618679422725359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF12,Rho guanine nucleotide exchange factor 12,23240,169,0.98 [0.86-1.12],0.8199733247320724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF5,Rho guanine nucleotide exchange factor 5,19511,122,1.05 [0.83-1.32],0.7045790230219338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID3A,AT-rich interactive domain-containing protein 3A,19511,122,1.11 [0.73-1.69],0.6338133504024895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID4B,AT-rich interactive domain-containing protein 4B,22749,164,0.94 [0.67-1.33],0.7374395169293329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL13B,ADP-ribosylation factor-like protein 13B,19476,122,1.04 [0.82-1.34],0.7357422652255513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19476,122,0.84 [0.54-1.31],0.4348777164567714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARMCX2,Armadillo repeat-containing X-linked protein 2,19511,122,1.15 [0.90-1.49],0.2679528720787871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNT,Aryl hydrocarbon receptor nuclear translocator,22853,166,1.00 [0.69-1.46],0.9877339232524917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19476,122,1.11 [0.81-1.51],0.5270612400864912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSA,Arylsulfatase A,23278,167,1.04 [0.77-1.40],0.7890664919669113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSB,Arylsulfatase B,23153,167,1.14 [0.90-1.45],0.2834534876905568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART3,Ecto-ADP-ribosyltransferase 3,23375,171,1.04 [0.72-1.50],0.8499877741365472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART5,Ecto-ADP-ribosyltransferase 5,19511,122,1.07 [0.83-1.39],0.6053474074736931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARTN,Artemin,22853,166,1.25 [0.99-1.59],0.0611925109754548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH1,Acid ceramidase,19989,128,1.20 [0.86-1.67],0.2866536964844626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH2,Neutral ceramidase,23062,169,0.79 [0.64-0.99],0.0410572223351034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,23062,169,1.98 [1.33-2.93],0.0007184784730036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR2,Asialoglycoprotein receptor 2,20188,130,1.22 [0.65-2.26],0.5361237428250673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPN,Asporin,20163,130,0.74 [0.39-1.40],0.356868242935158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPSCR1,Tether containing UBX domain for GLUT4,20124,129,0.88 [0.68-1.13],0.3085531094862319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASRGL1,Isoaspartyl peptidase/L-asparaginase,19613,127,0.92 [0.78-1.09],0.3557857047892538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASS1,Argininosuccinate synthase,19476,122,1.04 [0.83-1.31],0.716077013324911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF2,Cyclic AMP-dependent transcription factor ATF-2,22749,164,1.10 [0.92-1.31],0.3079201308999123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF4,Cyclic AMP-dependent transcription factor ATF-4,19464,125,1.08 [0.65-1.79],0.7788815638933007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG16L1,Autophagy-related protein 16-1,20100,129,0.97 [0.80-1.18],0.7584749861726034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG4A,Cysteine protease ATG4A,22716,165,0.85 [0.67-1.09],0.1988418207636146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATOX1,Copper transport protein ATOX1,23327,169,1.14 [0.93-1.38],0.1996797537784469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19476,122,1.06 [0.75-1.50],0.7229216682029533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19476,122,0.60 [0.33-1.09],0.0912009754523807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19476,122,0.82 [0.50-1.35],0.4353886217692745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B4,Protein ATP1B4,19464,125,1.18 [0.80-1.73],0.4013512964741135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP2B4,Plasma membrane calcium-transporting ATPase 4,19476,122,0.96 [0.71-1.29],0.7840625679957438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5F1D,"ATP synthase subunit delta, mitochondrial",19476,122,0.90 [0.62-1.30],0.5758893049620226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5IF1,"ATPase inhibitor, mitochondrial",23346,169,1.09 [0.96-1.23],0.1893403452159439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5PO,"ATP synthase subunit O, mitochondrial",22749,164,1.33 [1.03-1.73],0.0298257656610603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6AP2,Renin receptor,22716,165,1.43 [1.09-1.88],0.0106747646321586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1D,V-type proton ATPase subunit D,23153,167,1.00 [0.59-1.68],0.9866625958142018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1F,V-type proton ATPase subunit F,22716,164,1.00 [0.81-1.23],0.9932963108072204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G1,V-type proton ATPase subunit G 1,19613,127,0.86 [0.68-1.10],0.2320618794831107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G2,V-type proton ATPase subunit G 2,19476,122,0.99 [0.82-1.20],0.9450012460133972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRAID,All-trans retinoic acid-induced differentiation factor,20100,129,1.41 [0.94-2.11],0.0970266582690166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRN,"Attractin, Isoform 2",20185,128,0.82 [0.30-2.27],0.6998673882351878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN10,Ataxin-10,22749,164,1.14 [0.94-1.38],0.1787934822857428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2,Ataxin-2,19511,122,1.12 [0.97-1.28],0.1299545289559408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2L,Ataxin-2-like protein,20124,129,0.84 [0.57-1.24],0.3778782197510321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN3,Ataxin-3,20115,129,0.75 [0.57-0.99],0.0387361107271412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXIN1,Axin-1,23240,169,0.99 [0.86-1.14],0.8671260395656233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXL,Tyrosine-protein kinase receptor UFO,23375,171,1.93 [1.20-3.09],0.0065504761260869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZI2,5-azacytidine-induced protein 2,20124,129,0.76 [0.55-1.05],0.0974394880698197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZU1,Azurocidin,22610,163,0.93 [0.77-1.12],0.4477605508113764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B2M,Beta-2-microglobulin,20185,128,1.47 [1.09-1.99],0.01195318190811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19476,122,0.47 [0.19-1.16],0.1031115050663632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19613,127,1.63 [1.02-2.58],0.0390862656777439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",23346,169,2.62 [1.67-4.10],2.7152300848659783e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GAT1,"Beta-1,4-glucuronyltransferase 1",23278,167,1.05 [0.60-1.85],0.8570125232549768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BABAM1,BRISC and BRCA1-A complex member 1,19566,122,0.61 [0.31-1.20],0.1515854227957441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BACH1,Transcription regulator protein BACH1,23240,169,0.95 [0.79-1.15],0.6198991468363246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG3,BAG family molecular chaperone regulator 3,23021,168,1.61 [1.14-2.29],0.0070403966103307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG4,BAG family molecular chaperone regulator 4,19566,122,0.93 [0.65-1.34],0.7087593286728551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG6,Large proline-rich protein BAG6,22843,165,1.04 [0.71-1.52],0.8332976368560723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22716,165,1.34 [1.10-1.62],0.0029846950111568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,22716,165,2.25 [1.57-3.24],1.1075089622638234e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BANK1,B-cell scaffold protein with ankyrin repeats,23240,169,0.96 [0.85-1.09],0.5672029975067683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAP18,Chromatin complexes subunit BAP18,20115,129,0.93 [0.72-1.20],0.5877178995367549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BATF,Basic leucine zipper transcriptional factor ATF-like,19624,123,1.04 [0.85-1.27],0.686432931958693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAX,Apoptosis regulator BAX,22707,164,1.03 [0.88-1.20],0.7083649184117028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAM,Basal cell adhesion molecule,23278,167,1.53 [0.90-2.60],0.1127929807463794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAN,Brevican core protein,23062,169,0.70 [0.47-1.03],0.0668705896624694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20163,130,1.37 [0.83-2.26],0.2128497899908579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19511,122,1.08 [0.79-1.47],0.6443625263515425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCHE,Cholinesterase,19814,128,0.70 [0.38-1.30],0.2609322766015379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2,Apoptosis regulator Bcl-2,20100,129,1.01 [0.74-1.38],0.9278757629716438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L1,Bcl-2-like protein 1,20115,129,0.96 [0.81-1.14],0.6647361996397264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",23240,169,1.16 [0.83-1.63],0.3918015256296153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L15,Bcl-2-like protein 15,19566,122,0.83 [0.60-1.15],0.2675370909045466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7A,B-cell CLL/lymphoma 7 protein family member A,19464,125,0.86 [0.64-1.16],0.3199943900844373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7B,B-cell CLL/lymphoma 7 protein family member B,20093,131,1.19 [0.86-1.64],0.2909432904432246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCR,Breakpoint cluster region protein,23240,169,0.96 [0.83-1.11],0.5646516696604487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BDNF,Brain-derived neurotrophic factor,20171,128,0.96 [0.78-1.17],0.6668915866962039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BECN1,Beclin-1,19613,127,0.82 [0.61-1.11],0.1980391041430402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BEX3,Protein BEX3,19464,125,1.18 [0.86-1.63],0.3045461644949137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGLAP,Osteocalcin,20171,128,1.19 [0.97-1.44],0.0900312620389999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGN,Biglycan,22681,165,0.96 [0.85-1.08],0.5133273783878259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHLHE40,Class E basic helix-loop-helix protein 40,19511,122,1.05 [0.83-1.34],0.6738804042885215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19476,122,0.69 [0.35-1.35],0.2830043476215408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BID,BH3-interacting domain death agonist,23240,169,1.02 [0.84-1.25],0.820083016483258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIN2,Bridging integrator 2,23278,167,1.01 [0.87-1.18],0.8962871121595577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIRC2,Baculoviral IAP repeat-containing protein 2,22716,165,1.10 [0.89-1.36],0.3904509391728021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLMH,Bleomycin hydrolase,23559,171,0.92 [0.59-1.41],0.6899911433745822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLNK,B-cell linker protein,19566,122,0.67 [0.41-1.09],0.1083714657102964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19511,122,0.78 [0.59-1.03],0.0784701345693902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,20115,129,0.91 [0.60-1.38],0.6508256979956853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLVRB,Flavin reductase,23278,167,0.81 [0.65-1.00],0.0507053330980012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP10,Bone morphogenetic protein 10,19710,123,1.01 [0.55-1.87],0.9648718572070788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP4,Bone morphogenetic protein 4,23021,168,1.07 [0.81-1.43],0.6261694511274585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP6,Bone morphogenetic protein 6,22809,165,0.87 [0.61-1.23],0.4191966847647286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMPER,BMP-binding endothelial regulator protein,19710,123,1.97 [0.96-4.03],0.0647605500678606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,20163,130,1.12 [0.69-1.82],0.648057886858763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19566,122,1.12 [0.76-1.64],0.5758533907786076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOC,Brother of CDO,22843,165,1.28 [0.71-2.31],0.41689887866118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA1,BolA-like protein 1,19511,122,1.07 [0.78-1.47],0.6749695111264143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA2_BOLA2B,BolA-like protein 2,19613,127,0.71 [0.52-0.98],0.0396685133486617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFA2,BPI fold-containing family A member 2,18953,123,0.93 [0.80-1.09],0.3927916210427822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB1,BPI fold-containing family B member 1,23229,168,0.94 [0.76-1.16],0.5853501067267188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB2,BPI fold-containing family B member 2,20126,130,1.12 [0.87-1.44],0.3874265930113297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRAP,BRCA1-associated protein,19902,129,0.94 [0.80-1.09],0.40373132656799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD1,Bromodomain-containing protein 1,19814,126,1.29 [0.77-2.17],0.3302378081498217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD2,Bromodomain-containing protein 2,19511,122,1.17 [0.74-1.83],0.5035672068027639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD3,Bromodomain-containing protein 3,19476,122,1.24 [0.91-1.67],0.1706903356754309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRDT,Bromodomain testis-specific protein,19476,122,1.16 [0.73-1.84],0.5405022350805953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRK1,Protein BRICK1,22749,164,1.53 [1.15-2.05],0.0039551672584402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRME1,Break repair meiotic recombinase recruitment factor 1,19511,122,0.99 [0.64-1.52],0.9616516630783176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRSK2,Serine/threonine-protein kinase BRSK2,20124,129,0.95 [0.60-1.51],0.8292236854386053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSG,Basigin,23498,168,2.41 [1.30-4.49],0.0054478694744647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSND,Barttin,19464,125,0.93 [0.55-1.57],0.7751736941483416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,23472,168,1.15 [0.84-1.58],0.3721207306236697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,23472,168,1.66 [1.36-2.03],5.326395565016365e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTC,Probetacellulin,22716,165,0.99 [0.82-1.19],0.9084634949566488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTD,Biotinidase,20185,128,0.76 [0.34-1.70],0.4985161494795191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTLA,B- and T-lymphocyte attenuator,19464,125,0.91 [0.72-1.14],0.3964077356396137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN1A1,Butyrophilin subfamily 1 member A1,20055,131,0.91 [0.57-1.46],0.7068033701775838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,23346,169,2.37 [1.55-3.63],7.155068455698005e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,23240,169,1.75 [1.34-2.29],3.993054102611174e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTNL10,Butyrophilin-like protein 10,19464,125,1.02 [0.67-1.57],0.9157002156503804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C19orf12,Protein C19orf12,22749,164,1.15 [0.96-1.39],0.1364340964739994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1GALT1C1,C1GALT1-specific chaperone 1,19476,122,1.22 [0.76-1.97],0.4186703983060104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QA,Complement C1q subcomponent subunit A,23427,167,1.96 [1.10-3.52],0.0234634009186678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",20124,129,1.09 [0.88-1.35],0.4375617359146114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QL2,Complement C1q-like protein 2,19566,122,0.80 [0.52-1.21],0.2860252101898621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23375,171,1.20 [0.88-1.62],0.2460005083566058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19710,123,1.00 [0.62-1.60],0.9925364388626332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,20124,129,0.97 [0.57-1.66],0.9082392977388803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19679,123,0.84 [0.60-1.18],0.311162221862942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1R,Complement C1r subcomponent,20185,128,0.30 [0.10-0.90],0.0311958771584263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1RL,Complement C1r subcomponent-like protein,20146,128,2.11 [0.87-5.14],0.0979851118937846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1S,Complement C1s subcomponent,20185,128,0.89 [0.40-2.01],0.7852772528714039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2,Complement C2,23341,171,2.93 [1.48-5.82],0.0021177790342142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2CD2L,Phospholipid transfer protein C2CD2L,22716,164,1.17 [0.85-1.60],0.3375551832083949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2orf69,UPF0565 protein C2orf69,19624,123,0.93 [0.68-1.29],0.6744594776311994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C3,Complement C3,19160,122,1.31 [0.94-1.82],0.1152638272519233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C4BPB,C4b-binding protein beta chain,23327,169,1.17 [0.83-1.66],0.3653669958715919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C5,Complement C5,20185,128,0.98 [0.31-3.09],0.9719018627602788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,19698,125,2.19 [1.31-3.64],0.0027432398514668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7orf50,Uncharacterized protein C7orf50,20115,129,0.65 [0.27-1.57],0.3380096964745144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C8B,Complement component C8 beta chain,20185,128,0.77 [0.45-1.34],0.3615195735448506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9,Complement component C9,20188,130,1.27 [0.94-1.71],0.1182755272452944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9orf40,Uncharacterized protein C9orf40,20100,129,0.80 [0.64-0.99],0.0364613790803967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA1,Carbonic anhydrase 1,22786,168,0.74 [0.58-0.94],0.0143947575236503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA11,Carbonic anhydrase-related protein 11,22716,165,0.98 [0.62-1.56],0.9388052903807954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,23153,167,1.89 [1.32-2.70],0.0004758466731363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA13,Carbonic anhydrase 13,22999,169,0.98 [0.86-1.12],0.7807509046883285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA14,Carbonic anhydrase 14,23465,170,0.83 [0.57-1.20],0.3284313449464294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA2,Carbonic anhydrase 2,23200,167,0.79 [0.64-0.97],0.0244693380128674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA3,Carbonic anhydrase 3,23526,171,1.10 [0.88-1.37],0.3984909389046134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA4,Carbonic anhydrase 4,23559,171,1.48 [0.85-2.55],0.1639378856119662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA5A,"Carbonic anhydrase 5A, mitochondrial",22843,165,1.16 [1.00-1.34],0.0511970932847022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,23206,167,0.66 [0.54-0.82],0.0001612043357851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA7,Carbonic anhydrase 7,19814,126,1.27 [0.83-1.94],0.2711115501320278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA8,Carbonic anhydrase-related protein,19566,122,0.60 [0.26-1.39],0.2326280160851773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA9,Carbonic anhydrase 9,23465,170,1.27 [0.97-1.66],0.0866684030955675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CABP2,Calcium-binding protein 2,19624,123,1.26 [1.00-1.60],0.0541951154739429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19511,122,0.96 [0.55-1.67],0.8728893981743686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19476,122,0.81 [0.56-1.18],0.2786428333715546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19511,122,1.10 [0.83-1.46],0.4931266569035561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,20124,129,1.04 [0.85-1.27],0.7098482844107254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACYBP,Calcyclin-binding protein,19678,123,0.96 [0.81-1.14],0.6497331462148986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CADPS,Calcium-dependent secretion activator 1,19624,123,1.14 [0.78-1.68],0.5006154978985549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB1,Calbindin,23153,167,1.36 [1.00-1.84],0.0464822512058652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB2,Calretinin,22749,164,1.61 [1.26-2.07],0.0001846241816621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCA,Calcitonin,23029,169,1.10 [0.91-1.33],0.3429978895370735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCB,Calcitonin gene-related peptide 2,20115,129,1.35 [0.94-1.93],0.1065286474238163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,23396,169,0.98 [0.86-1.12],0.7388254474047595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19613,127,0.90 [0.71-1.13],0.3606845607099262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALY,Neuron-specific vesicular protein calcyon,19476,122,1.11 [0.72-1.70],0.6354814160789077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22716,165,1.43 [1.08-1.89],0.0112414693139763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19624,123,1.14 [0.84-1.54],0.3887340509170811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,20124,129,0.91 [0.77-1.07],0.2401989550989375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CANT1,Soluble calcium-activated nucleotidase 1,23190,169,2.10 [1.09-4.06],0.0266209677645711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPG,Macrophage-capping protein,23096,168,0.98 [0.78-1.23],0.8687432718618917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,20093,131,1.76 [1.36-2.27],1.662724677638154e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPS,Calcyphosin,20115,129,1.07 [0.92-1.25],0.3894739491743347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CARHSP1,Calcium-regulated heat-stable protein 1,22749,164,0.83 [0.63-1.10],0.1890200930972023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASC3,Protein CASC3,19624,123,1.09 [0.73-1.62],0.67919280242949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP1,Caspase-1,22749,164,1.11 [0.92-1.33],0.2643307856011914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP10,Caspase-10,22749,164,1.04 [0.86-1.26],0.6837313716388771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP2,Caspase-2,23240,169,1.01 [0.83-1.23],0.930206799030095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP3,Caspase-3,23559,171,0.95 [0.81-1.10],0.4865427411284817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP4,Caspase-4,19814,126,0.99 [0.89-1.10],0.8793938537365792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP7,Caspase-7,20115,129,0.95 [0.77-1.16],0.6012439341363254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP8,Caspase-8,23404,170,0.94 [0.75-1.17],0.578677509379788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP9,Caspase-9,19566,122,1.12 [0.85-1.47],0.4152877314270283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASQ2,Calsequestrin-2,19476,122,1.06 [0.75-1.50],0.7506184686952699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAT,Catalase,19896,124,0.70 [0.50-0.98],0.0394055457524661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLIF,Cobalamin binding intrinsic factor,23237,170,1.09 [0.91-1.30],0.3621713211844946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN1,Cerebellin-1,19511,122,1.05 [0.88-1.25],0.5714373904927557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN4,Cerebellin-4,23465,170,0.52 [0.35-0.79],0.0021301581331884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBS,Cystathionine beta-synthase,19613,127,1.20 [0.89-1.63],0.2371361396356955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBX2,Chromobox protein homolog 2,19476,122,1.15 [0.77-1.70],0.4918676228148092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,23062,169,1.05 [0.88-1.27],0.577850172808771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCAR2,Cell cycle and apoptosis regulator protein 2,20115,129,0.80 [0.54-1.19],0.2691621352881452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC134,Coiled-coil domain-containing protein 134,20093,131,0.99 [0.71-1.39],0.9595773343692742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC28A,Coiled-coil domain-containing protein 28A,19624,123,0.91 [0.51-1.62],0.7395925653161723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC50,Coiled-coil domain-containing protein 50,20124,129,1.08 [0.88-1.33],0.4418542964628896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,23267,170,1.92 [1.37-2.70],0.0001454392998509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19613,127,1.15 [0.89-1.50],0.2865651214621747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL11,Eotaxin,23536,169,1.41 [0.98-2.03],0.0612948489802682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL13,C-C motif chemokine 13,23502,169,0.94 [0.77-1.15],0.5727162583055272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL14,C-C motif chemokine 14,23227,170,1.31 [0.97-1.77],0.0808909621827485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL15,C-C motif chemokine 15,23559,171,1.30 [0.97-1.74],0.076348773073464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL16,C-C motif chemokine 16,23559,171,1.31 [1.00-1.72],0.0519471278410174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL17,C-C motif chemokine 17,23188,169,1.14 [0.99-1.32],0.0775176793096432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL18,C-C motif chemokine 18,22975,170,1.17 [0.99-1.38],0.0688824335846351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL19,C-C motif chemokine 19,23472,168,1.07 [0.97-1.19],0.1751825050691554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL2,C-C motif chemokine 2,23021,168,0.89 [0.69-1.16],0.3893683546292804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL20,C-C motif chemokine 20,23536,169,1.21 [1.06-1.38],0.0054617300020128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,23346,169,1.60 [1.23-2.07],0.00044261656712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,22998,168,1.49 [1.18-1.89],0.0008292571974738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL23,C-C motif chemokine 23,23346,169,1.31 [0.95-1.80],0.0947748976497019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL24,C-C motif chemokine 24,23310,169,0.97 [0.82-1.14],0.6792253288220673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL25,C-C motif chemokine 25,23536,169,1.28 [0.97-1.68],0.0802734296341222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL26,C-C motif chemokine 26,23240,169,0.94 [0.80-1.09],0.4016784489430017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL27,C-C motif chemokine 27,23267,170,1.13 [0.91-1.41],0.2688890996597994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL28,C-C motif chemokine 28,23161,169,1.02 [0.81-1.28],0.8985765174514087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL3,C-C motif chemokine 3,23240,169,1.20 [1.02-1.41],0.0322131381611109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL4,C-C motif chemokine 4,23271,169,1.08 [0.89-1.31],0.4556975089042365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL5,C-C motif chemokine 5,23375,171,1.05 [0.92-1.20],0.4871437358273263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL7,C-C motif chemokine 7,23240,169,1.27 [1.03-1.55],0.0223604176881254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL8,C-C motif chemokine 8,23430,170,1.08 [0.86-1.35],0.4975201850023814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN1,CCN family member 1,23118,167,1.09 [0.90-1.31],0.4005026890266253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN2,CCN family member 2,23232,169,1.10 [0.86-1.39],0.4545947249215857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,23514,171,2.11 [1.51-2.96],1.3194569699437943e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,23465,170,1.44 [1.04-1.99],0.0298586881260345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN5,CCN family member 5,23278,167,1.67 [1.19-2.36],0.0034163852009946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCND2,G1/S-specific cyclin-D2,19814,126,1.04 [0.66-1.66],0.8529079860419548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCNE1,G1/S-specific cyclin-E1,19566,122,0.88 [0.69-1.12],0.2823330608061368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCS,Copper chaperone for superoxide dismutase,23062,169,0.85 [0.63-1.14],0.2734196757505465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCT5,T-complex protein 1 subunit epsilon,22716,165,1.03 [0.76-1.40],0.8532874693883692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD101,Immunoglobulin superfamily member 2,20100,129,0.93 [0.64-1.37],0.7209021318586746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD109,CD109 antigen,23278,167,1.00 [0.66-1.50],0.995672307676554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD14,Monocyte differentiation antigen CD14,22835,168,1.50 [1.09-2.07],0.0135166308913851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD160,CD160 antigen,23536,169,1.34 [1.03-1.76],0.0304520741217525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,23375,171,1.79 [1.34-2.38],6.703210822472128e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164,Sialomucin core protein 24,23278,167,1.32 [0.89-1.96],0.1648697480331272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164L2,CD164 sialomucin-like 2 protein,19624,123,1.01 [0.63-1.63],0.969826536273798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD177,CD177 antigen,23236,166,1.09 [0.98-1.22],0.1261749745030912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD1C,T-cell surface glycoprotein CD1c,23327,169,0.96 [0.55-1.65],0.8699370674057519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2,T-cell surface antigen CD2,19476,122,1.09 [0.72-1.66],0.6814178432678459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200,OX-2 membrane glycoprotein,23240,169,1.02 [0.62-1.68],0.9390267468465248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200R1,Cell surface glycoprotein CD200 receptor 1,23160,169,1.01 [0.69-1.49],0.939896197769746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD207,C-type lectin domain family 4 member K,22737,164,1.30 [0.91-1.84],0.1467166890345174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD209,CD209 antigen,23336,170,1.20 [0.85-1.69],0.3121347934852995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD22,B-cell receptor CD22,23536,169,1.19 [0.87-1.61],0.2786309558986461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD226,CD226 antigen,19566,122,1.07 [0.71-1.61],0.7489140475598789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,23536,169,2.32 [1.47-3.64],0.0002682828470815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD248,Endosialin,20171,128,0.86 [0.57-1.31],0.4875690217030567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,23327,169,2.03 [1.55-2.65],2.2119058538031617e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,23062,169,1.78 [1.27-2.51],0.0009005264178025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,23227,169,1.65 [1.12-2.44],0.0115908527596483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,22716,165,1.75 [1.35-2.28],2.576263987516985e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2AP,CD2-associated protein,23267,170,0.97 [0.78-1.21],0.7982868599789938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300A,CMRF35-like molecule 8,19710,123,2.09 [1.23-3.54],0.0061533107848556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,23472,168,2.12 [1.48-3.02],3.7673326222043184e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,23403,170,2.33 [1.77-3.07],1.646576142048426e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LF,CMRF35-like molecule 1,23465,170,1.43 [1.13-1.82],0.0034588296037871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LG,CMRF35-like molecule 9,23278,167,1.25 [0.87-1.79],0.2336365900077039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,23153,167,1.89 [1.29-2.77],0.0011605551501148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD33,Myeloid cell surface antigen CD33,23327,169,1.13 [0.95-1.35],0.1651460160170759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD34,Hematopoietic progenitor cell antigen CD34,23401,168,0.81 [0.46-1.43],0.4617744800022536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD36,Platelet glycoprotein 4,19566,122,1.16 [0.80-1.68],0.4268618387800262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,23153,167,1.72 [1.16-2.57],0.0073091869048493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3D,T-cell surface glycoprotein CD3 delta chain,19511,122,1.40 [0.97-2.01],0.0684403112604769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3E,T-cell surface glycoprotein CD3 epsilon chain,19814,126,0.88 [0.52-1.50],0.6367042153096822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3G,T-cell surface glycoprotein CD3 gamma chain,19566,122,1.19 [1.03-1.38],0.0201744874783789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,23204,169,2.11 [1.56-2.86],1.354293330953632e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40,Tumor necrosis factor receptor superfamily member 5,23235,169,1.49 [1.16-1.91],0.0015416902601374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40LG,CD40 ligand,23536,169,1.08 [0.91-1.29],0.3526334808373264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD46,Membrane cofactor protein,23155,170,1.78 [1.16-2.73],0.0080837830813269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,23310,169,2.84 [1.91-4.22],2.288570668727927e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5,T-cell surface glycoprotein CD5,23430,170,1.50 [1.08-2.07],0.0157053330515686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD55,Complement decay-accelerating factor,22469,166,1.46 [0.90-2.38],0.123086265079298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD58,Lymphocyte function-associated antigen 3,23182,169,0.74 [0.34-1.60],0.4405177313177433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD59,CD59 glycoprotein,22455,161,2.14 [1.32-3.48],0.0021582861169138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5L,CD5 antigen-like,20082,127,1.39 [0.98-1.97],0.0618413795060637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD6,T-cell differentiation antigen CD6,23498,168,1.00 [0.77-1.29],0.977414172509524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD63,CD63 antigen,23021,168,1.10 [0.83-1.44],0.5123862176755092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD69,Early activation antigen CD69,23152,170,1.01 [0.87-1.18],0.8551814911985727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD7,T-cell antigen CD7,19535,122,1.19 [0.81-1.75],0.3672292532918423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD70,CD70 antigen,23240,169,1.29 [0.95-1.75],0.1018767448281562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD72,B-cell differentiation antigen CD72,19710,123,1.36 [0.92-2.00],0.1229132641268111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,23472,168,2.41 [1.70-3.43],8.81559267025965e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD79B,B-cell antigen receptor complex-associated protein beta chain,23536,169,1.53 [1.18-1.99],0.0014339375229348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,20163,130,2.56 [1.73-3.79],2.642538453829466e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD82,CD82 antigen,19814,126,0.92 [0.59-1.44],0.7096356346021464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,23240,169,2.11 [1.49-2.98],2.598272188066976e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD84,SLAM family member 5,23240,169,1.09 [0.71-1.67],0.6946270927970561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD86,T-lymphocyte activation antigen CD86,20100,129,1.79 [1.04-3.09],0.0346042690189077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD8A,T-cell surface glycoprotein CD8 alpha chain,23472,168,1.13 [0.87-1.46],0.3658325490734553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD93,Complement component C1q receptor,22416,168,1.37 [0.89-2.10],0.1527957006299308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,23278,167,2.38 [1.26-4.50],0.0078649146822924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99L2,CD99 antigen-like protein 2,23278,167,2.00 [1.16-3.44],0.0123992619585625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDA,Cytidine deaminase,20127,130,0.88 [0.62-1.26],0.4968069158895073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDAN1,Codanin-1,20115,129,0.85 [0.39-1.81],0.6668988501648486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC123,Cell division cycle protein 123 homolog,19464,125,0.83 [0.60-1.13],0.2349426945273722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC25A,M-phase inducer phosphatase 1,19464,125,0.92 [0.58-1.47],0.7294347173090336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC26,Anaphase-promoting complex subunit CDC26,20060,129,1.08 [0.85-1.37],0.5445396670200353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC27,Cell division cycle protein 27 homolog,22716,165,1.18 [0.96-1.46],0.12119937170502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC37,Hsp90 co-chaperone Cdc37,23327,169,1.03 [0.88-1.22],0.6852116405793249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC42BPB,Serine/threonine-protein kinase MRCK beta,20100,129,0.97 [0.82-1.15],0.7394005767002908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,23062,169,1.54 [1.25-1.90],5.980086624331398e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,22512,168,1.40 [1.06-1.86],0.0195070285549662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH15,Cadherin-15,23439,168,0.91 [0.75-1.11],0.344644731192649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH17,Cadherin-17,23267,170,1.02 [0.84-1.24],0.8620517816061608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH2,Cadherin-2,23267,170,1.45 [1.00-2.11],0.0524387672306657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH22,Cadherin-22,19814,126,1.09 [0.59-1.99],0.78380277073874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH23,Cadherin-23,20115,129,0.82 [0.42-1.59],0.551208169351084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH3,Cadherin-3,23472,168,1.55 [1.09-2.20],0.0151783176155797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH4,Cadherin-4,19511,122,1.13 [0.80-1.59],0.4902310274010348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH5,Cadherin-5,23559,171,0.81 [0.52-1.28],0.3747294554294101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH6,Cadherin-6,23267,170,1.08 [0.76-1.54],0.6530602196335272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR1,Cadherin-related family member 1,22749,164,0.99 [0.71-1.38],0.9647725002580636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR2,Cadherin-related family member 2,23153,167,1.03 [0.83-1.27],0.8135803718689639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR5,Cadherin-related family member 5,23267,170,0.89 [0.63-1.25],0.5011314561711466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK1,Cyclin-dependent kinase 1,19464,125,0.90 [0.56-1.45],0.6677547592524453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,20124,129,1.11 [0.85-1.45],0.436956589126211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKL5,Cyclin-dependent kinase-like 5,19511,122,1.09 [0.79-1.51],0.5914233704177029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN1A,Cyclin-dependent kinase inhibitor 1,23153,167,1.05 [0.92-1.19],0.4709645524168764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,23153,167,1.01 [0.88-1.17],0.8617982419643281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDNF,Cerebral dopamine neurotrophic factor,23153,167,1.31 [0.91-1.89],0.1427614458977174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,23263,169,1.36 [0.80-2.30],0.254634311682421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDSN,Corneodesmosin,23469,169,1.23 [0.91-1.67],0.178040645395156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,23291,169,1.26 [0.70-2.28],0.447734248145594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20100,129,0.90 [0.73-1.10],0.2908449515213059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19814,126,0.85 [0.64-1.14],0.2810436859557957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,20100,129,1.01 [0.66-1.53],0.9772514037253878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19814,126,1.39 [1.03-1.88],0.0300126177624514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,23240,169,1.23 [1.06-1.43],0.0055916653428301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22716,165,1.05 [0.79-1.40],0.7259235428037418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22435,164,1.20 [0.97-1.49],0.0984247788475825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20171,128,1.24 [0.85-1.82],0.2620829546452614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22843,165,1.10 [0.84-1.44],0.4701620611119125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPA,CCAAT/enhancer-binding protein alpha,19566,122,1.01 [0.62-1.64],0.9831985424410236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPB,CCAAT/enhancer-binding protein beta,22843,165,0.98 [0.69-1.41],0.9325086270385076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA2A,Chymotrypsin-like elastase family member 2A,20171,128,0.70 [0.55-0.90],0.005196682249126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA3A,Chymotrypsin-like elastase family member 3A,23522,171,0.90 [0.72-1.13],0.3653233454210981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19710,123,0.92 [0.51-1.68],0.7973103080636439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEMIP2,Cell surface hyaluronidase,19566,122,1.31 [0.83-2.06],0.2533422886669607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEND1,Cell cycle exit and neuronal differentiation protein 1,19511,122,1.02 [0.77-1.35],0.902340495398655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPF,Centromere protein F,19814,126,0.79 [0.57-1.10],0.1664480283842686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPJ,Centromere protein J,19814,126,1.02 [0.80-1.31],0.8562007850016895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP112,Centrosomal protein of 112 kDa,19476,122,0.99 [0.67-1.46],0.9632983700287814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP152,Centrosomal protein of 152 kDa,19464,125,0.82 [0.53-1.27],0.36509597252388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP164,Centrosomal protein of 164 kDa,22853,166,1.06 [0.87-1.29],0.5750359635524833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP170,Centrosomal protein of 170 kDa,19613,127,0.91 [0.72-1.15],0.429972560853083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP20,Centrosomal protein 20,22716,165,1.12 [0.94-1.34],0.2108798655872658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP290,Centrosomal protein of 290 kDa,19814,126,1.00 [0.72-1.38],0.9930639084654308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP350,Centrosome-associated protein 350,19464,125,0.95 [0.60-1.53],0.8473384013882701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP43,Centrosomal protein 43,22665,164,1.01 [0.83-1.24],0.90938959099178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP85,Centrosomal protein of 85 kDa,22716,165,1.13 [0.92-1.39],0.2447180192401329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CERT,Ceramide transfer protein,22749,164,1.01 [0.81-1.27],0.9233811640735196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES1,Liver carboxylesterase 1,23332,171,1.00 [0.86-1.17],0.949662039385986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES2,Cocaine esterase,23153,167,1.10 [0.87-1.39],0.4263178840783757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES3,Carboxylesterase 3,23153,167,0.96 [0.79-1.17],0.6756525812616425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN2,Centrin-2,22749,164,1.14 [0.93-1.38],0.2073512623336796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN3,Centrin-3,20100,129,1.02 [0.82-1.26],0.8629257984539508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFB,Complement factor B,19833,127,1.58 [0.94-2.68],0.0872045760749696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFC1,Cryptic protein,22716,165,1.14 [0.86-1.52],0.3660631697063846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFD,Complement factor D,20185,128,1.00 [0.44-2.27],0.9992255987554464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFH,Complement factor H,19032,122,1.62 [0.76-3.46],0.2088800796921954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR2,Complement factor H-related protein 2,20047,128,1.38 [0.99-1.93],0.0548706014640554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR4,Complement factor H-related protein 4,20143,128,1.41 [1.10-1.82],0.0074661889401052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR5,Complement factor H-related protein 5,19932,128,1.09 [0.73-1.65],0.6710438882253009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFI,Complement factor I,20185,128,1.23 [0.52-2.92],0.6365237173341123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFP,Properdin,20185,128,0.73 [0.32-1.64],0.4422562905921914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGA,Glycoprotein hormones alpha chain,23278,167,1.29 [1.05-1.58],0.0159934790670325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,20188,130,1.02 [0.64-1.61],0.9395560352601386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGN,Cingulin,19624,123,1.10 [0.72-1.69],0.6492102957751736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,23267,170,1.47 [1.08-1.98],0.0132619746401677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22716,165,1.01 [0.80-1.28],0.9387669776900068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAD,Chondroadherin,19710,123,0.83 [0.58-1.20],0.3273223830918689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",20115,129,1.32 [0.91-1.91],0.1397769007458579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD6,MICOS complex subunit MIC25,20093,131,1.49 [0.91-2.44],0.1091984472740176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHEK2,Serine/threonine-protein kinase Chk2,22843,165,0.82 [0.53-1.27],0.3716644819632639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGA,Chromogranin-A,20171,128,1.10 [0.92-1.31],0.3098227202478904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGB,Secretogranin-1,23408,168,1.20 [0.87-1.65],0.2657067905673294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,22779,169,1.20 [1.04-1.39],0.0140061150640465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHIT1,Chitotriosidase-1,23374,170,1.10 [0.99-1.22],0.0786481251494716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHL1,Neural cell adhesion molecule L1-like protein,23339,171,1.20 [0.77-1.86],0.4147024768409695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHM,Rab proteins geranylgeranyltransferase component A 1,19624,123,0.86 [0.64-1.15],0.3021233558280843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP1A,Charged multivesicular body protein 1a,23062,169,1.08 [0.90-1.28],0.4099834565699837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP6,Charged multivesicular body protein 6,20163,130,0.93 [0.70-1.25],0.6407687739240857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHP1,Calcineurin B homologous protein 1,19511,122,1.04 [0.82-1.31],0.7624837344475965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,23310,169,2.71 [1.83-4.01],5.867307572295314e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL2,Chordin-like protein 2,23267,170,0.85 [0.63-1.13],0.2638414083775328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRM1,Muscarinic acetylcholine receptor M1,19624,123,1.22 [0.82-1.83],0.3245434550663357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIAPIN1,Anamorsin,23327,169,1.04 [0.84-1.30],0.7027277337292196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CILP,Cartilage intermediate layer protein 1,20171,128,1.23 [0.90-1.69],0.1997461876406129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CINP,Cyclin-dependent kinase 2-interacting protein,19814,126,0.85 [0.56-1.30],0.4529951506462032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIRBP,Cold-inducible RNA-binding protein,20100,129,1.02 [0.86-1.22],0.7896627404977368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIT,Citron Rho-interacting kinase,19624,123,1.02 [0.71-1.49],0.8983235105530423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,23424,168,1.96 [1.34-2.85],0.0004949849221521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKB,Creatine kinase B-type,20171,128,1.29 [0.97-1.73],0.0800519700272497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",23154,169,1.15 [0.93-1.42],0.2039251670069372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLASP1,CLIP-associating protein 1,19464,125,0.92 [0.72-1.18],0.5101481608647838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLC,Galectin-10,23230,169,0.97 [0.80-1.19],0.7838299459584688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC10A,C-type lectin domain family 10 member A,23062,169,1.23 [0.85-1.80],0.2731825402504185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC11A,C-type lectin domain family 11 member A,23245,167,1.42 [1.07-1.89],0.0149264615211568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC12A,C-type lectin domain family 12 member A,19566,122,1.23 [0.53-2.88],0.6315924746431922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,23278,167,1.79 [1.20-2.66],0.0041310160609027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1A,C-type lectin domain family 1 member A,22843,165,1.44 [0.97-2.12],0.0701544438860896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1B,C-type lectin domain family 1 member B,23472,168,1.06 [0.92-1.22],0.4284388463159938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC2L,C-type lectin domain family 2 member L,19624,123,1.24 [0.93-1.65],0.1456359480728986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC3B,Tetranectin,19727,126,0.52 [0.23-1.21],0.1309838961455668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4A,C-type lectin domain family 4 member A,23240,169,0.70 [0.48-1.00],0.0509067915084016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4C,C-type lectin domain family 4 member C,23240,169,1.10 [0.84-1.45],0.4879582952130301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4D,C-type lectin domain family 4 member D,23240,169,1.24 [1.00-1.53],0.0463936109349215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4G,C-type lectin domain family 4 member G,23240,169,1.69 [1.13-2.52],0.0106527004938169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4M,C-type lectin domain family 4 member M,20141,128,1.00 [0.71-1.41],0.9894479533145312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC5A,C-type lectin domain family 5 member A,23192,170,1.68 [1.11-2.55],0.0144559223863999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,22716,165,1.59 [1.22-2.08],0.0006590937589923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,23536,169,1.87 [1.40-2.49],1.923315407277199e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLGN,Calmegin,19624,123,1.18 [0.83-1.68],0.3495377015795115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIC5,Chloride intracellular channel protein 5,19624,123,1.32 [0.82-2.11],0.2479977640442986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLINT1,Clathrin interactor 1,19464,125,0.81 [0.53-1.22],0.3096701121297079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIP2,CAP-Gly domain-containing linker protein 2,23240,169,1.03 [0.91-1.16],0.6583270124242528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLMP,CXADR-like membrane protein,23465,170,1.91 [1.08-3.39],0.0267880589624008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLNS1A,Methylosome subunit pICln,19624,123,0.81 [0.48-1.37],0.4332217500934342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",23029,169,1.14 [0.99-1.31],0.0673038310439415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPS,Colipase,23235,167,1.02 [0.85-1.23],0.8156656390590429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSPN,Claspin,22716,164,0.99 [0.67-1.46],0.9518205057482736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN1,Calsyntenin-1,22749,164,0.92 [0.70-1.23],0.5867243074890387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN2,Calsyntenin-2,23536,169,1.12 [0.80-1.55],0.5130072443358973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN3,Calsyntenin-3,20115,129,1.80 [1.08-2.98],0.0239981663194862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLTA,Clathrin light chain A,22843,165,1.34 [1.03-1.75],0.0319958011667815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLU,Clusterin,20185,128,0.60 [0.25-1.43],0.247296002847528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLUL1,Clusterin-like protein 1,23224,170,0.96 [0.71-1.30],0.798137629746552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMC1,COX assembly mitochondrial protein homolog,20163,130,1.04 [0.87-1.25],0.6721755053239663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMIP,C-Maf-inducing protein,20093,131,0.99 [0.81-1.20],0.8959506292370963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,23375,171,0.69 [0.53-0.89],0.0047684189166565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNGB3,Cyclic nucleotide-gated cation channel beta-3,19511,122,0.85 [0.58-1.24],0.3933989176064705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19579,127,0.86 [0.69-1.07],0.170327339878114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY2,Protein canopy homolog 2,22843,165,1.09 [0.89-1.34],0.4108985613658044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY4,Protein canopy homolog 4,23153,167,1.09 [0.91-1.31],0.3448845414145387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNST,Consortin,23267,170,1.03 [0.91-1.17],0.6101953624380467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTF,Ciliary neurotrophic factor,19511,122,0.85 [0.51-1.42],0.546027209627004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN1,Contactin-1,23559,171,0.69 [0.42-1.12],0.1328945887489791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN2,Contactin-2,23465,170,1.17 [0.87-1.59],0.2993032821562021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN3,Contactin-3,23278,167,0.67 [0.42-1.07],0.0952721725962883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN4,Contactin-4,23278,167,1.05 [0.59-1.87],0.8723296386258381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN5,Contactin-5,23323,168,0.57 [0.39-0.84],0.0040224783428776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP2,Contactin-associated protein-like 2,23240,169,1.01 [0.73-1.38],0.9701110271646902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP4,Contactin-associated protein-like 4,19624,123,1.08 [0.93-1.25],0.3246280678770498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COCH,Cochlin,20163,130,1.26 [0.89-1.78],0.1905874683244785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL15A1,Collagen alpha-1(XV) chain,20171,128,1.10 [0.59-2.03],0.7680091802869664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,23370,171,3.42 [2.00-5.86],7.736710346642303e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL1A1,Collagen alpha-1(I) chain,23559,171,1.41 [0.81-2.46],0.2249428317406024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL24A1,Collagen alpha-1(XXIV) chain,20100,129,1.14 [0.84-1.53],0.4021039142290189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,19624,123,0.67 [0.53-0.85],0.0009219800460389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL2A1,Collagen alpha-1(II) chain,19613,127,1.10 [0.89-1.36],0.3793111507716703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL3A1,Collagen alpha-1(III) chain,20171,128,1.42 [0.70-2.87],0.3329064421858221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A1,Collagen alpha-1(IV) chain,23267,170,1.57 [1.13-2.18],0.0065008607662953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A4,Collagen alpha-4(IV) chain,19783,126,1.08 [0.78-1.51],0.641285426576252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL5A1,Collagen alpha-1(V) chain,19710,123,1.66 [1.15-2.40],0.0073814629333472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,23559,171,2.39 [1.76-3.24],1.9972452086261842e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A1,Collagen alpha-1(IX) chain,23240,169,1.03 [0.76-1.39],0.8424491690028685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A2,Collagen alpha-2(IX) chain,19814,126,1.31 [0.97-1.78],0.0773839092152671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,23227,169,2.86 [1.85-4.41],2.011684089822373e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD1,COMM domain-containing protein 1,19613,127,1.02 [0.77-1.36],0.8709921898336236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD9,COMM domain-containing protein 9,20093,131,1.08 [0.73-1.61],0.700752702479291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMP,Cartilage oligomeric matrix protein,23039,170,1.20 [0.80-1.80],0.3746184831985617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMT,Catechol O-methyltransferase,22587,163,1.07 [0.90-1.27],0.4412539099114327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPB2,Coatomer subunit beta',19476,122,0.63 [0.41-0.97],0.0346779921824064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPE,Coatomer subunit epsilon,22749,164,1.02 [0.77-1.36],0.8838294713444774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19613,127,1.24 [0.86-1.78],0.244702837117958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO1A,Coronin-1A,22827,161,1.01 [0.86-1.18],0.9472910347877366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO6,Coronin-6,19511,122,1.35 [0.92-1.96],0.1201573013913019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",23153,167,1.27 [1.05-1.52],0.0121561272696932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX6B1,Cytochrome c oxidase subunit 6B1,20163,130,0.95 [0.57-1.59],0.8518895788366045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA1,Carboxypeptidase A1,23559,171,0.89 [0.73-1.10],0.2881446745255629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA2,Carboxypeptidase A2,23404,168,1.01 [0.83-1.24],0.89275914467259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA4,Carboxypeptidase A4,19325,119,1.08 [0.71-1.63],0.7215399720476772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB1,Carboxypeptidase B,23559,171,0.98 [0.79-1.22],0.88290859533991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB2,Carboxypeptidase B2,20152,127,0.68 [0.32-1.44],0.3176274353388423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPE,Carboxypeptidase E,23274,167,0.73 [0.53-1.00],0.0495096081865574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPLX2,Complexin-2,19464,125,0.97 [0.55-1.68],0.9039074934492106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPM,Carboxypeptidase M,23356,168,1.47 [1.00-2.16],0.0477815174355975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19566,122,0.82 [0.42-1.61],0.5639468843934425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPPED1,Serine/threonine-protein phosphatase CPPED1,23472,168,0.89 [0.72-1.10],0.2685534620243468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPQ,Carboxypeptidase Q,20138,128,0.89 [0.57-1.39],0.5984575499369711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPTP,Ceramide-1-phosphate transfer protein,19476,122,1.09 [0.71-1.68],0.6921036800147349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPVL,Probable serine carboxypeptidase CPVL,23418,170,1.34 [0.96-1.89],0.0873385043487821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM1,Probable carboxypeptidase X1,23327,169,1.11 [0.91-1.34],0.300019885430381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM2,Inactive carboxypeptidase-like protein X2,20163,130,2.42 [1.37-4.28],0.0023608676266333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR1,Complement receptor type 1,20113,130,1.80 [1.13-2.85],0.0129473821600322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR2,Complement receptor type 2,23375,171,1.21 [0.91-1.61],0.1799219341817378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22716,165,0.98 [0.83-1.16],0.8231945119670808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRADD,Death domain-containing protein CRADD,23029,169,0.98 [0.82-1.18],0.8409889087981892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREB3,Cyclic AMP-responsive element-binding protein 3,19464,125,1.17 [0.88-1.54],0.2791119884564559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREBZF,CREB/ATF bZIP transcription factor,19464,125,0.90 [0.46-1.77],0.757835972698186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREG1,Protein CREG1,22958,168,0.95 [0.68-1.33],0.7682374923867707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD1,Protein disulfide isomerase CRELD1,19710,123,1.31 [0.82-2.08],0.2546097906229645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD2,Protein disulfide isomerase CRELD2,23310,169,1.20 [0.93-1.55],0.1590487350016304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRH,Corticoliberin,22679,165,1.04 [0.89-1.23],0.5946259847169559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,23227,169,2.15 [1.32-3.50],0.0021905286807141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHR1,Corticotropin-releasing factor receptor 1,22843,165,0.94 [0.74-1.19],0.5978948039447639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIM1,Cysteine-rich motor neuron 1 protein,23346,169,2.59 [1.37-4.92],0.00358921399201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,23062,169,1.70 [1.32-2.18],3.978220612053142e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP2,Cysteine-rich secretory protein 2,23465,170,1.05 [0.82-1.35],0.7109803130805512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP3,Cysteine-rich secretory protein 3,20001,129,1.01 [0.55-1.87],0.9664964124791844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRKL,Crk-like protein,23265,169,0.99 [0.87-1.13],0.9218146552308226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRLF1,Cytokine receptor-like factor 1,23346,169,1.32 [0.77-2.28],0.3143271460989405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRNN,Cornulin,22609,165,1.18 [0.96-1.44],0.1109752561006391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAC1,Cartilage acidic protein 1,23559,171,0.57 [0.37-0.86],0.0075194581482551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,23062,169,1.63 [1.26-2.11],0.0002196889561003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAP,Cartilage-associated protein,19624,123,0.95 [0.66-1.38],0.8003240250805446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRX,Cone-rod homeobox protein,22843,165,0.94 [0.81-1.08],0.3782439733248514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB1,Beta-crystallin B1,20163,130,1.20 [0.93-1.54],0.1530945621231166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,20115,129,1.49 [1.32-1.67],2.422530133087745e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYGD,Gamma-crystallin D,20115,129,0.88 [0.74-1.04],0.1403873788837569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYM,Ketimine reductase mu-crystallin,19511,122,0.99 [0.78-1.26],0.9445345914336074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYZL1,Quinone oxidoreductase-like protein 1,19613,127,0.91 [0.75-1.10],0.3272572433670512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSDE1,Cold shock domain-containing protein E1,19476,122,1.02 [0.88-1.18],0.777343032007954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,23346,169,2.54 [1.60-4.04],7.483262031524862e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,20188,130,2.05 [1.47-2.87],2.4444530472486923e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2,Granulocyte-macrophage colony-stimulating factor,19476,122,0.92 [0.56-1.49],0.7284066079490608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,23062,169,1.18 [0.96-1.47],0.1233542905190262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RB,Cytokine receptor common subunit beta,19566,122,1.19 [0.78-1.80],0.4241247689454656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3,Granulocyte colony-stimulating factor,22853,166,0.89 [0.66-1.18],0.4118832700063018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3R,Granulocyte colony-stimulating factor receptor,19566,122,1.00 [0.57-1.78],0.988004767262618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSH1,Chorionic somatomammotropin hormone 1,20188,130,1.08 [0.61-1.92],0.7932416313392308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK1D,Casein kinase I isoform delta,19566,122,0.96 [0.72-1.27],0.7607914260225416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK2A1,Casein kinase II subunit alpha,20124,129,1.03 [0.71-1.51],0.8613155061756921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG4,Chondroitin sulfate proteoglycan 4,20171,128,1.39 [0.84-2.31],0.2057623749999442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG5,Chondroitin sulfate proteoglycan 5,19511,122,0.94 [0.65-1.35],0.7264137029436535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSRP3,Cysteine and glycine-rich protein 3,19476,122,1.16 [0.99-1.36],0.0586929966750509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST1,Cystatin-SN,17528,109,0.95 [0.79-1.15],0.6190448186276039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,23331,171,2.55 [1.72-3.76],2.697958985692866e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST5,Cystatin-D,22778,166,0.98 [0.77-1.26],0.8853620840804124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST6,Cystatin-M,22667,166,1.22 [0.93-1.61],0.151395657806347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST7,Cystatin-F,23271,169,1.03 [0.90-1.18],0.6811931307138235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSTB,Cystatin-B,22962,165,1.45 [1.08-1.96],0.0135373123361874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTAG1A_CTAG1B,Cancer/testis antigen 1,19779,126,0.88 [0.61-1.26],0.4851397934629207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTBS,Di-N-acetylchitobiase,19901,130,1.08 [0.58-2.02],0.8077814382407971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTF1,Cardiotrophin-1,22843,165,1.01 [0.86-1.19],0.8955040784961862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTHRC1,Collagen triple helix repeat-containing protein 1,20171,128,2.10 [1.20-3.68],0.0090475466676313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTLA4,Cytotoxic T-lymphocyte protein 4,20171,128,0.84 [0.47-1.49],0.5463872255536868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTNNA1,Catenin alpha-1,19511,122,1.02 [0.61-1.70],0.945700830271142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRB1,Chymotrypsinogen B,23278,167,0.88 [0.70-1.11],0.283714435054375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRC,Chymotrypsin-C,23228,169,0.81 [0.66-0.99],0.0429277520802549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRL,Chymotrypsin-like protease CTRL-1,20115,129,0.81 [0.64-1.02],0.0758154729101143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSB,Cathepsin B,23293,171,1.03 [0.79-1.34],0.8221549474155019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSC,Dipeptidyl peptidase 1,23179,169,0.94 [0.69-1.28],0.6972331117410493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSD,Cathepsin D,21791,162,1.23 [0.90-1.68],0.2005842554172304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSE,Cathepsin E,19710,123,0.98 [0.71-1.35],0.8989131088984337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSF,Cathepsin F,23327,169,0.74 [0.53-1.04],0.0794281841789235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSH,Pro-cathepsin H,22756,165,1.10 [0.92-1.33],0.2999586015826962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSL,Cathepsin L1,23267,170,2.19 [1.30-3.67],0.0030194980549675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSO,Cathepsin O,23536,169,1.25 [0.82-1.91],0.3036651184036598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSS,Cathepsin S,18316,137,2.09 [1.06-4.10],0.032513183856513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSV,Cathepsin L2,23377,170,0.86 [0.61-1.20],0.3713502209737659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSZ,Cathepsin Z,23303,171,1.48 [0.98-2.23],0.0621131997109011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CUZD1,CUB and zona pellucida-like domain-containing protein 1,19624,123,0.71 [0.43-1.19],0.1973392931506723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CWC15,Spliceosome-associated protein CWC15 homolog,19987,128,1.16 [0.92-1.47],0.2199161129270197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CX3CL1,Fractalkine,23062,169,1.42 [0.96-2.11],0.0767464415567981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,23240,169,1.64 [1.28-2.09],7.046860136885474e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL1,Growth-regulated alpha protein,23198,169,0.96 [0.83-1.11],0.5783477133041267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL10,C-X-C motif chemokine 10,23346,169,1.29 [1.08-1.55],0.0062292491077771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL11,C-X-C motif chemokine 11,23472,168,1.12 [0.95-1.31],0.1830091418946921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL12,Stromal cell-derived factor 1,22853,166,1.23 [0.87-1.73],0.2453617209358868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL13,C-X-C motif chemokine 13,23472,168,1.22 [1.03-1.46],0.0238417427740871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL14,C-X-C motif chemokine 14,22853,166,1.13 [0.91-1.40],0.2552736616245979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL16,C-X-C motif chemokine 16,23524,171,2.46 [1.42-4.24],0.0012432009975453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL17,C-X-C motif chemokine 17,23536,169,1.21 [0.90-1.63],0.204629903854966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL3,C-X-C motif chemokine 3,23235,169,0.95 [0.83-1.10],0.5190816991745293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL5,C-X-C motif chemokine 5,23191,169,0.98 [0.87-1.11],0.7716857618857526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL6,C-X-C motif chemokine 6,23536,169,1.06 [0.89-1.27],0.5283496544679605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL8,Interleukin-8,23101,169,0.87 [0.70-1.07],0.1965645657661696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,23346,169,1.40 [1.18-1.67],0.0001741169530423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5A,Cytochrome b5,19464,125,0.80 [0.60-1.06],0.1206670040133808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5R2,NADH-cytochrome b5 reductase 2,19892,128,0.99 [0.73-1.33],0.938019644534012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19476,122,0.93 [0.74-1.16],0.518920746764342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTH3,Cytohesin-3,19464,125,1.04 [0.83-1.31],0.7291794751815794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTL1,Cytokine-like protein 1,20171,128,0.80 [0.41-1.56],0.5052768994290922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAAM1,Disheveled-associated activator of morphogenesis 1,19710,123,0.89 [0.72-1.10],0.2880185605629196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAB2,Disabled homolog 2,23465,170,1.07 [0.94-1.21],0.3010227757133494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAG1,Dystroglycan,23346,169,1.26 [0.95-1.68],0.1119023704543163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAND5,DAN domain family member 5,19566,122,0.96 [0.71-1.29],0.7690392288765112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPK2,Death-associated protein kinase 2,19566,122,0.97 [0.71-1.33],0.8529633147421976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,23240,169,0.99 [0.89-1.11],0.9291482946763884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DARS1,"Aspartate--tRNA ligase, cytoplasmic",23029,169,0.99 [0.82-1.20],0.9347408816609312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBH,Dopamine beta-hydroxylase,20152,130,0.97 [0.84-1.12],0.6843274503307304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBI,Acyl-CoA-binding protein,23166,166,1.11 [0.93-1.33],0.2372421746166813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBN1,Drebrin,19566,122,0.80 [0.55-1.15],0.2281704185416425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBNL,Drebrin-like protein,23346,169,1.01 [0.87-1.17],0.8886135172812721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23327,169,1.53 [1.05-2.22],0.0256955939027242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCC,Netrin receptor DCC,19624,123,0.97 [0.45-2.10],0.93896852604534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCDC2C,Doublecortin domain-containing protein 2C,19464,125,0.95 [0.71-1.27],0.7290570174714877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCLRE1C,Protein artemis,19464,125,0.88 [0.50-1.57],0.6713235780866742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCN,Decorin,22843,165,1.35 [0.75-2.42],0.3149586340638579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTD,Deoxycytidylate deaminase,19710,123,0.97 [0.81-1.16],0.7217858410773275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN1,Dynactin subunit 1,23465,170,0.99 [0.80-1.22],0.8921602376861968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN2,Dynactin subunit 2,23153,167,0.97 [0.84-1.13],0.7202457067426096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN6,Dynactin subunit 6,22749,164,1.13 [0.95-1.35],0.1721323528839677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTPP1,dCTP pyrophosphatase 1,23267,170,1.27 [0.83-1.95],0.2689349627375315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D1,DCN1-like protein 1,19511,122,0.93 [0.72-1.20],0.5840606049513694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D2,DCN1-like protein 2,19464,125,0.99 [0.79-1.24],0.9369338642136036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCXR,L-xylulose reductase,23327,169,0.90 [0.70-1.16],0.4219349629705944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDA1,DET1- and DDB1-associated protein 1,19476,122,1.00 [0.64-1.58],0.9897779145386196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",23153,167,1.29 [0.96-1.73],0.0882522166278415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDC,Aromatic-L-amino-acid decarboxylase,23237,170,1.08 [0.81-1.43],0.6156701445621587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDHD2,Phospholipase DDHD2,20124,129,0.85 [0.66-1.11],0.2333720846918607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDI2,Protein DDI1 homolog 2,19710,123,0.71 [0.56-0.89],0.0034228349047311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDR1,Epithelial discoidin domain-containing receptor 1,23472,168,2.01 [1.17-3.46],0.011407567864239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDT,D-dopachrome decarboxylase,20171,128,0.74 [0.48-1.13],0.1579138954265245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX1,ATP-dependent RNA helicase DDX1,20100,129,1.16 [0.84-1.59],0.3672104148441446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX25,ATP-dependent RNA helicase DDX25,19624,123,0.79 [0.46-1.35],0.3852907791931725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX39A,ATP-dependent RNA helicase DDX39A,19566,122,0.96 [0.46-2.03],0.9230670759551785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX4,Probable ATP-dependent RNA helicase DDX4,19566,122,1.06 [0.78-1.45],0.697722682504317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX53,Probable ATP-dependent RNA helicase DDX53,19624,123,0.93 [0.57-1.52],0.7642864875119575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX58,Antiviral innate immune response receptor RIG-I,22716,165,0.84 [0.65-1.10],0.2106270221823739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",23240,169,1.05 [0.91-1.21],0.5414111514233286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFA1_DEFA1B,Neutrophil defensin 1,22807,169,1.11 [0.87-1.41],0.3925227865255464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB103A_DEFB103B,Beta-defensin 103,19418,121,1.34 [0.97-1.86],0.0757500802472872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB104A_DEFB104B,Beta-defensin 104,19511,122,1.03 [0.75-1.41],0.8671992358158755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB116,Beta-defensin 116,19511,122,1.10 [0.88-1.36],0.4016115616268121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB118,Beta-defensin 118,19511,122,1.12 [0.86-1.46],0.4054830153419479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB4A_DEFB4B,Beta-defensin 4A,22919,167,1.02 [0.93-1.12],0.7205445963363561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENND2B,DENN domain-containing protein 2B,19476,122,1.15 [0.84-1.57],0.4002172116319753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENR,Density-regulated protein,19566,122,0.81 [0.58-1.13],0.2156675445623915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DFFA,DNA fragmentation factor subunit alpha,23536,169,0.98 [0.80-1.20],0.8487312793181571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGCR6,Protein DGCR6,19511,122,1.12 [0.76-1.66],0.5676748845573731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKA,Diacylglycerol kinase alpha,19566,122,0.89 [0.65-1.24],0.5059414376359033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKZ,Diacylglycerol kinase zeta,22853,166,1.12 [0.77-1.63],0.5623735461428103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHODH,Dihydroorotate dehydrogenase,19476,122,1.03 [0.71-1.51],0.8686012822569545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHPS,Deoxyhypusine synthase,20093,131,0.77 [0.48-1.21],0.2538405923074004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,20115,129,1.06 [0.74-1.50],0.7614093201879573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIABLO,"Diablo homolog, mitochondrial",23192,170,1.06 [0.94-1.20],0.3571023836323573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK1C,Divergent protein kinase domain 1C,19624,123,0.95 [0.61-1.46],0.7983820172620886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK2B,Divergent protein kinase domain 2B,19710,123,0.81 [0.44-1.48],0.4877295133400136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK1,Dickkopf-related protein 1,23472,168,1.04 [0.83-1.31],0.7127104026826441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK3,Dickkopf-related protein 3,23559,171,1.13 [0.72-1.79],0.5888298284623561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK4,Dickkopf-related protein 4,23021,169,1.22 [0.92-1.61],0.1737952984127253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKKL1,Dickkopf-like protein 1,23153,167,1.08 [0.91-1.28],0.3562956573165461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLG4,Disks large homolog 4,20115,129,0.95 [0.75-1.20],0.6600162935506477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLGAP5,Disks large-associated protein 5,20124,129,0.79 [0.51-1.22],0.2873204243038355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLK1,Protein delta homolog 1,23559,171,0.92 [0.73-1.16],0.4713500591836523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,23327,169,1.95 [1.29-2.95],0.0014562262650007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL4,Delta-like protein 4,19613,127,0.99 [0.82-1.20],0.9197663143470778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMD,Dystrophin,19613,127,1.11 [0.80-1.55],0.5230622421651863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMP1,Dentin matrix acidic phosphoprotein 1,19613,127,0.82 [0.62-1.08],0.1604190932892275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA1,DnaJ homolog subfamily A member 1,19464,125,0.57 [0.36-0.91],0.0196064351269773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA2,DnaJ homolog subfamily A member 2,23462,169,1.04 [0.88-1.23],0.6259220282038024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA4,DnaJ homolog subfamily A member 4,20115,129,0.75 [0.59-0.96],0.0202040408831771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB1,DnaJ homolog subfamily B member 1,23153,167,0.98 [0.83-1.15],0.7758718698136068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB14,DnaJ homolog subfamily B member 14,20100,129,0.90 [0.69-1.18],0.4589990864731939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB2,DnaJ homolog subfamily B member 2,19710,123,0.74 [0.53-1.04],0.081618508964869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB6,DnaJ homolog subfamily B member 6,19529,123,0.95 [0.77-1.17],0.6394677413331111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB8,DnaJ homolog subfamily B member 8,22843,165,1.09 [0.87-1.38],0.4530783587276731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC21,DnaJ homolog subfamily C member 21,20115,129,0.65 [0.41-1.05],0.0781001083636429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC6,Putative tyrosine-protein phosphatase auxilin,19613,127,0.95 [0.77-1.16],0.6143815710298609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC9,DnaJ homolog subfamily C member 9,20100,129,0.92 [0.74-1.15],0.4511985562181658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNER,Delta and Notch-like epidermal growth factor-related receptor,23191,169,0.62 [0.37-1.04],0.0681027472535132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNLZ,DNL-type zinc finger protein,19511,122,1.02 [0.83-1.25],0.8606431786534879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM1,Dynamin-1,20100,129,0.98 [0.85-1.14],0.8370712909340221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM3,Dynamin-3,20124,129,1.11 [0.84-1.48],0.4564965191095873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNMBP,Dynamin-binding protein,23062,169,1.01 [0.80-1.26],0.962618975910902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPEP,Aspartyl aminopeptidase,20115,129,1.01 [0.75-1.37],0.927696032228364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,23301,169,0.86 [0.66-1.13],0.2874413579308462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOC2B,Double C2-like domain-containing protein beta,19624,123,1.13 [0.74-1.72],0.5656451706961925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOCK9,Dedicator of cytokinesis protein 9,19511,122,1.15 [1.01-1.30],0.0323597689996089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK1,Docking protein 1,20115,129,0.95 [0.84-1.08],0.4300900056149966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK2,Docking protein 2,23267,170,1.05 [0.94-1.17],0.4280279184157941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP1,Dipeptidase 1,23029,169,0.94 [0.71-1.26],0.6920579190192608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP2,Dipeptidase 2,23153,167,1.31 [0.84-2.05],0.2356151345117059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP10,Inactive dipeptidyl peptidase 10,23240,169,1.11 [0.77-1.58],0.5791896397663692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP4,Dipeptidyl peptidase 4,22850,170,0.90 [0.55-1.47],0.67858751564875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP6,Dipeptidyl aminopeptidase-like protein 6,23153,167,0.89 [0.60-1.33],0.582697877107754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP7,Dipeptidyl peptidase 2,23088,169,1.02 [0.82-1.26],0.8734492211450637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPT,Dermatopontin,23559,171,2.15 [1.22-3.78],0.0077134365905799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPY30,Protein dpy-30 homolog,23402,170,1.29 [1.06-1.58],0.0123346342850801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRAXIN,Draxin,23062,169,1.31 [0.96-1.79],0.0854075547974646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRG2,Developmentally-regulated GTP-binding protein 2,23153,167,1.10 [0.87-1.40],0.4277210880177159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,22999,166,2.39 [1.68-3.40],1.2637850805826297e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSCAM,Down syndrome cell adhesion molecule,20124,129,1.28 [0.81-2.02],0.2949965191509907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG2,Desmoglein-2,23278,167,1.23 [0.75-2.02],0.4136391613819142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG3,Desmoglein-3,23385,169,1.51 [1.04-2.20],0.0293389655146028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG4,Desmoglein-4,23077,167,1.04 [0.79-1.38],0.7801817195482639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTD1,D-aminoacyl-tRNA deacylase 1,19710,123,1.06 [0.87-1.29],0.5884909918194865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTNB,Dystrobrevin beta,20053,131,1.40 [1.00-1.96],0.0519209260408009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX2,Probable E3 ubiquitin-protein ligase DTX2,19624,123,0.70 [0.48-1.00],0.0521464223206549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX3,Probable E3 ubiquitin-protein ligase DTX3,23153,167,1.88 [1.18-3.01],0.0082617221520858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTYMK,Thymidylate kinase,20163,130,0.88 [0.68-1.13],0.3091599582677435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUOX2,Dual oxidase 2,22843,165,1.09 [0.92-1.31],0.3198037458288573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP13,Dual specificity protein phosphatase 13 isoform A,20093,131,0.74 [0.49-1.11],0.1432202822871334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP29,Dual specificity phosphatase 29,19624,123,0.99 [0.76-1.29],0.9457120917813272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP3,Dual specificity protein phosphatase 3,22749,164,0.82 [0.68-0.99],0.0401004056796533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",20100,129,1.05 [0.90-1.24],0.5278769515166422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DXO,Decapping and exoribonuclease protein,20115,129,0.93 [0.64-1.36],0.72451467248534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,20093,131,0.94 [0.65-1.37],0.7559284527389237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT1,Dynein light chain Tctex-type 1,19624,123,1.00 [0.80-1.24],0.9707998426606742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT3,Dynein light chain Tctex-type 3,20093,131,0.95 [0.65-1.39],0.7950690860918085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,23062,169,1.11 [0.96-1.28],0.171586630599961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBI3_IL27,Interleukin-27,23439,170,1.66 [1.08-2.56],0.0220091213283644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECE1,Endothelin-converting enzyme 1,22749,164,1.22 [0.84-1.77],0.2857537172854758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20163,130,1.10 [0.89-1.36],0.3941845744577444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHS1,"Enoyl-CoA hydratase, mitochondrial",19613,127,1.07 [0.90-1.28],0.4528563499496668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECI2,Enoyl-CoA delta isomerase 2,19476,122,0.99 [0.74-1.32],0.949935422687857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECM1,Extracellular matrix protein 1,19660,125,0.89 [0.56-1.39],0.6000884168870273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECSCR,Endothelial cell-specific chemotaxis regulator,19511,122,0.82 [0.55-1.24],0.3488914472373908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,23465,170,1.99 [1.47-2.69],7.847386832331187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDAR,Tumor necrosis factor receptor superfamily member EDAR,23240,169,0.96 [0.83-1.12],0.5992873860385846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDDM3B,Epididymal secretory protein E3-beta,20093,131,1.00 [0.75-1.32],0.984463377534154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19476,122,1.20 [0.79-1.83],0.3889888693666093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDF1,Endothelial differentiation-related factor 1,20124,129,0.92 [0.71-1.20],0.5312320164665278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22843,165,1.11 [0.76-1.64],0.5852824815219619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDN1,Endothelin-1,19613,127,1.24 [0.70-2.20],0.4603436683259411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDNRB,Endothelin receptor type B,19566,122,1.12 [0.77-1.64],0.5428089998023813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EEF1D,Elongation factor 1-delta,20163,130,0.90 [0.75-1.09],0.2814684239433962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB14,EF-hand calcium-binding domain-containing protein 14,20100,129,1.43 [0.92-2.24],0.1130199313715747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB2,Dynein regulatory complex protein 8,19814,126,1.30 [0.81-2.07],0.2721303238996816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23340,171,2.05 [1.38-3.04],0.0003854742202418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFHD1,EF-hand domain-containing protein D1,20124,129,1.30 [0.85-1.99],0.233139266279186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,23236,167,2.80 [1.92-4.08],8.757257207257973e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,23021,168,2.81 [2.06-3.84],5.879179887151136e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNB2,Ephrin-B2,19624,123,1.34 [1.08-1.65],0.006878172916341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGF,Pro-epidermal growth factor,23193,168,0.98 [0.86-1.12],0.7559007784555971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFL7,Epidermal growth factor-like protein 7,22716,165,1.22 [0.86-1.72],0.259532648418028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFLAM,Pikachurin,20100,129,1.20 [0.71-2.05],0.4972518059342083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFR,Epidermal growth factor receptor,23559,171,0.37 [0.20-0.68],0.0014308212108606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGLN1,Egl nine homolog 1,23240,169,1.05 [0.84-1.32],0.6442216601878139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHBP1,EH domain-binding protein 1,20163,130,0.97 [0.77-1.21],0.787293406979333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHD3,EH domain-containing protein 3,19613,127,0.95 [0.83-1.10],0.5149047467131946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",20115,129,1.14 [0.87-1.50],0.3511679810451656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",20022,128,0.99 [0.85-1.16],0.9035110746056532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19476,122,0.76 [0.56-1.02],0.0652331252540111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19613,127,0.96 [0.63-1.45],0.8434686402764892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4B,Eukaryotic translation initiation factor 4B,23062,169,1.10 [0.86-1.41],0.4609587175634062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4E,Eukaryotic translation initiation factor 4E,19566,122,0.96 [0.78-1.16],0.6480519391387993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,23267,170,0.96 [0.78-1.19],0.7355523692551812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,23536,169,1.08 [0.94-1.24],0.2896030256558112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,20124,129,0.86 [0.66-1.12],0.2714211516717681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5,Eukaryotic translation initiation factor 5,19476,122,0.92 [0.61-1.40],0.7093252073028309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5A,Eukaryotic translation initiation factor 5A-1,22853,166,1.12 [0.72-1.72],0.6179580055461189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAC1,Zinc phosphodiesterase ELAC protein 1,20124,129,0.99 [0.81-1.21],0.94575698070558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAVL4,ELAV-like protein 4,19511,122,1.06 [0.87-1.30],0.5518601282458394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELN,Elastin,20163,130,1.88 [1.18-2.99],0.0079085663780832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOA,Elongin-A,23153,167,0.99 [0.78-1.27],0.9588114199952694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOB,Elongin-B,19476,122,0.90 [0.56-1.45],0.6577983992918062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENAH,Protein enabled homolog,22853,166,1.27 [0.97-1.67],0.0803299963343756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENDOU,Poly(U)-specific endoribonuclease,18611,121,0.87 [0.63-1.19],0.3900796466371372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENG,Endoglin,23559,171,0.50 [0.23-1.10],0.085566957400001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO1,Alpha-enolase,23257,167,1.06 [0.89-1.27],0.5065255756350029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO2,Gamma-enolase,23472,168,1.07 [0.87-1.32],0.5105731409522885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO3,Beta-enolase,19613,127,0.76 [0.56-1.02],0.0687559819216901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOPH1,Enolase-phosphatase E1,20093,131,0.83 [0.58-1.20],0.3184986068168092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19476,122,0.51 [0.26-1.01],0.0517362578210765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPEP,Glutamyl aminopeptidase,19476,122,1.10 [0.76-1.58],0.6231523766097921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23559,171,1.83 [1.09-3.08],0.0222040636773309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,23346,169,0.83 [0.63-1.09],0.1745079593310373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19613,127,0.61 [0.38-0.98],0.0404216064180194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22554,165,1.04 [0.88-1.23],0.6368002910369682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENSA,Alpha-endosulfine,20093,131,1.03 [0.75-1.40],0.8731682046323543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22716,165,1.39 [1.02-1.90],0.0365524333036622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22843,165,1.32 [0.70-2.48],0.3959220688635941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22843,165,1.46 [0.85-2.50],0.171944389893117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTR1,Endosome-associated-trafficking regulator 1,19613,127,0.88 [0.66-1.18],0.4034316830592349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EP300,Histone acetyltransferase p300,19566,122,1.03 [0.60-1.78],0.9049950264806428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPB41L5,Band 4.1-like protein 5,19624,123,0.89 [0.66-1.20],0.4570142000959117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPCAM,Epithelial cell adhesion molecule,23223,169,1.00 [0.87-1.16],0.9577476953377398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPGN,Epigen,20093,131,1.03 [0.72-1.47],0.8752317496988437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA1,Ephrin type-A receptor 1,23301,169,1.21 [0.79-1.84],0.3872457631365247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA10,Ephrin type-A receptor 10,22749,164,0.98 [0.79-1.22],0.8845911569977816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,22399,163,2.48 [1.74-3.53],4.624437497399186e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA4,Ephrin type-A receptor 4,19710,123,0.80 [0.45-1.45],0.4701335043730348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,23559,171,2.75 [1.75-4.33],1.2362099837777832e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB6,Ephrin type-B receptor 6,23029,169,1.77 [1.20-2.63],0.0042411082123023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHX2,Bifunctional epoxide hydrolase 2,22843,165,0.93 [0.73-1.18],0.561285766911123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPN1,Epsin-1,19814,126,1.12 [0.76-1.64],0.5749018600427399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPO,Erythropoietin,23240,169,1.08 [0.91-1.28],0.3862455680363029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPPK1,Epiplakin,19613,127,0.99 [0.78-1.25],0.9213713212416051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23428,170,1.48 [0.97-2.25],0.0658596391672516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB2,Receptor tyrosine-protein kinase erbB-2,23327,169,0.79 [0.46-1.37],0.4076367421499707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB3,Receptor tyrosine-protein kinase erbB-3,23143,169,1.12 [0.56-2.24],0.739840205626078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB4,Receptor tyrosine-protein kinase erbB-4,23327,169,0.90 [0.51-1.59],0.7204318201694312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBIN,Erbin,23153,167,1.07 [0.93-1.22],0.3383508652703477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERC2,ERC protein 2,19624,123,0.96 [0.75-1.23],0.7342623240067916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERCC1,DNA excision repair protein ERCC-1,19464,125,0.99 [0.58-1.68],0.961314693078372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EREG,Proepiregulin,23029,169,1.05 [0.89-1.24],0.59157432780047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERI1,3'-5' exoribonuclease 1,19814,126,0.92 [0.55-1.53],0.7450336722972244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERMAP,Erythroid membrane-associated protein,19566,122,1.13 [0.77-1.66],0.5433082239547872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,20093,131,0.74 [0.46-1.18],0.2065278166733687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP29,Endoplasmic reticulum resident protein 29,19710,123,1.00 [0.87-1.16],0.951756492308895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP44,Endoplasmic reticulum resident protein 44,23118,167,1.36 [0.81-2.30],0.2453794783994036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19476,122,0.67 [0.42-1.06],0.085475254730339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,23559,171,1.52 [1.02-2.25],0.0374405535781285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESM1,Endothelial cell-specific molecule 1,23227,169,1.27 [0.86-1.88],0.2252889211748489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESPL1,Separin,19464,125,1.14 [0.87-1.50],0.3265494965825359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESR1,Estrogen receptor,19566,122,0.89 [0.63-1.26],0.5081678172214881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESYT2,Extended synaptotagmin-2,20115,129,0.92 [0.75-1.13],0.4323594641400402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI2B,Protein EVI2B,19464,125,0.72 [0.42-1.22],0.2163048622477948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI5,Ecotropic viral integration site 5 protein homolog,19566,122,0.94 [0.77-1.14],0.5257772426466762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVPL,Envoplakin,19814,126,1.49 [0.98-2.28],0.0640214813890246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXOSC10,Exosome component 10,19476,122,1.02 [0.76-1.38],0.8712185774114423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXTL1,Exostosin-like 1,19476,122,0.76 [0.49-1.16],0.1978026141600448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EZR,Ezrin,23472,168,1.20 [0.70-2.05],0.5049612727706537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F10,Coagulation factor X,20188,130,0.87 [0.48-1.56],0.630319227018382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11,Coagulation factor XI,19895,126,1.48 [1.03-2.14],0.0359366597782888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11R,Junctional adhesion molecule A,23278,167,1.11 [0.88-1.42],0.3771275850850389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F12,Coagulation factor XII,20185,128,0.99 [0.66-1.50],0.978619196923651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F13B,Coagulation factor XIII B chain,20082,127,0.84 [0.43-1.62],0.6017763584216024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2,Prothrombin,20185,128,0.43 [0.14-1.32],0.1407772165012855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2R,Proteinase-activated receptor 1,23310,169,1.20 [0.95-1.52],0.1276569016066253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F3,Tissue factor,23317,169,1.21 [0.72-2.02],0.4722955824860652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F7,Coagulation factor VII,23334,171,0.96 [0.63-1.48],0.8622213070109839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F9,Coagulation factor IX,23341,171,0.79 [0.38-1.63],0.5225669500299823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",23227,169,1.31 [1.15-1.49],6.034560223832808e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP2,"Fatty acid-binding protein, intestinal",23267,170,1.25 [1.07-1.46],0.0055101178418651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",20163,130,1.49 [1.14-1.94],0.0033645707692415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",23559,171,1.64 [1.30-2.08],4.0267191717085e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP5,Fatty acid-binding protein 5,23393,168,1.21 [0.99-1.47],0.0633411341863259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP6,Gastrotropin,22810,164,1.39 [1.13-1.72],0.0018923649187035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP9,Fatty acid-binding protein 9,23240,169,1.14 [0.90-1.44],0.2712878436078303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FADD,FAS-associated death domain protein,23267,170,0.96 [0.80-1.15],0.6438364336767525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM13A,Protein FAM13A,20100,129,1.00 [0.78-1.28],0.993110611783948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171A2,Protein FAM171A2,20124,129,0.98 [0.88-1.10],0.738226121810782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171B,Protein FAM171B,20093,131,1.53 [0.97-2.41],0.0656564010932368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM172A,Cotranscriptional regulator FAM172A,19613,127,0.89 [0.67-1.18],0.4272430953162238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM20A,Pseudokinase FAM20A,20163,130,1.63 [0.93-2.84],0.0859202327860318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3B,Protein FAM3B,23153,167,1.85 [1.24-2.75],0.0024890887200855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,23237,170,2.33 [1.55-3.49],4.213703144287042e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3D,Protein FAM3D,20100,129,1.21 [0.99-1.46],0.0576192420127953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAP,Prolyl endopeptidase FAP,23559,171,0.82 [0.50-1.33],0.4131798721967865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FARSA,Phenylalanine--tRNA ligase alpha subunit,19624,123,0.94 [0.73-1.22],0.6551392922377917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAS,Tumor necrosis factor receptor superfamily member 6,23483,171,1.50 [1.14-1.98],0.0036286196344346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FASLG,Tumor necrosis factor ligand superfamily member 6,23536,169,1.28 [0.89-1.85],0.1845491073798162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBLN2,Fibulin-2,20171,128,1.21 [0.72-2.03],0.4693253767364691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBN2,Fibrillin-2,19624,123,1.27 [0.95-1.69],0.1107980784132389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBP1,"Fructose-1,6-bisphosphatase 1",23267,170,1.17 [0.98-1.40],0.0795941601970339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,20163,130,1.17 [0.93-1.47],0.1819713317191059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAR,Immunoglobulin alpha Fc receptor,23240,169,1.17 [0.89-1.55],0.2538431005778638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,20124,129,1.80 [0.96-3.38],0.0683674656390897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER2,Low affinity immunoglobulin epsilon Fc receptor,23278,167,1.22 [0.97-1.55],0.0920353504895277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,23183,170,1.05 [0.83-1.34],0.6624844271479615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22716,165,1.13 [0.90-1.42],0.3020193075392646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,23299,171,1.08 [0.82-1.43],0.5703604998836473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN1,Ficolin-1,20152,130,1.05 [0.77-1.42],0.7751963044560977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN2,Ficolin-2,23183,169,0.99 [0.71-1.37],0.9301990104657164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL1,Fc receptor-like protein 1,23267,170,1.25 [0.94-1.66],0.1220277997438578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL2,Fc receptor-like protein 2,23426,168,1.45 [1.15-1.82],0.0014839536879825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL3,Fc receptor-like protein 3,22853,166,1.22 [0.96-1.57],0.1049255854787173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL5,Fc receptor-like protein 5,23278,167,1.13 [0.90-1.41],0.3102295915667581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL6,Fc receptor-like protein 6,23240,169,1.20 [0.98-1.46],0.0719051624008369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRLB,Fc receptor-like B,22716,165,1.15 [0.94-1.40],0.1725184336977233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX1,"Adrenodoxin, mitochondrial",19476,122,1.17 [0.91-1.50],0.2157060608174884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX2,"Ferredoxin-2, mitochondrial",19476,122,1.04 [0.76-1.42],0.7997071184225294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FEN1,Flap endonuclease 1,22716,165,0.90 [0.71-1.13],0.3429075205296555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FES,Tyrosine-protein kinase Fes/Fps,22716,165,0.85 [0.63-1.16],0.3156553680506115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FETUB,Fetuin-B,23341,171,1.20 [0.77-1.85],0.4222095325260996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGA,Fibrinogen alpha chain,19723,126,0.81 [0.46-1.43],0.4698320168683978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",20124,129,0.95 [0.77-1.18],0.6591989287114792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF12,Fibroblast growth factor 12,19566,122,0.90 [0.59-1.38],0.6367627173286292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF16,Fibroblast growth factor 16,19566,122,0.95 [0.64-1.40],0.7770651697165452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF19,Fibroblast growth factor 19,23346,169,1.03 [0.87-1.23],0.7018262321596336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF2,Fibroblast growth factor 2,23240,169,1.10 [0.91-1.33],0.3230640514541019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF20,Fibroblast growth factor 20,19566,122,0.82 [0.52-1.30],0.3969950011494363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF21,Fibroblast growth factor 21,23439,170,1.13 [1.02-1.26],0.0209138254073176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,23424,170,1.41 [1.16-1.71],0.0006169046748021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF3,Fibroblast growth factor 3,19566,122,0.60 [0.30-1.21],0.1531210055569714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,22853,166,1.92 [1.35-2.72],0.0002811698835708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF6,Fibroblast growth factor 6,19566,122,0.97 [0.62-1.53],0.9023014290896656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF7,Fibroblast growth factor 7,19464,125,0.98 [0.78-1.23],0.8480934745532748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF9,Fibroblast growth factor 9,19430,125,0.57 [0.38-0.86],0.0075529241264454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP1,Fibroblast growth factor-binding protein 1,23327,169,0.58 [0.39-0.86],0.0067142796207216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP2,Fibroblast growth factor-binding protein 2,20171,128,0.93 [0.67-1.30],0.6817687000736234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP3,Fibroblast growth factor-binding protein 3,20115,129,0.85 [0.54-1.33],0.468972905851554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR2,Fibroblast growth factor receptor 2,23327,169,1.95 [1.11-3.42],0.0202180463030942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR4,Fibroblast growth factor receptor 4,19710,123,1.12 [0.81-1.55],0.5055934439049588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,20188,130,1.55 [1.22-1.97],0.0003902812987048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGR,Tyrosine-protein kinase Fgr,22749,164,1.01 [0.81-1.26],0.8976098603399547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FH,"Fumarate hydratase, mitochondrial",19511,122,1.03 [0.84-1.27],0.7549171194192716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIP2A,FHF complex subunit HOOK interacting protein 2A,19476,122,1.01 [0.71-1.45],0.9361818460200289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIT,Bis(5'-adenosyl)-triphosphatase,22749,164,0.93 [0.76-1.12],0.4330862112742841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FIS1,Mitochondrial fission 1 protein,23226,169,1.07 [0.90-1.28],0.4331398750809845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,20124,129,1.03 [0.87-1.22],0.7540491090860493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,23352,166,1.03 [0.91-1.16],0.6726210676120965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,23062,169,1.23 [0.89-1.70],0.2149558197433611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,23062,169,1.08 [0.93-1.25],0.3300378859728157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22716,164,1.03 [0.77-1.37],0.8585532675442014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBPL,FK506-binding protein-like,20100,129,1.00 [0.75-1.33],0.9924875231551162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLI1,Friend leukemia integration 1 transcription factor,22716,165,1.10 [0.98-1.24],0.1136749986882454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,23062,169,2.61 [1.71-4.01],1.0313286182663965e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT1,Vascular endothelial growth factor receptor 1,23114,166,1.56 [0.91-2.69],0.1060366616268582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3,Receptor-type tyrosine-protein kinase FLT3,22716,165,0.76 [0.47-1.22],0.257452999195362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3LG,Fms-related tyrosine kinase 3 ligand,23536,169,1.17 [0.80-1.72],0.4186861039133115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT4,Vascular endothelial growth factor receptor 3,23327,169,1.28 [0.85-1.92],0.2346821247540564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMNL1,Formin-like protein 1,22749,164,0.96 [0.77-1.19],0.6844033797698724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMR1,Synaptic functional regulator FMR1,22716,165,1.35 [0.92-1.96],0.1214643167602747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FN1,Fibronectin,20185,128,0.76 [0.41-1.42],0.3922071973080366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNDC1,Fibronectin type III domain-containing protein 1,20115,129,1.35 [0.95-1.93],0.0963082925067257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,20093,131,1.21 [0.77-1.90],0.4002286008147807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLH1,Glutamate carboxypeptidase 2,19566,122,0.98 [0.82-1.17],0.8408778050291826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR1,Folate receptor alpha,23228,167,1.71 [1.13-2.59],0.0117403400593549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,23472,168,2.25 [1.44-3.49],0.000334123743199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR3,Folate receptor gamma,23252,169,1.00 [0.94-1.07],0.9399399418328372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOS,Proto-oncogene c-Fos,19430,125,1.13 [0.70-1.81],0.6191910249070018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOSB,Protein fosB,22749,164,1.02 [0.72-1.44],0.9258170870352522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXJ3,Forkhead box protein J3,19566,122,0.80 [0.53-1.22],0.3090328044974433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO1,Forkhead box protein O1,23240,169,0.98 [0.84-1.15],0.7987999608261518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO3,Forkhead box protein O3,22716,165,1.00 [0.86-1.16],0.9924314761348731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD4B,FERM domain-containing protein 4B,19476,122,0.77 [0.58-1.01],0.0561485882413887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD7,FERM domain-containing protein 7,19624,123,0.93 [0.56-1.56],0.7903786143989415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRZB,Secreted frizzled-related protein 3,22991,168,0.98 [0.57-1.69],0.9470561208415856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSHB,Follitropin subunit beta,19613,127,1.23 [0.85-1.78],0.2674886852263388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FST,Follistatin,23310,169,0.96 [0.72-1.27],0.7548367544135777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL1,Follistatin-related protein 1,19613,127,1.60 [0.77-3.31],0.2079762972956048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,23195,168,2.43 [1.71-3.45],8.030196214941276e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FTCD,Formimidoyltransferase-cyclodeaminase,20075,129,0.99 [0.81-1.20],0.893250850759218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUCA1,Tissue alpha-L-fucosidase,23399,170,0.92 [0.79-1.08],0.3253318050507371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUOM,Fucose mutarotase,19710,123,1.19 [0.91-1.55],0.205892080791675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FURIN,Furin,23327,169,0.82 [0.54-1.23],0.337176048575263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUS,RNA-binding protein FUS,22675,165,1.21 [0.87-1.68],0.2627054998974915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19782,125,0.93 [0.69-1.25],0.6364573262800237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23472,168,1.23 [0.92-1.64],0.1624334346796023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT8,"Alpha-(1,6)-fucosyltransferase",23062,169,0.98 [0.78-1.24],0.887995985118027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXN,"Frataxin, mitochondrial",23465,170,1.15 [0.96-1.39],0.1266684085116068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXYD5,FXYD domain-containing ion transport regulator 5,22853,166,1.04 [0.85-1.29],0.6868826665700478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FYB1,FYN-binding protein 1,23235,167,1.04 [0.90-1.20],0.6079993773599244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD10,Frizzled-10,19624,123,1.30 [1.06-1.58],0.0106134823642213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD8,Frizzled-8,19511,122,1.10 [0.75-1.61],0.637789420678544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAP,Gamma-aminobutyric acid receptor-associated protein,20093,131,1.05 [0.74-1.48],0.8020679802663537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19814,126,1.10 [0.87-1.40],0.4258704066822305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19511,122,1.12 [0.88-1.43],0.3732103344306011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD1,Glutamate decarboxylase 1,19464,125,1.15 [0.60-2.21],0.6799292755709534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD2,Glutamate decarboxylase 2,19566,122,0.98 [0.67-1.43],0.9037408344631508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19814,126,1.03 [0.72-1.47],0.8915720627706049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19613,127,1.04 [0.75-1.42],0.8318772238335568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAGE2A,G antigen 2A,19464,125,0.90 [0.67-1.22],0.5038229795964058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAL,Galanin peptides,23346,169,0.91 [0.74-1.11],0.3542174304376206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,23153,167,1.67 [1.03-2.70],0.0369830654505232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23465,170,0.58 [0.35-0.95],0.0318620945934388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22853,166,0.98 [0.71-1.35],0.8978129888855382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,20163,130,1.61 [0.93-2.79],0.0859440697366585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT7,N-acetylgalactosaminyltransferase 7,23153,167,1.44 [0.74-2.79],0.2826195986731461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAMT,Guanidinoacetate N-methyltransferase,19476,122,0.60 [0.32-1.12],0.1080692650559281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,19277,121,0.87 [0.49-1.53],0.6254758052364484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GART,Trifunctional purine biosynthetic protein adenosine-3,20124,129,0.99 [0.51-1.91],0.9813663502878364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS2,Growth arrest-specific protein 2,19814,126,1.21 [0.91-1.60],0.1962992539466765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS6,Growth arrest-specific protein 6,23416,171,2.25 [1.32-3.84],0.0029351504949047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GASK1A,Golgi-associated kinase 1A,19476,122,0.86 [0.57-1.30],0.4762328472153333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAST,Gastrin,20115,129,1.16 [1.04-1.30],0.0068241491938419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19464,125,0.57 [0.30-1.10],0.0951705286734408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19613,127,1.01 [0.81-1.26],0.9297355310207278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBA,Lysosomal acid glucosylceramidase,19624,123,0.86 [0.62-1.19],0.3542596693999403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP1,Guanylate-binding protein 1,20076,129,1.15 [0.88-1.49],0.305964554068998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP2,Guanylate-binding protein 2,22853,166,1.04 [0.83-1.31],0.718629723759234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,22749,164,1.63 [1.30-2.03],1.842942873438216e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP6,Guanylate-binding protein 6,19476,122,1.15 [0.81-1.63],0.4321678080219223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GC,Vitamin D-binding protein,20185,128,1.03 [0.54-1.99],0.919546301077662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCC1,GRIP and coiled-coil domain-containing protein 1,20115,129,0.95 [0.81-1.11],0.5135535898205739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCG,Pro-glucagon,22716,165,1.10 [0.99-1.23],0.0769514249385763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19209,119,0.99 [0.69-1.42],0.9547322216927364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCLM,Glutamate--cysteine ligase regulatory subunit,19476,122,0.74 [0.47-1.15],0.1834597652937935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",23153,167,2.00 [1.37-2.92],0.0003442326137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,23559,171,2.06 [1.66-2.55],3.738353260766097e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF2,Growth/differentiation factor 2,23267,170,0.93 [0.63-1.35],0.6904023222002118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDNF,Glial cell line-derived neurotrophic factor,22749,164,1.35 [0.95-1.91],0.0931040455235325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GET3,ATPase GET3,20163,130,0.96 [0.70-1.32],0.8035906630140536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFAP,Glial fibrillary acidic protein,22678,165,1.46 [1.11-1.92],0.0061636078243136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFER,FAD-linked sulfhydryl oxidase ALR,22716,165,1.19 [0.96-1.47],0.1124992322924062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22716,165,0.98 [0.87-1.10],0.7393524235584172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,23439,170,2.70 [1.78-4.08],2.7186686077163032e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA2,GDNF family receptor alpha-2,23153,167,1.61 [0.84-3.11],0.1520136308409854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA3,GDNF family receptor alpha-3,22990,169,1.75 [1.09-2.80],0.0201957378695739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRAL,GDNF family receptor alpha-like,19531,124,0.89 [0.67-1.19],0.4422949086637008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGA1,ADP-ribosylation factor-binding protein GGA1,22749,164,1.15 [0.96-1.38],0.1388310803044869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGACT,Gamma-glutamylaminecyclotransferase,20163,130,1.11 [0.88-1.41],0.3737645596655276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGCT,Gamma-glutamylcyclotransferase,20130,130,0.85 [0.59-1.21],0.3608603758420662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGH,Gamma-glutamyl hydrolase,22892,171,1.32 [0.89-1.94],0.16460672598898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,23236,167,1.41 [1.11-1.79],0.0050802605168838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT5,Glutathione hydrolase 5 proenzyme,23062,169,1.97 [1.15-3.35],0.0127997702797668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH1,Somatotropin,23237,170,1.00 [0.92-1.08],0.9211576670469525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH2,Growth hormone variant,22716,165,0.98 [0.90-1.07],0.6704080716861289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,19710,123,0.32 [0.17-0.58],0.0001984643188078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRHR,Growth hormone-releasing hormone receptor,22749,164,1.02 [0.79-1.31],0.8896499487414834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRL,Appetite-regulating hormone,23267,170,0.83 [0.71-0.98],0.0254010769740389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GID8,Glucose-induced degradation protein 8 homolog,20124,129,0.92 [0.54-1.56],0.7468582402255597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIGYF2,GRB10-interacting GYF protein 2,20124,129,0.86 [0.68-1.08],0.2003933676728154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP7,GTPase IMAP family member 7,19710,123,0.96 [0.55-1.66],0.8770267278020856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP8,GTPase IMAP family member 8,19464,125,1.01 [0.72-1.44],0.936689560895134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIP,Gastric inhibitory polypeptide,19613,127,0.96 [0.69-1.32],0.7869849397202628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC2,PDZ domain-containing protein GIPC2,20115,129,0.99 [0.57-1.70],0.9583736616686216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC3,PDZ domain-containing protein GIPC3,20100,129,1.00 [0.85-1.19],0.9785363852583724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPR,Gastric inhibitory polypeptide receptor,19566,122,1.03 [0.70-1.51],0.8925286297880921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIT1,ARF GTPase-activating protein GIT1,19566,122,0.89 [0.74-1.07],0.2229102344435719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GJA8,Gap junction alpha-8 protein,19464,125,0.84 [0.61-1.15],0.2747890734250515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GKN1,Gastrokine-1,22329,161,1.28 [0.78-2.12],0.3321897454312938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLA,Alpha-galactosidase A,19678,123,1.13 [0.72-1.78],0.5891667755823737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLB1,Beta-galactosidase,23062,169,1.05 [0.77-1.45],0.7554884619710506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLI2,Zinc finger protein GLI2,19566,122,0.76 [0.41-1.38],0.3587518696195012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLO1,Lactoylglutathione lyase,22843,165,0.97 [0.76-1.24],0.8064880432397926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLOD4,Glyoxalase domain-containing protein 4,23190,169,0.97 [0.66-1.45],0.9000699027644844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLP1R,Glucagon-like peptide 1 receptor,19511,122,0.79 [0.47-1.33],0.3738471273871516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX,Glutaredoxin-1,23119,168,0.74 [0.58-0.95],0.0187051168189531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19710,123,0.95 [0.78-1.16],0.640864420190861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22749,164,1.03 [0.76-1.40],0.8388815368899273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLYR1,Putative oxidoreductase GLYR1,20093,131,1.21 [0.94-1.55],0.1367166891776517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GM2A,Ganglioside GM2 activator,19681,125,1.42 [1.00-2.02],0.0487579060341923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMFG,Glia maturation factor gamma,20163,130,0.94 [0.75-1.19],0.6251907754188162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR,GMP reductase 1,23536,169,0.84 [0.64-1.10],0.1969101964585077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR2,GMP reductase 2,19710,123,0.90 [0.69-1.18],0.45275245113961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNAS,Neuroendocrine secretory protein 55,20124,129,0.89 [0.72-1.10],0.2832796641594008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22716,165,1.13 [0.92-1.38],0.2564586780775277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19624,123,0.94 [0.65-1.35],0.7204487051751374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNLY,Granulysin,23278,167,1.27 [1.00-1.62],0.0543848817992725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA1,Glucosamine-6-phosphate isomerase 1,19613,127,0.78 [0.44-1.39],0.3999451693412073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA2,Glucosamine-6-phosphate isomerase 2,19710,123,0.99 [0.62-1.58],0.9694299764133032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLGA3,Golgin subfamily A member 3,20124,129,0.88 [0.70-1.11],0.273935402560478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLM2,Protein GOLM2,23472,168,1.29 [0.72-2.31],0.3861465701462867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,23240,169,0.98 [0.86-1.12],0.8061490508667707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GORASP2,Golgi reassembly-stacking protein 2,20100,129,1.22 [0.87-1.72],0.2476363798182648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOT1,"Aspartate aminotransferase, cytoplasmic",20171,128,1.01 [0.68-1.49],0.9775140210039954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BA,Platelet glycoprotein Ib alpha chain,23188,170,1.08 [0.72-1.62],0.6996493351601576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BB,Platelet glycoprotein Ib beta chain,19476,122,1.01 [0.78-1.30],0.9594476305243068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22547,160,0.94 [0.79-1.12],0.4684674708264588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP5,Platelet glycoprotein V,19710,123,1.05 [0.65-1.69],0.8325138809466153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP6,Platelet glycoprotein VI,23235,167,1.02 [0.87-1.19],0.7967761205621103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPA33,Cell surface A33 antigen,23153,167,0.98 [0.88-1.08],0.6590273668056383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC1,Glypican-1,23465,170,1.15 [0.73-1.82],0.5347518595632303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC5,Glypican-5,23062,169,0.99 [0.78-1.26],0.937378067049335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPD1,Glycerol-3-phosphate dehydrogenase,20093,131,1.09 [0.81-1.48],0.5633254206702399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPHA2,Glycoprotein hormone alpha-2,20100,129,1.04 [0.71-1.52],0.8340439786334859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPI,Glucose-6-phosphate isomerase,20188,130,1.03 [0.73-1.47],0.8554015741518499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,20100,129,0.93 [0.75-1.17],0.535294876662745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPKOW,G-patch domain and KOW motifs-containing protein,22749,164,1.43 [1.03-1.99],0.0305889956795169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,22637,166,2.27 [1.42-3.62],0.0005716757226894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR101,Probable G-protein coupled receptor 101,19511,122,1.19 [0.93-1.53],0.1666995099179241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR158,Probable G-protein coupled receptor 158,20124,129,1.20 [0.76-1.88],0.4306807359937954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,20100,129,1.49 [1.16-1.91],0.0019781859177997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,22843,165,1.55 [1.26-1.91],3.4700779028227435e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPRC5C,G-protein coupled receptor family C group 5 member C,20093,131,1.44 [1.15-1.80],0.0012792266635336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRAP2,GRB2-related adapter protein 2,23267,170,1.00 [0.90-1.11],0.9617157811820648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,20163,130,0.92 [0.70-1.21],0.5694924963990328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIK2,"Glutamate receptor ionotropic, kainate 2",20124,129,0.98 [0.65-1.47],0.911258854028342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19511,122,0.83 [0.57-1.22],0.3440329960340806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRK5,G protein-coupled receptor kinase 5,22843,165,1.02 [0.78-1.34],0.8590662178537659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRN,Progranulin,23153,166,2.09 [1.25-3.49],0.0047395824769762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRP,Gastrin-releasing peptide,19613,127,0.89 [0.65-1.22],0.468326997864101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRPEL1,"GrpE protein homolog 1, mitochondrial",23153,167,1.38 [1.13-1.69],0.0017189081901945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRSF1,G-rich sequence factor 1,19356,125,1.04 [0.84-1.28],0.7255598891267465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSAP,Gamma-secretase-activating protein,22716,165,0.92 [0.77-1.11],0.3949259529809978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSN,Gelsolin,20105,130,0.62 [0.26-1.48],0.2851704114896359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSR,"Glutathione reductase, mitochondrial",20078,130,1.21 [0.57-2.53],0.6207873164756192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA1,Glutathione S-transferase A1,23230,169,0.99 [0.84-1.16],0.8824606507130378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA3,Glutathione S-transferase A3,22716,165,0.92 [0.77-1.11],0.386051738171164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTM4,Glutathione S-transferase Mu 4,19476,122,0.97 [0.76-1.24],0.8005198177530137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTP1,Glutathione S-transferase P,22602,162,1.03 [0.84-1.26],0.7758282408481614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTT2B,Glutathione S-transferase theta-2B,20115,129,0.96 [0.89-1.03],0.2258156364972173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19814,126,1.06 [0.84-1.34],0.6159496756938359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTPBP2,GTP-binding protein 2,19624,123,0.89 [0.71-1.10],0.2718979894250214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,23157,166,2.12 [1.50-2.99],1.8929595204347463e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCY2C,Heat-stable enterotoxin receptor,19814,126,1.09 [0.90-1.33],0.3759322710665848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUK1,Guanylate kinase,19476,122,0.75 [0.44-1.26],0.2704064546210689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUSB,Beta-glucuronidase,23367,170,1.00 [0.80-1.24],0.9736530554010068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GYS1,"Glycogen [starch] synthase, muscle",22843,165,1.04 [0.90-1.21],0.5690597682762507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMA,Granzyme A,23536,169,1.46 [1.00-2.13],0.0479256352260843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMB,Granzyme B,23240,169,0.98 [0.80-1.20],0.830001718850903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMH,Granzyme H,22843,165,1.12 [0.96-1.30],0.1591850726526293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),H2AP,Huntingtin-interacting protein M,19464,125,1.15 [0.86-1.53],0.3532198451179775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19476,122,1.03 [0.81-1.32],0.7957683445902424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23404,170,0.80 [0.66-0.98],0.0283408298941718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAO1,Hydroxyacid oxidase 1,23465,170,1.07 [0.96-1.20],0.1983287459030173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HARS1,"Histidine--tRNA ligase, cytoplasmic",23278,167,1.03 [0.86-1.23],0.7861784809050572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,23430,170,1.41 [1.17-1.71],0.0003093263280965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,23278,167,2.56 [1.86-3.51],6.032612928261888e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBEGF,Proheparin-binding EGF-like growth factor,23404,170,1.04 [0.87-1.25],0.6765895031129945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBQ1,Hemoglobin subunit theta-1,23465,170,0.71 [0.56-0.89],0.0035467083543085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBZ,Hemoglobin subunit zeta,20163,130,0.93 [0.79-1.09],0.3642637145929136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCG22,Protein PBMUCL2,19476,122,0.59 [0.36-0.97],0.0359787853675405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCLS1,Hematopoietic lineage cell-specific protein,23536,169,1.05 [0.82-1.34],0.7133190920398623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC8,Histone deacetylase 8,19566,122,0.77 [0.53-1.11],0.1636046936902359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC9,Histone deacetylase 9,19511,122,1.05 [0.82-1.34],0.7022217616474105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDDC2,5'-deoxynucleotidase HDDC2,20100,129,0.85 [0.58-1.25],0.4083924664106302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGF,Hepatoma-derived growth factor,23426,170,1.08 [0.93-1.25],0.3348544287612205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGFL2,Hepatoma-derived growth factor-related protein 2,20115,129,0.86 [0.66-1.14],0.2981051914279626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEBP1,Heme-binding protein 1,22843,165,1.02 [0.79-1.33],0.8751326421444818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEG1,Protein HEG homolog 1,19710,123,0.86 [0.46-1.62],0.6432833127350024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPACAM2,HEPACAM family member 2,20115,129,0.66 [0.45-0.97],0.0359579141183078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPH,Hephaestin,20163,130,1.69 [0.87-3.29],0.1230734594395624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEXIM1,Protein HEXIM1,23240,169,0.99 [0.83-1.17],0.8695411306360183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGF,Hepatocyte growth factor,23536,169,1.54 [1.07-2.23],0.020153059216438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGFAC,Hepatocyte growth factor activator,20007,129,0.88 [0.48-1.62],0.6822476993629738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22716,165,1.13 [0.95-1.35],0.1538528041697247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HHEX,Hematopoietically-expressed homeobox protein HHEX,20115,129,1.03 [0.83-1.29],0.7742387545501925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIF1A,Hypoxia-inducible factor 1-alpha,19566,122,1.18 [0.94-1.48],0.1613741555366175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1,Huntingtin-interacting protein 1,19476,122,0.91 [0.53-1.57],0.7285619708974467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1R,Huntingtin-interacting protein 1-related protein,20075,128,1.15 [0.83-1.58],0.3965987668333773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HJV,Hemojuvelin,20124,129,1.16 [0.80-1.70],0.4329884825846217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HK2,Hexokinase-2,22843,165,1.03 [0.62-1.72],0.9103546117322624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-A,"HLA class I histocompatibility antigen, A alpha chain",20124,129,1.22 [0.73-2.04],0.4387621808866118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23163,169,1.80 [1.27-2.53],0.0008620873213958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",23240,169,2.15 [1.45-3.20],0.0001368540711293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMBS,Porphobilinogen deaminase,23465,170,0.68 [0.49-0.94],0.0212157769866543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMCN2,Hemicentin-2,19674,123,0.91 [0.67-1.22],0.5180863846712993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19613,127,0.90 [0.63-1.29],0.5566665530341991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19476,122,0.80 [0.52-1.23],0.3174291465134378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMMR,Hyaluronan mediated motility receptor,19424,125,0.87 [0.59-1.29],0.4847873319055411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX1,Heme oxygenase 1,23013,169,1.25 [0.95-1.63],0.1048540148081342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX2,Heme oxygenase 2,22749,164,1.31 [1.02-1.69],0.0336407538349924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNF1A,Hepatocyte nuclear factor 1-alpha,19624,123,1.06 [0.85-1.32],0.6226583161060848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,22958,168,1.63 [1.24-2.13],0.0003970884588863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22764,164,1.07 [0.90-1.28],0.4301172740790787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,20124,129,1.04 [0.74-1.44],0.8316469171982184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPCAL1,Hippocalcin-like protein 1,23536,169,0.99 [0.83-1.19],0.9420004512837744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPGDS,Hematopoietic prostaglandin D synthase,22716,165,0.67 [0.46-0.98],0.0396296439180653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPSE,Heparanase,19920,128,0.94 [0.79-1.13],0.5155392223000633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRAS,GTPase Hras,19778,126,0.88 [0.71-1.09],0.2426325180837037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19613,127,0.84 [0.48-1.46],0.5362774001857422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRG,Histidine-rich glycoprotein,20082,127,0.83 [0.50-1.38],0.4695670118200492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS1BP3,HCLS1-binding protein 3,19613,127,1.02 [0.84-1.23],0.8365635407222546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,23153,167,1.11 [0.77-1.59],0.5781758861870367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23465,170,1.27 [0.88-1.83],0.1982075645406751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19566,122,1.29 [0.83-2.02],0.2555481460203183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSBP1,Heat shock factor-binding protein 1,19613,127,0.93 [0.77-1.12],0.4384660076229025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,23240,169,0.87 [0.63-1.22],0.4191889761121025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,20115,129,1.23 [0.94-1.61],0.1311832045778171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B3,Testosterone 17-beta-dehydrogenase 3,19476,122,0.69 [0.46-1.04],0.0764979677623831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19613,127,0.94 [0.66-1.34],0.7292471723163871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSP90B1,Endoplasmin,22640,164,1.03 [0.83-1.27],0.7854770530084694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA1A,Heat shock 70 kDa protein 1A,23301,169,1.07 [0.88-1.29],0.4970020057605266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA2,Heat shock-related 70 kDa protein 2,20093,131,1.27 [0.83-1.93],0.2683007124325011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB1,Heat shock protein beta-1,22907,167,1.02 [0.84-1.24],0.8348510869954335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,23465,170,1.70 [1.26-2.30],0.0005747019197115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23112,170,2.18 [1.45-3.29],0.0001986320259975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1A,5-hydroxytryptamine receptor 1A,19511,122,1.09 [0.88-1.35],0.4375644965013893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1B,5-hydroxytryptamine receptor 1B,19511,122,0.96 [0.63-1.45],0.8486949735203396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTRA2,"Serine protease HTRA2, mitochondrial",23327,169,1.13 [0.91-1.41],0.268893253578231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYAL1,Hyaluronidase-1,23167,170,2.15 [1.24-3.71],0.0060133323485467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYOU1,Hypoxia up-regulated protein 1,23559,171,1.91 [1.09-3.35],0.0246552111871429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICA1,Islet cell autoantigen 1,22853,166,1.01 [0.85-1.20],0.8956207234602411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM1,Intercellular adhesion molecule 1,23182,170,1.83 [1.18-2.83],0.0068228201371803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM2,Intercellular adhesion molecule 2,23559,171,1.37 [0.90-2.09],0.1376527672901931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,23559,171,2.17 [1.38-3.43],0.0008609514856038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM4,Intercellular adhesion molecule 4,23240,169,1.09 [0.84-1.42],0.5055089492375778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM5,Intercellular adhesion molecule 5,23267,170,0.97 [0.72-1.30],0.8274297212929058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICOSLG,ICOS ligand,23153,167,1.22 [0.60-2.50],0.5828917597322253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ID4,DNA-binding protein inhibitor ID-4,19814,126,1.06 [0.72-1.55],0.7721681265183697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,22749,164,1.54 [1.21-1.96],0.0004562404806663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDO1,"Indoleamine 2,3-dioxygenase 1",19613,127,1.09 [0.83-1.42],0.5447684861216666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDS,Iduronate 2-sulfatase,23536,169,0.74 [0.17-3.18],0.6848881922222356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDUA,Alpha-L-iduronidase,23465,170,1.27 [0.95-1.70],0.1109767465480293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19621,128,1.73 [1.18-2.53],0.0050967113523655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19814,126,1.14 [0.83-1.58],0.4212658966594996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19814,126,1.15 [0.75-1.75],0.5258618466365549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNAR1,Interferon alpha/beta receptor 1,20100,129,1.15 [0.60-2.20],0.6799855616616566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNG,Interferon gamma,22853,166,1.12 [0.99-1.27],0.063128115602439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,23346,169,2.35 [1.49-3.71],0.000237666416502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR2,Interferon gamma receptor 2,23062,169,1.19 [0.93-1.53],0.1695695536276782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL1,Interferon lambda-1,22749,164,1.43 [1.09-1.88],0.0091210934036725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL2,Interferon lambda-2,19511,122,0.90 [0.65-1.25],0.5415186346491097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNLR1,Interferon lambda receptor 1,23240,169,1.29 [0.92-1.82],0.1385121196110393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNW1,Interferon omega-1,19476,122,0.99 [0.60-1.62],0.9586509715791534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFT20,Intraflagellar transport protein 20 homolog,19624,123,1.13 [0.76-1.67],0.5395984716642477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGBP1,Immunoglobulin-binding protein 1,20124,129,0.93 [0.71-1.23],0.6279456532374462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19511,122,0.83 [0.55-1.26],0.3895408825485568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20171,128,0.57 [0.32-0.99],0.0474756002866867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF1R,Insulin-like growth factor 1 receptor,23153,167,2.15 [1.23-3.73],0.0067625349019502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19476,122,1.21 [0.85-1.71],0.2858245631439542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2R,Cation-independent mannose-6-phosphate receptor,23278,167,1.67 [0.95-2.94],0.0760557457612449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP1,Insulin-like growth factor-binding protein 1,23526,171,1.08 [0.97-1.20],0.183128990438162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,23524,171,1.48 [1.19-1.84],0.0005168871218302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP3,Insulin-like growth factor-binding protein 3,23375,171,0.62 [0.43-0.89],0.0094753543803409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,23002,166,1.69 [1.31-2.17],4.632105413442875e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP6,Insulin-like growth factor-binding protein 6,23187,170,1.67 [1.15-2.43],0.0067263325870286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,23559,171,1.65 [1.17-2.34],0.004342138148452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBPL1,Insulin-like growth factor-binding protein-like 1,23267,170,1.54 [1.07-2.23],0.0215339268820486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFL4,Insulin growth factor-like family member 4,19566,122,1.09 [0.89-1.35],0.4082409700690015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGHMBP2,DNA-binding protein SMUBP-2,19476,122,1.02 [0.75-1.40],0.8852722789849826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLC2,Immunoglobulin lambda constant 2,20158,128,1.68 [1.11-2.52],0.0131408686914801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLON5,IgLON family member 5,19464,125,1.03 [0.87-1.23],0.7170414175631838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF21,Immunoglobulin superfamily member 21,19613,127,0.85 [0.54-1.34],0.4761182655592427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF3,Immunoglobulin superfamily member 3,23153,167,1.32 [0.94-1.86],0.1058980078420428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF8,Immunoglobulin superfamily member 8,23267,170,1.80 [1.23-2.63],0.002465746032803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF9,Protein turtle homolog A,20163,130,1.07 [0.88-1.29],0.5065694315123973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKBKG,NF-kappa-B essential modulator,23240,169,0.95 [0.82-1.11],0.5181035441113402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKZF2,Zinc finger protein Helios,22716,165,0.99 [0.85-1.17],0.9504579758694736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10,Interleukin-10,22853,166,1.04 [0.87-1.23],0.6830493926446527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RA,Interleukin-10 receptor subunit alpha,22853,166,1.13 [0.92-1.39],0.2445229224658317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,23346,169,2.33 [1.68-3.21],3.0057406466293496e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL11,Interleukin-11,22853,166,0.89 [0.70-1.14],0.3674283991871654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12A_IL12B,Interleukin-12,23153,167,1.32 [1.12-1.56],0.0011115979631465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12B,Interleukin-12 subunit beta,23536,169,1.36 [1.07-1.74],0.0118995458107325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,22853,166,1.85 [1.30-2.62],0.0005927711412801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB2,Interleukin-12 receptor subunit beta-2,19566,122,1.27 [0.86-1.86],0.229597802757261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13,Interleukin-13,22853,166,0.78 [0.54-1.11],0.1668602317086739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA1,Interleukin-13 receptor subunit alpha-1,22973,167,1.06 [0.60-1.88],0.8392605268876053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA2,Interleukin-13 receptor subunit alpha-2,19511,122,0.76 [0.42-1.38],0.3705842360870747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15,Interleukin-15,23240,169,1.26 [0.84-1.89],0.269470963281824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,22853,166,2.04 [1.39-2.99],0.0002523819269409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL16,Pro-interleukin-16,23536,169,1.32 [1.00-1.74],0.0502510289315346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17A,Interleukin-17A,22807,163,1.15 [0.87-1.54],0.3278837185790042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,22853,166,1.42 [1.22-1.65],5.912140290248685e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17D,Interleukin-17D,22853,166,1.22 [0.87-1.71],0.240498017668006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17F,Interleukin-17F,22853,166,1.03 [0.86-1.24],0.7582689609679377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RA,Interleukin-17 receptor A,23278,167,1.10 [0.81-1.49],0.5588012847380753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RB,Interleukin-17 receptor B,22949,167,1.07 [0.83-1.38],0.5829196384481516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,23148,169,1.66 [1.26-2.18],0.0003586310424435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,23375,171,2.18 [1.49-3.19],6.44093577393186e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18R1,Interleukin-18 receptor 1,23536,169,1.70 [1.14-2.53],0.0088273859666033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18RAP,Interleukin-18 receptor accessory protein,22914,168,0.96 [0.89-1.05],0.4023110571348618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL19,Interleukin-19,22688,168,1.36 [1.16-1.59],0.0001162980667965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1A,Interleukin-1 alpha,22853,166,1.05 [0.85-1.30],0.6268427468160669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1B,Interleukin-1 beta,22745,166,0.99 [0.78-1.26],0.9360723172680494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R1,Interleukin-1 receptor type 1,23236,167,1.75 [1.00-3.04],0.0484694221650584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R2,Interleukin-1 receptor type 2,23186,169,1.28 [0.65-2.50],0.480331491412166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RAP,Interleukin-1 receptor accessory protein,23278,167,0.88 [0.65-1.20],0.4166674843934527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL1,Interleukin-1 receptor-like 1,23483,171,1.57 [1.17-2.10],0.0026311369316731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL2,Interleukin-1 receptor-like 2,22853,166,0.71 [0.49-1.01],0.0585226212163408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RN,Interleukin-1 receptor antagonist protein,23189,169,1.36 [1.10-1.68],0.0048656139985985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2,Interleukin-2,22853,166,0.97 [0.63-1.50],0.9063078303965834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20,Interleukin-20,22853,166,1.21 [0.96-1.53],0.1037442453688045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RA,Interleukin-20 receptor subunit alpha,22853,166,1.12 [0.85-1.48],0.4039940728647077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RB,Interleukin-20 receptor subunit beta,19566,122,1.01 [0.66-1.53],0.9760509222390036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL21R,Interleukin-21 receptor,19566,122,0.97 [0.70-1.35],0.8780661255231714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,20093,131,1.44 [1.18-1.77],0.0004406737966397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22RA1,Interleukin-22 receptor subunit alpha-1,22853,166,1.10 [0.83-1.47],0.5055961147675263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL24,Interleukin-24,22853,166,0.87 [0.64-1.18],0.3776481059102247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL25,Interleukin-25,19393,125,0.75 [0.46-1.24],0.2599333143259189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,23121,166,1.89 [1.46-2.46],1.5826071831957688e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RB,Interleukin-2 receptor subunit beta,22853,166,0.93 [0.63-1.36],0.7020821090875313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RG,Cytokine receptor common subunit gamma,20093,131,1.61 [1.16-2.24],0.0047222235685735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3,Interleukin-3,19464,125,1.20 [0.89-1.62],0.2360267344085115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31,Interleukin-31,19566,122,1.08 [0.80-1.46],0.610370834866141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31RA,Interleukin-31 receptor subunit alpha,19499,122,1.09 [0.69-1.73],0.7080588536145304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL32,Interleukin-32,23240,169,1.26 [0.94-1.69],0.1257448962961773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL33,Interleukin-33,22853,166,1.08 [0.76-1.53],0.6683751516419733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL34,Interleukin-34,22707,164,1.14 [0.77-1.69],0.5032928481687997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36A,Interleukin-36 alpha,19566,122,0.79 [0.55-1.14],0.2079400385667958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36G,Interleukin-36 gamma,19498,121,1.05 [0.82-1.34],0.6846531130471635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3RA,Interleukin-3 receptor subunit alpha,22853,166,1.44 [0.94-2.19],0.0906099461865437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4,Interleukin-4,22853,166,1.02 [0.88-1.19],0.7995049732748027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,23240,169,1.79 [1.29-2.49],0.0005240517394174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5,Interleukin-5,22853,166,1.04 [0.94-1.14],0.4381023137613583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5RA,Interleukin-5 receptor subunit alpha,23240,169,1.17 [0.93-1.47],0.1918679229204908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6,Interleukin-6,23153,167,1.20 [1.03-1.39],0.0177369823287097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6R,Interleukin-6 receptor subunit alpha,23153,170,1.14 [0.77-1.69],0.5055658190757941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6ST,Interleukin-6 receptor subunit beta,23267,170,2.39 [1.14-5.00],0.0205451533367276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7,Interleukin-7,23240,169,0.95 [0.77-1.17],0.6257964903517848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7R,Interleukin-7 receptor subunit alpha,23278,167,0.84 [0.65-1.09],0.1964272246751787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL9,Interleukin-9,19814,126,1.17 [0.90-1.52],0.229008623969495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22708,164,1.01 [0.80-1.29],0.905797867367373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMMT,MICOS complex subunit MIC60,20093,131,1.35 [0.97-1.87],0.0749177485833111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPA1,Inositol monophosphatase 1,23062,169,1.00 [0.80-1.26],0.9790478700065884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPACT,Protein IMPACT,20115,129,0.79 [0.58-1.08],0.1446189943278439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPG1,Interphotoreceptor matrix proteoglycan 1,19511,122,1.29 [0.79-2.12],0.3102444089880596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ING1,Inhibitor of growth protein 1,22716,164,1.04 [0.79-1.37],0.7781445972933461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBB,Inhibin beta B chain,19710,123,1.48 [1.09-2.01],0.0122919533476788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBC,Inhibin beta C chain,23278,167,1.27 [0.88-1.82],0.1976227083037833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP1,Inositol polyphosphate 1-phosphatase,23153,167,1.12 [0.87-1.44],0.3946645798525668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19613,127,0.76 [0.56-1.04],0.090527325394789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",20124,129,0.67 [0.42-1.08],0.0997231511505928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",23153,167,0.99 [0.86-1.14],0.8444898063305187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL3,Insulin-like 3,20115,129,0.80 [0.67-0.96],0.0163511375167323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL4,Early placenta insulin-like peptide,20093,131,1.11 [0.80-1.54],0.5411499071920838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL5,Insulin-like peptide INSL5,20100,129,1.27 [1.09-1.48],0.0026032720694192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSR,Insulin receptor,19566,122,1.59 [0.59-4.32],0.3599551892892545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IPCEF1,Interactor protein for cytohesin exchange factors 1,23021,168,1.06 [0.91-1.24],0.4552612050838691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IQGAP2,Ras GTPase-activating-like protein IQGAP2,23153,167,1.15 [0.90-1.47],0.2778674832125318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22843,165,0.97 [0.82-1.13],0.6812980588340298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK1,Interleukin-1 receptor-associated kinase 1,22853,166,1.05 [0.86-1.28],0.6506174308064028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK4,Interleukin-1 receptor-associated kinase 4,23240,169,0.99 [0.87-1.13],0.92691976982237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,22420,162,0.94 [0.65-1.36],0.7562990512162203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM1,Isthmin-1,23240,169,0.97 [0.68-1.36],0.8402920480608486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM2,Isthmin-2,20171,128,1.02 [0.69-1.50],0.9297735767933474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IST1,IST1 homolog,19946,129,1.00 [0.84-1.19],0.9687995109594884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA11,Integrin alpha-11,23240,169,0.62 [0.42-0.93],0.0197025723770606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA2,Integrin alpha-2,19710,123,0.89 [0.54-1.46],0.6342584318406809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,23278,167,1.96 [1.16-3.34],0.0125806734707928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA6,Integrin alpha-6,23240,169,1.20 [0.93-1.54],0.1529337533208283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAL,Integrin alpha-L,19566,122,1.46 [0.96-2.22],0.0770397458218206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAM,Integrin alpha-M,23278,167,0.97 [0.63-1.49],0.8804656725137854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAV,Integrin alpha-V,23465,170,0.48 [0.26-0.87],0.0161365140596381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAX,Integrin alpha-X,19814,126,0.86 [0.61-1.23],0.4098553561534691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1,Integrin beta-1,23263,171,1.02 [0.54-1.93],0.9516336920224876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP1,Integrin beta-1-binding protein 1,22716,165,0.79 [0.56-1.11],0.1780076837255064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP2,Integrin beta-1-binding protein 2,22843,165,1.06 [0.93-1.19],0.395563568708803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB2,Integrin beta-2,23156,170,1.39 [0.87-2.20],0.1690621048623919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB5,Integrin beta-5,23327,169,1.14 [0.81-1.61],0.4586708832639609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB6,Integrin beta-6,22853,166,0.89 [0.57-1.40],0.6153956760596403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB7,Integrin beta-7,23465,170,1.41 [1.07-1.86],0.0135520290588506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGBL1,Integrin beta-like protein 1,20171,128,1.31 [0.88-1.96],0.1891266352174841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,20185,128,0.45 [0.18-1.11],0.0823886534874215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23375,171,1.87 [1.31-2.67],0.0005427329754771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,20185,128,1.70 [0.96-3.03],0.0698670298868052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,20093,131,0.87 [0.59-1.30],0.4954263858351639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITM2A,Integral membrane protein 2A,23240,169,1.08 [0.87-1.34],0.4963158433786324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPA,Inosine triphosphate pyrophosphatase,19476,122,0.88 [0.67-1.14],0.3271061897100031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19613,127,1.07 [0.84-1.37],0.5631258851428504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19511,122,1.10 [0.76-1.59],0.6293016904256763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22749,164,1.27 [1.00-1.61],0.0496665574595499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IZUMO1,Izumo sperm-egg fusion protein 1,19464,125,1.28 [0.96-1.70],0.089861136606725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM2,Junctional adhesion molecule B,23472,168,1.72 [1.08-2.75],0.0215760401581367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM3,Junctional adhesion molecule C,19710,123,1.16 [0.83-1.61],0.3835578623268035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JCHAIN,Immunoglobulin J chain,22853,166,1.11 [0.89-1.39],0.3442584345386194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19464,125,0.92 [0.67-1.26],0.6140922995719733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JPT2,Jupiter microtubule associated homolog 2,20100,129,1.00 [0.82-1.21],0.971544737310035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JUN,Transcription factor AP-1,22853,166,1.33 [1.07-1.64],0.0088601631299003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,23153,167,1.15 [0.84-1.56],0.3839814430415679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZN,Kazrin,20100,129,0.95 [0.81-1.12],0.550331801505086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNC4,Potassium voltage-gated channel subfamily C member 4,19511,122,1.09 [0.81-1.47],0.5726268500870915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNH2,Potassium voltage-gated channel subfamily H member 2,19624,123,1.02 [0.81-1.28],0.867963022849267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNIP4,Kv channel-interacting protein 4,22749,164,0.97 [0.73-1.29],0.834158553196217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCTD5,BTB/POZ domain-containing protein KCTD5,19732,127,0.83 [0.56-1.23],0.3552103954644352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDM3A,Lysine-specific demethylase 3A,19566,122,0.99 [0.81-1.22],0.9377151643793192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDR,Vascular endothelial growth factor receptor 2,23327,169,0.82 [0.48-1.39],0.4561618326694999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KEL,Kell blood group glycoprotein,22749,164,0.92 [0.63-1.34],0.6574507048032998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHDC3L,KH domain-containing protein 3,19464,125,1.02 [0.80-1.31],0.8646945240907742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHK,Ketohexokinase,19613,127,1.01 [0.77-1.33],0.9410480195494952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA0319,Dyslexia-associated protein KIAA0319,20115,129,0.74 [0.42-1.32],0.3080026972461896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549,UPF0606 protein KIAA1549,19814,126,1.01 [0.78-1.29],0.9674293822523712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549L,UPF0606 protein KIAA1549L,19814,126,0.85 [0.45-1.60],0.6141430989724377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA2013,Uncharacterized protein KIAA2013,20093,131,1.06 [0.79-1.44],0.6844567511330903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF1C,Kinesin-like protein KIF1C,19476,122,1.38 [0.92-2.05],0.1160494415783056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF20B,Kinesin-like protein KIF20B,19511,122,0.90 [0.70-1.15],0.3955957618959261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF22,Kinesin-like protein KIF22,19476,122,0.97 [0.84-1.11],0.6232592236366135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIFBP,KIF-binding protein,23153,167,1.11 [0.94-1.31],0.2177069848539209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,20093,131,1.16 [0.97-1.40],0.1075328529819109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22716,165,1.27 [1.07-1.51],0.0057527580863735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,20100,129,1.03 [0.94-1.14],0.5272666297544217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22716,165,1.07 [0.96-1.19],0.2528300286684389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19464,125,0.89 [0.70-1.14],0.3569467074901298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL1,Kin of IRRE-like protein 1,19511,122,1.31 [1.05-1.64],0.016184049363511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL2,Kin of IRRE-like protein 2,22749,164,1.04 [0.74-1.47],0.8118464256283187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIT,Mast/stem cell growth factor receptor Kit,23341,171,0.83 [0.52-1.31],0.4143455832551732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KITLG,Kit ligand,23267,170,0.77 [0.54-1.08],0.1317160364570385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLB,Beta-klotho,22749,164,1.05 [0.87-1.26],0.6236670847276808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLF4,Krueppel-like factor 4,19511,122,1.17 [0.80-1.73],0.4194441368133764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLHL41,Kelch-like protein 41,20124,129,1.29 [0.98-1.70],0.0658330185534881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK1,Kallikrein-1,23051,167,1.06 [0.95-1.17],0.2862579752590155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK10,Kallikrein-10,23263,169,1.49 [1.11-1.98],0.0069234978695682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,23108,169,1.79 [1.35-2.36],4.125597484749375e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK12,Kallikrein-12,22716,165,0.99 [0.90-1.10],0.8772401743171518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK13,Kallikrein-13,22729,165,1.17 [0.87-1.58],0.2871049346980999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK14,Kallikrein-14,23465,170,1.26 [0.95-1.67],0.1154398929501014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK15,Kallikrein-15,20052,130,1.16 [0.84-1.61],0.3632065000077918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK3,Prostate-specific antigen,20171,128,0.90 [0.78-1.05],0.1824293426352347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,23465,170,1.54 [1.30-1.83],6.097964113655998e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK6,Kallikrein-6,23285,169,1.35 [0.88-2.09],0.173509628186422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK7,Kallikrein-7,19223,119,1.19 [0.77-1.84],0.4355116578178063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK8,Kallikrein-8,22477,164,1.62 [1.14-2.30],0.0071725133238003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLKB1,Plasma kallikrein,19773,125,1.19 [0.59-2.39],0.6277711112708748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,23536,169,2.04 [1.48-2.81],1.274288969626044e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19511,122,1.10 [0.85-1.43],0.4747092686168349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRD1,Natural killer cells antigen CD94,23536,169,1.58 [1.19-2.09],0.0015104784930671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRF1,Killer cell lectin-like receptor subfamily F member 1,19566,122,1.30 [0.97-1.74],0.08222084426241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRK1,NKG2-D type II integral membrane protein,20115,129,1.38 [0.98-1.93],0.0667495638219337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT14,"Keratin, type I cytoskeletal 14",22059,160,1.22 [0.80-1.85],0.3600953933049295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT17,"Keratin, type I cytoskeletal 17",19476,122,1.01 [0.66-1.56],0.959481605348574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT18,"Keratin, type I cytoskeletal 18",23153,167,1.11 [0.95-1.30],0.1883491381574671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",23197,169,1.24 [1.03-1.50],0.0233214579136603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT5,"Keratin, type II cytoskeletal 5",22749,164,1.33 [1.04-1.69],0.0223456785546256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT6C,"Keratin, type II cytoskeletal 6C",19476,122,0.79 [0.47-1.33],0.3683157797099271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT8,"Keratin, type II cytoskeletal 8",19511,122,1.12 [0.95-1.33],0.183607737271728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYAT1,Kynurenine--oxoglutarate transaminase 1,23232,170,0.93 [0.73-1.18],0.5396512237703919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYNU,Kynureninase,23536,169,1.11 [0.83-1.49],0.4872669249339192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L1CAM,Neural cell adhesion molecule L1,23327,169,1.11 [0.70-1.75],0.6597975470998281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,20163,130,0.95 [0.79-1.15],0.5945145340008713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACRT,Extracellular glycoprotein lacritin,20054,130,0.88 [0.58-1.31],0.5203448702621765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACTB2,Endoribonuclease LACTB2,23267,170,1.01 [0.82-1.24],0.9402217231119344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAG3,Lymphocyte activation gene 3 protein,23153,167,1.45 [1.08-1.95],0.0138247124060174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23227,169,1.95 [1.54-2.48],3.374034421575212e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,23062,169,1.08 [0.95-1.24],0.2368490581223141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA1,Laminin subunit alpha-1,19476,122,1.05 [0.76-1.46],0.7691646887783292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA4,Laminin subunit alpha-4,23346,169,1.61 [1.10-2.35],0.0134119711059922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMB1,Laminin subunit beta-1,19613,127,1.11 [0.64-1.93],0.7051020294358218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP1,Lysosome-associated membrane glycoprotein 1,19621,125,1.17 [0.68-1.99],0.5709711905738868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP2,Lysosome-associated membrane glycoprotein 2,22557,157,0.73 [0.37-1.41],0.3459293351589099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP3,Lysosome-associated membrane glycoprotein 3,23498,168,1.38 [1.07-1.77],0.0124804363293443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMTOR5,Ragulator complex protein LAMTOR5,20093,131,1.06 [0.71-1.59],0.7757648096211223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAP3,Cytosol aminopeptidase,22853,166,1.18 [0.90-1.54],0.237911433382822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LARP1,La-related protein 1,20093,131,0.84 [0.62-1.12],0.2370869006761698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT,Linker for activation of T-cells family member 1,23536,169,1.08 [0.91-1.30],0.3780073838219986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT2,Linker for activation of T-cells family member 2,23153,167,1.10 [0.98-1.22],0.0930400979187822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LATS1,Serine/threonine-protein kinase LATS1,19566,122,1.03 [0.84-1.26],0.7825396242386965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,23029,169,2.21 [1.61-3.03],7.856843256607303e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBP,Lipopolysaccharide-binding protein,23375,171,1.42 [1.14-1.79],0.002279948795823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBR,Delta(14)-sterol reductase LBR,23472,168,1.11 [0.93-1.33],0.2496923029914728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCAT,Phosphatidylcholine-sterol acyltransferase,20188,130,0.40 [0.19-0.85],0.0165060238298236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN15,Lipocalin-15,20124,129,1.15 [0.90-1.46],0.2647331151337665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN2,Neutrophil gelatinase-associated lipocalin,22575,170,1.29 [0.94-1.78],0.1154366724281029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCP1,Plastin-2,20171,128,1.04 [0.74-1.47],0.81520837300183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLR,Low-density lipoprotein receptor,23337,168,0.97 [0.74-1.26],0.79533218093999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLRAP1,Low density lipoprotein receptor adapter protein 1,20124,129,1.01 [0.85-1.20],0.903818182257282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LECT2,Leukocyte cell-derived chemotaxin-2,20163,130,1.31 [1.03-1.67],0.0266604918650494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEFTY2,Left-right determination factor 2,23439,170,1.09 [0.84-1.41],0.5348636926524114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEG1,Protein LEG1 homolog,19058,117,1.07 [0.83-1.37],0.6051645558146187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LELP1,Late cornified envelope-like proline-rich protein 1,19511,122,1.00 [0.78-1.28],0.9841866954710392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEO1,RNA polymerase-associated protein LEO1,20124,129,1.04 [0.61-1.79],0.8746186066130454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEP,Leptin,23267,170,1.22 [1.00-1.49],0.0497890427508382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEPR,Leptin receptor,23267,170,1.13 [0.75-1.72],0.5618593705472235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LETM1,Mitochondrial proton/calcium exchanger protein,20124,129,1.22 [0.91-1.64],0.1738667427951716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS1,Galectin-1,23267,170,1.57 [1.10-2.24],0.0126021385186051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3,Galectin-3,23341,170,1.62 [1.04-2.52],0.0340276540873665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3BP,Galectin-3-binding protein,20185,128,1.22 [0.73-2.03],0.4489398085965282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,23227,169,1.61 [1.29-1.99],1.739695403835178e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS7_LGALS7B,Galectin-7,23200,170,1.40 [1.07-1.82],0.0140447935447151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS8,Galectin-8,23472,168,1.11 [0.89-1.38],0.3575505411775532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,23235,169,2.83 [1.93-4.14],9.493524507955972e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGMN,Legumain,23346,169,1.25 [0.87-1.81],0.2297314805013436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHB,Lutropin subunit beta,22716,165,1.02 [0.87-1.19],0.8160473124938907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,23264,169,0.86 [0.69-1.08],0.207917835776507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIF,Leukemia inhibitory factor,22749,164,1.07 [0.83-1.39],0.5947594409791895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIFR,Leukemia inhibitory factor receptor,23240,169,1.66 [0.97-2.86],0.0656570637574332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,23278,167,1.99 [1.33-2.97],0.0007791370871187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,20171,128,1.19 [1.00-1.42],0.0525198673066206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19476,122,0.99 [0.69-1.41],0.9408402972768236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,23237,170,2.04 [1.36-3.05],0.0005445115925879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,20163,130,1.20 [0.96-1.51],0.1064622396552089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23559,171,1.54 [0.95-2.50],0.0815070700887351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23448,171,1.80 [1.20-2.70],0.0046122340107537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22853,166,1.99 [1.50-2.64],1.72428635704682e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23559,171,1.12 [0.92-1.37],0.2593524448227456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIPF,Gastric triacylglycerol lipase,19613,127,0.76 [0.57-1.00],0.048606984383936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB1,Lamin-B1,20065,129,0.88 [0.66-1.16],0.3648380438073887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB2,Lamin-B2,20115,129,1.26 [0.70-2.25],0.4444007581807235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD1,Leiomodin-1,20124,129,1.39 [0.93-2.07],0.1122794687409865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD2,Leiomodin-2,19511,122,0.84 [0.61-1.15],0.2801237690570525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LONP1,"Lon protease homolog, mitochondrial",19613,127,0.97 [0.79-1.18],0.7345502203242564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPA,Apolipoprotein(a),19727,124,0.96 [0.87-1.06],0.4123025573909888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPCAT2,Lysophosphatidylcholine acyltransferase 2,23153,167,0.99 [0.72-1.35],0.9347078722600888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPL,Lipoprotein lipase,23267,170,0.93 [0.70-1.23],0.596992689117728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPO,Lactoperoxidase,22444,165,1.18 [0.95-1.48],0.1415693689600675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPP,Lipoma-preferred partner,19476,122,0.81 [0.62-1.06],0.1271575790077893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19476,122,0.99 [0.77-1.28],0.9326913552520872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19624,123,0.93 [0.62-1.40],0.7387482177607199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRG1,Leucine-rich alpha-2-glycoprotein,20185,128,1.46 [0.78-2.74],0.2342276994965734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23404,170,1.58 [1.09-2.29],0.0158136532853102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19507,122,0.89 [0.46-1.74],0.74217912491463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP1,Prolow-density lipoprotein receptor-related protein 1,23153,167,1.19 [0.72-1.96],0.49795707219688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,23267,170,1.65 [1.16-2.34],0.0049301350564666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2,Low-density lipoprotein receptor-related protein 2,19624,123,0.93 [0.57-1.52],0.7805404679439566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2BP,LRP2-binding protein,19624,123,1.09 [0.90-1.33],0.3696375843954046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23472,168,1.06 [0.84-1.34],0.6017311607748579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC25,Leucine-rich repeat-containing protein 25,23153,167,1.51 [1.11-2.04],0.0076730033287528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC37A2,Leucine-rich repeat-containing protein 37A2,20100,129,0.95 [0.65-1.40],0.7990175633876003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC38,Leucine-rich repeat-containing protein 38,19624,123,1.01 [0.70-1.46],0.9664499595146198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC59,Leucine-rich repeat-containing protein 59,20163,130,0.92 [0.64-1.31],0.6336073155029345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,20093,131,0.75 [0.52-1.09],0.1309665126683797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRN1,Leucine-rich repeat neuronal protein 1,22853,166,0.77 [0.55-1.07],0.1230311058669662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19624,123,0.82 [0.52-1.30],0.4050645091196774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,20124,129,0.72 [0.36-1.42],0.3417424866879917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM1,U6 snRNA-associated Sm-like protein LSm1,22716,165,1.12 [0.89-1.41],0.3421458412220975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM8,U6 snRNA-associated Sm-like protein LSm8,19814,126,1.05 [0.86-1.28],0.6566343602970108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSP1,Lymphocyte-specific protein 1,23240,169,1.21 [0.87-1.68],0.2506817052381886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA,Lymphotoxin-alpha,23240,169,1.17 [0.84-1.65],0.3556383114509721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA4H,Leukotriene A-4 hydrolase,23465,170,1.23 [0.99-1.52],0.0586198353053598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTB,Lymphotoxin-beta,20093,131,1.26 [0.84-1.88],0.2705299777280098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,23559,171,1.91 [1.28-2.86],0.0015017634795264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP3,Latent-transforming growth factor beta-binding protein 3,22716,165,1.20 [0.95-1.51],0.1251784330083314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,23107,169,2.31 [1.56-3.41],2.782543755139289e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTO1,Protein LTO1 homolog,22853,166,1.07 [0.77-1.47],0.6892624589950566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LUZP2,Leucine zipper protein 2,20093,131,1.33 [0.97-1.83],0.0815822587977942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LXN,Latexin,22949,169,0.87 [0.71-1.07],0.2016046494284443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,23115,168,1.70 [1.28-2.26],0.0002285300097576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY75,Lymphocyte antigen 75,23240,169,1.35 [0.94-1.93],0.1042872580813285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY9,T-lymphocyte surface antigen Ly-9,22973,164,1.97 [1.28-3.03],0.0020184855992022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,23062,169,1.85 [1.36-2.52],8.7888907828869e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYAR,Cell growth-regulating nucleolar protein,22716,165,1.06 [0.84-1.34],0.6023235203371184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYN,Tyrosine-protein kinase Lyn,23153,167,1.17 [0.99-1.37],0.0661178361512273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD1,Ly6/PLAUR domain-containing protein 1,22749,164,1.01 [0.81-1.26],0.9219414853633766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD3,Ly6/PLAUR domain-containing protein 3,23151,169,1.31 [0.88-1.95],0.1838190634380214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD8,Ly6/PLAUR domain-containing protein 8,22716,165,1.25 [0.98-1.58],0.0698169533740062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPLA2,Acyl-protein thioesterase 2,19511,122,1.06 [0.91-1.23],0.4482047731072358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19624,123,1.10 [0.95-1.28],0.2144528080208051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20185,128,1.02 [0.43-2.45],0.964462443913511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYZL2,Lysozyme-like protein 2,19464,125,1.57 [1.08-2.30],0.0186376374198369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LZTFL1,Leucine zipper transcription factor-like protein 1,19710,123,1.03 [0.81-1.31],0.8180963889068066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),M6PR,Cation-dependent mannose-6-phosphate receptor,19613,127,0.95 [0.60-1.51],0.8319486640785818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22989,169,1.30 [1.06-1.59],0.0101889157510354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAEA,E3 ubiquitin-protein transferase MAEA,22716,165,1.03 [0.72-1.47],0.8744102939138894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAG,Myelin-associated glycoprotein,19624,123,0.66 [0.48-0.92],0.0126983988620559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGEA3,Melanoma-associated antigen 3,19814,126,1.08 [0.88-1.34],0.4539380978088022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGED1,Melanoma-associated antigen D1,22716,165,1.19 [0.91-1.56],0.2060535659910758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC2,MAM domain-containing protein 2,20163,130,1.45 [0.92-2.29],0.1095306119978836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC4,Apical endosomal glycoprotein,20093,131,1.10 [0.83-1.46],0.5245579564214349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19613,127,1.11 [0.57-2.16],0.7703271414337235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN2B2,Epididymis-specific alpha-mannosidase,20163,130,1.17 [0.88-1.55],0.2716887643765815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19464,125,1.20 [0.87-1.65],0.2665486097340954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANF,Mesencephalic astrocyte-derived neurotrophic factor,23346,169,1.03 [0.92-1.15],0.6590736442840359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC1,MANSC domain-containing protein 1,23327,169,1.42 [0.88-2.29],0.1504160311575388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC4,MANSC domain-containing protein 4,19476,122,1.22 [0.96-1.55],0.1022944013528381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19511,122,0.97 [0.56-1.68],0.9213615754385382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19476,122,1.00 [0.76-1.31],0.9737765041437428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2,Microtubule-associated protein 2,20115,129,1.15 [0.82-1.62],0.4074262329856573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,20100,129,1.02 [0.78-1.32],0.897220658262491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,23240,169,1.00 [0.87-1.15],0.9890877040662246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22716,165,1.01 [0.87-1.16],0.9371623312276312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,23029,169,1.08 [0.95-1.22],0.2397908193365217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK13,Mitogen-activated protein kinase 13,19464,125,1.28 [0.92-1.79],0.1416717305685241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK9,Mitogen-activated protein kinase 9,23240,169,1.06 [0.77-1.46],0.7111359420071003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPKAPK2,MAP kinase-activated protein kinase 2,19814,126,0.98 [0.77-1.23],0.8483953539580535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPRE3,Microtubule-associated protein RP/EB family member 3,19464,125,1.09 [0.99-1.22],0.0876959428044992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPT,Microtubule-associated protein tau,22749,164,1.19 [0.90-1.58],0.2215737506774866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARCO,Macrophage receptor MARCO,23267,170,2.21 [1.31-3.73],0.0029108187142266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARS1,"Methionine--tRNA ligase, cytoplasmic",19678,123,0.94 [0.76-1.15],0.5361026510260756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MASP1,Mannan-binding lectin serine protease 1,23029,169,0.81 [0.45-1.45],0.480925057966752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,23263,169,2.40 [1.54-3.74],0.0001151288298353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN3,Matrilin-3,23021,168,0.92 [0.61-1.38],0.6782098810672001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAVS,Mitochondrial antiviral-signaling protein,22716,165,1.06 [0.91-1.23],0.4795015361158949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAX,Protein max,22749,164,1.13 [1.00-1.29],0.0587350745045053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MB,Myoglobin,23559,171,1.28 [1.03-1.60],0.0266204571991031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MBL2,Mannose-binding protein C,19904,126,0.98 [0.84-1.14],0.7965501099283132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCAM,Cell surface glycoprotein MUC18,23375,171,1.15 [0.76-1.74],0.5014192843954591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",20124,129,1.10 [0.75-1.61],0.6192973934284149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEMP1,Mast cell-expressed membrane protein 1,19566,122,0.95 [0.78-1.17],0.6440987720110736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCFD2,Multiple coagulation factor deficiency protein 2,23147,169,1.32 [0.98-1.78],0.0666450027073031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCTS1,Malignant T-cell-amplified sequence 1,20100,129,0.70 [0.35-1.41],0.318623705256441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,23062,169,1.09 [0.89-1.32],0.4049201893689845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDH1,"Malate dehydrogenase, cytoplasmic",20083,130,0.80 [0.51-1.24],0.3097350001624174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDK,Midkine,23249,168,1.35 [1.07-1.71],0.0107365726712664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDM1,Nuclear protein MDM1,19624,123,0.74 [0.42-1.31],0.3007665360568485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19613,127,1.01 [0.84-1.21],0.9261326270046364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED18,Mediator of RNA polymerase II transcription subunit 18,22716,165,1.05 [0.87-1.26],0.6032392321734613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED21,Mediator of RNA polymerase II transcription subunit 21,19476,122,1.00 [0.70-1.43],0.9886155653766672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF10,Multiple epidermal growth factor-like domains protein 10,23227,169,1.00 [0.71-1.41],0.980353648763366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF11,Multiple epidermal growth factor-like domains protein 11,19476,122,0.72 [0.39-1.34],0.3038443242289508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF9,Multiple epidermal growth factor-like domains protein 9,23483,171,1.17 [0.60-2.30],0.64664270397472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MELTF,Melanotransferrin,20163,130,1.15 [0.66-1.98],0.6215384140929765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MENT,Protein MENT,19710,123,0.55 [0.27-1.13],0.106602805144456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1A,Meprin A subunit alpha,20100,129,0.96 [0.76-1.20],0.6954476503424692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1B,Meprin A subunit beta,23267,170,0.88 [0.78-0.98],0.0213149094408655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEPE,Matrix extracellular phosphoglycoprotein,23227,169,0.75 [0.44-1.30],0.3107937291073369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MERTK,Tyrosine-protein kinase Mer,23536,169,2.15 [1.26-3.66],0.0047086184624891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MESD,LRP chaperone MESD,23278,167,1.06 [0.95-1.18],0.3316812667503021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MET,Hepatocyte growth factor receptor,23331,168,1.00 [0.50-2.00],0.9909969218516432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1,Methionine aminopeptidase 1,22749,164,0.81 [0.50-1.33],0.4127604583021789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",23240,169,1.06 [0.90-1.24],0.5193517108588348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP2,Methionine aminopeptidase 2,23439,170,1.02 [0.80-1.30],0.8831722848773904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3,Microfibril-associated glycoprotein 3,22843,165,0.79 [0.57-1.09],0.1501015142408177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3L,Microfibrillar-associated protein 3-like,19624,123,0.94 [0.71-1.25],0.6763789134345273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP4,Microfibril-associated glycoprotein 4,19710,123,0.98 [0.57-1.68],0.9467537060437216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP5,Microfibrillar-associated protein 5,23559,171,1.27 [0.91-1.78],0.1523231294963818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFGE8,Lactadherin,23278,167,1.16 [0.86-1.56],0.3183635920986031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGLL,Monoglyceride lipase,23310,169,1.02 [0.87-1.19],0.7978780955511828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGMT,Methylated-DNA--protein-cysteine methyltransferase,23240,169,1.02 [0.91-1.14],0.7330268604340198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIA,Melanoma-derived growth regulatory protein,23327,169,1.47 [1.05-2.05],0.026061011769245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICALL2,MICAL-like protein 2,19624,123,0.86 [0.65-1.13],0.2843592336470578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,23240,169,1.08 [0.98-1.20],0.1318837045214439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIF,Macrophage migration inhibitory factor,23232,167,0.92 [0.75-1.13],0.4162366468673476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,22853,166,1.40 [1.08-1.80],0.0099972410619987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,20093,131,0.95 [0.82-1.11],0.5566420688814164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINK1,Misshapen-like kinase 1,20115,129,0.97 [0.81-1.16],0.7348273172394576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MITD1,MIT domain-containing protein 1,23062,169,1.01 [0.88-1.16],0.9093532323727304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MKI67,Proliferation marker protein Ki-67,19566,122,1.11 [0.74-1.67],0.6075479296851969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLLT1,Protein ENL,19464,125,0.88 [0.66-1.17],0.3692547147457088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLN,Promotilin,23240,169,1.09 [0.93-1.27],0.278913505142735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MME,Neprilysin,23153,167,1.23 [1.04-1.45],0.0149877533983651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP1,Interstitial collagenase,22486,162,1.10 [0.94-1.29],0.2257240251207959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP10,Stromelysin-2,23185,169,1.40 [1.13-1.72],0.0020926052561711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,23297,169,1.60 [1.27-2.01],5.191289150938502e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP13,Collagenase 3,22749,164,1.73 [1.12-2.65],0.0129219786880912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP15,Matrix metalloproteinase-15,20163,130,0.95 [0.67-1.36],0.7826797071244815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP3,Stromelysin-1,23278,167,1.29 [0.98-1.68],0.0645509407552723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP7,Matrilysin,22811,165,1.36 [1.02-1.82],0.0342970333051074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP8,Neutrophil collagenase,23435,168,1.09 [0.91-1.31],0.3697695690734948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP9,Matrix metalloproteinase-9,23243,167,1.09 [0.87-1.37],0.4536172423588545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19476,122,0.88 [0.62-1.27],0.4994244297456413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MN1,Transcriptional activator MN1,19624,123,1.16 [0.88-1.51],0.2897936028676318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNAT1,CDK-activating kinase assembly factor MAT1,19814,126,1.16 [0.81-1.64],0.4160662635741119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNDA,Myeloid cell nuclear differentiation antigen,23230,169,0.91 [0.79-1.05],0.1800609877447696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOCS2,Molybdopterin synthase catalytic subunit,19710,123,1.02 [0.78-1.32],0.8886649787961746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOG,Myelin-oligodendrocyte glycoprotein,23465,170,1.47 [1.00-2.18],0.0503989386294617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORC3,MORC family CW-type zinc finger protein 3,20115,129,0.74 [0.38-1.45],0.3883511473252489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L1,Mortality factor 4-like protein 1,19814,126,1.14 [0.77-1.70],0.5015988206582995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L2,Mortality factor 4-like protein 2,19464,125,1.19 [0.78-1.83],0.4244197974568641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORN4,MORN repeat-containing protein 4,19464,125,0.92 [0.73-1.17],0.4909368900159506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPHOSPH8,M-phase phosphoprotein 8,22843,165,1.18 [0.99-1.40],0.0656776856251232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPI,Mannose-6-phosphate isomerase,23153,167,1.09 [0.93-1.28],0.2932755882096287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,23310,169,1.03 [0.86-1.23],0.7620687400638688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPO,Myeloperoxidase,23278,167,1.12 [0.84-1.49],0.4261115768051281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPRIP,Myosin phosphatase Rho-interacting protein,20061,130,0.95 [0.65-1.40],0.8081248570432668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,20188,130,3.28 [1.92-5.60],1.3798950485630453e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRI1,Methylthioribose-1-phosphate isomerase,19624,123,0.77 [0.60-0.98],0.0346939067943478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL24,"39S ribosomal protein L24, mitochondrial",19476,122,0.82 [0.49-1.35],0.4287491056093035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL28,"39S ribosomal protein L28, mitochondrial",20124,129,0.97 [0.61-1.56],0.9011938256961546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL46,"39S ribosomal protein L46, mitochondrial",22749,164,1.39 [0.91-2.12],0.1230311238434375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL52,"39S ribosomal protein L52, mitochondrial",19424,125,1.03 [0.55-1.93],0.936986744219142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",20124,129,1.02 [0.81-1.29],0.8422499775519912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPS16,"28S ribosomal protein S16, mitochondrial",19566,122,0.75 [0.37-1.53],0.4301037562269961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLN,Mesothelin,23113,167,1.30 [1.05-1.62],0.0152960211792167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLNL,Mesothelin-like protein,19624,123,1.05 [0.66-1.67],0.838559393279869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSMB,Beta-microseminoprotein,23244,168,1.16 [0.95-1.40],0.1428226484995525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,23472,168,1.74 [1.32-2.31],0.0001049454733288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSRA,Mitochondrial peptide methionine sulfoxide reductase,23327,169,1.01 [0.84-1.22],0.9189042737477764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MST1,Hepatocyte growth factor-like protein,19894,129,1.14 [0.85-1.53],0.3889514719405611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSTN,Growth/differentiation factor 8,22843,165,0.87 [0.67-1.12],0.2651604756048423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTDH,Protein LYRIC,19566,122,1.08 [0.90-1.30],0.4027097487613084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",20115,129,1.16 [0.61-2.20],0.6453619471352762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19814,126,1.00 [0.86-1.16],0.9972953492112848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTIF3,"Translation initiation factor IF-3, mitochondrial",20100,129,1.06 [0.88-1.28],0.5449243508301624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTPN,Myotrophin,22843,165,0.87 [0.56-1.36],0.5409897526188572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTR,Methionine synthase,19476,122,1.02 [0.78-1.32],0.912508769907414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS1,Protein MTSS 1,20100,129,0.92 [0.79-1.06],0.253008357835376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS2,Protein MTSS 2,20093,131,0.97 [0.82-1.15],0.7207723183966128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTUS1,Microtubule-associated tumor suppressor 1,19814,126,1.20 [0.90-1.59],0.2197531647234628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC13,Mucin-13,22749,164,1.29 [1.00-1.67],0.0492670798839798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC16,Mucin-16,23153,167,0.98 [0.92-1.06],0.6546005545569171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC2,Mucin-2,20171,128,0.91 [0.76-1.09],0.2975742703414772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUCL3,Mucin-like protein 3,19464,125,1.24 [0.89-1.71],0.1991203521713674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MVK,Mevalonate kinase,22853,166,1.15 [0.98-1.35],0.0960206884743994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MXRA8,Matrix remodeling-associated protein 8,19710,123,0.71 [0.40-1.26],0.2443968482855842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC1,"Myosin-binding protein C, slow-type",20163,130,1.26 [1.03-1.53],0.0250051385560033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC2,"Myosin-binding protein C, fast-type",19613,127,1.14 [0.95-1.36],0.1538397026475874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,20124,129,1.10 [0.86-1.40],0.4648051330914001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYDGF,Myeloid-derived growth factor,20163,130,1.05 [0.89-1.25],0.5571737239151968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH4,Myosin-4,19476,122,0.95 [0.63-1.41],0.7885617303075185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH7B,Myosin-7B,19464,125,1.29 [0.92-1.81],0.1354439250678092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH9,Myosin-9,20171,128,0.97 [0.84-1.13],0.7281657578777425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19476,122,1.10 [0.72-1.67],0.661828516520313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL3,Myosin light chain 3,19613,127,1.16 [0.94-1.44],0.163006967332018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL4,Myosin light chain 4,19613,127,0.92 [0.66-1.27],0.5944432988520028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL6B,Myosin light chain 6B,19624,123,1.05 [0.88-1.26],0.5648553862808758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19624,123,1.22 [0.93-1.60],0.1610302773430643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO6,Unconventional myosin-VI,20124,129,0.76 [0.46-1.27],0.2930787770755017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO9B,Unconventional myosin-IXb,22853,166,0.97 [0.79-1.20],0.7842497579327169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOC,Myocilin,23278,167,1.07 [0.79-1.46],0.6520940936409886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM1,Myomesin-1,19511,122,1.37 [1.06-1.77],0.0170813549519689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM2,Myomesin-2,19476,122,1.41 [1.10-1.81],0.007558617068573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM3,Myomesin-3,19710,123,1.07 [0.90-1.28],0.4350343569030834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZB1,Marginal zone B- and B1-cell-specific protein,23299,169,1.43 [1.11-1.83],0.0050004926572046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZT1,Mitotic-spindle organizing protein 1,22716,165,0.99 [0.75-1.30],0.9415455348531256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA10,N-alpha-acetyltransferase 10,19476,122,0.87 [0.62-1.22],0.4208768372243949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA80,N-alpha-acetyltransferase 80,19624,123,0.97 [0.84-1.12],0.6695173045718119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAAA,N-acylethanolamine-hydrolyzing acid amidase,22955,169,0.94 [0.74-1.18],0.5793777109937317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NACC1,Nucleus accumbens-associated protein 1,20093,131,0.88 [0.64-1.20],0.418869784229099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NADK,NAD kinase,23267,170,0.99 [0.78-1.26],0.9566195233277328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGA,Alpha-N-acetylgalactosaminidase,19535,122,0.85 [0.60-1.21],0.3787475076208644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGK,N-acetyl-D-glucosamine kinase,19579,127,1.01 [0.74-1.36],0.9679621397613548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19710,123,1.86 [0.84-4.13],0.1250107964092743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAMPT,Nicotinamide phosphoribosyltransferase,22716,165,1.02 [0.80-1.31],0.8493549150591416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAP1L4,Nucleosome assembly protein 1-like 4,20060,129,0.73 [0.50-1.04],0.082409668941575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAPRT,Nicotinate phosphoribosyltransferase,20115,129,0.81 [0.48-1.37],0.4284605402261043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NARS1,"Asparagine--tRNA ligase, cytoplasmic",20124,129,0.83 [0.58-1.18],0.301306962282896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,23327,169,2.28 [1.44-3.61],0.000447138325805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBN,Nibrin,22853,166,1.10 [0.89-1.37],0.3712108918883234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM1,Neural cell adhesion molecule 1,23375,171,0.93 [0.61-1.40],0.7185072420851673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM2,Neural cell adhesion molecule 2,23278,167,0.51 [0.31-0.85],0.0104612406074703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAN,Neurocan core protein,23472,168,0.60 [0.42-0.85],0.0036895618100959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCF2,Neutrophil cytosol factor 2,23193,169,0.94 [0.80-1.11],0.4484134822921766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCK2,Cytoplasmic protein NCK2,23346,169,1.04 [0.91-1.18],0.5901997598796114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCLN,Nicalin,22853,166,1.17 [0.94-1.47],0.1665907570273379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR1,Natural cytotoxicity triggering receptor 1,23207,166,1.46 [1.03-2.08],0.0319183189456138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20100,129,1.56 [0.99-2.47],0.0565232073094913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCS1,Neuronal calcium sensor 1,23465,170,1.46 [0.92-2.34],0.1093564894099767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDRG1,Protein NDRG1,22749,164,1.06 [0.86-1.29],0.5893209492063439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,20093,131,1.16 [0.91-1.48],0.221986099144964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19535,122,0.69 [0.42-1.14],0.1494890387272821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,20100,129,1.01 [0.83-1.21],0.9503720797488396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22716,165,1.16 [1.00-1.34],0.0500455275576814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEB,Nebulin,19476,122,1.22 [0.82-1.82],0.3181695451484507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECAP2,Adaptin ear-binding coat-associated protein 2,19476,122,1.03 [0.79-1.34],0.8250104569363462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN1,Nectin-1,19566,122,1.42 [0.94-2.14],0.0961997299091025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,23237,170,2.03 [1.37-3.01],0.0003951442789545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN4,Nectin-4,23327,169,1.74 [1.24-2.45],0.0013068197267994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19566,122,0.95 [0.66-1.37],0.8019148243432379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD9,Enhancer of filamentation 1,19566,122,0.90 [0.53-1.51],0.6814448039816521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,22681,163,1.88 [1.52-2.32],4.732691516886663e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEK7,Serine/threonine-protein kinase Nek7,19814,126,1.01 [0.80-1.28],0.901120891894272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL1,Protein kinase C-binding protein NELL1,23327,169,0.76 [0.55-1.05],0.0949035007404342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL2,Protein kinase C-binding protein NELL2,23346,169,0.99 [0.62-1.58],0.971278624898806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NENF,Neudesin,20093,131,1.12 [0.98-1.27],0.0842868368350837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEO1,Neogenin,20124,129,0.79 [0.37-1.70],0.5465449031036612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEXN,Nexilin,20188,130,1.04 [0.82-1.32],0.7743522791487557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,23536,169,1.58 [1.01-2.47],0.0441135890672578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFAT5,Nuclear factor of activated T-cells 5,19566,122,0.82 [0.65-1.03],0.0900404831206046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",23240,169,0.98 [0.85-1.12],0.7440259522802211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22853,166,1.15 [0.93-1.42],0.2010908139088421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFE2,Transcription factor NF-E2 45 kDa subunit,19613,127,0.91 [0.72-1.15],0.4437271825280143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFIC,Nuclear factor 1 C-type,20124,129,0.84 [0.53-1.32],0.4505228609725369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB1,Nuclear factor NF-kappa-B p105 subunit,19476,122,0.88 [0.69-1.12],0.2888831667111734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB2,Nuclear factor NF-kappa-B p100 subunit,19814,126,0.92 [0.65-1.31],0.651280145590589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKBIE,NF-kappa-B inhibitor epsilon,22716,165,1.19 [0.91-1.56],0.2142288317418555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",20100,129,1.05 [0.90-1.24],0.5306500205008337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFX1,Transcriptional repressor NF-X1,19476,122,0.83 [0.64-1.09],0.1900433373135186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFYA,Nuclear transcription factor Y subunit alpha,19476,122,0.94 [0.60-1.48],0.8006728488087567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGF,Beta-nerve growth factor,23062,169,1.11 [0.37-3.38],0.8508972253921174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGFR,Tumor necrosis factor receptor superfamily member 16,20163,130,1.50 [1.01-2.24],0.0459588072802652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGRN,Neugrin,20115,129,0.91 [0.42-1.96],0.8124527385395456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NHLRC3,NHL repeat-containing protein 3,19241,122,1.65 [0.95-2.88],0.0762817970231822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID1,Nidogen-1,23303,170,1.07 [0.74-1.56],0.7148386319515473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID2,Nidogen-2,23278,167,1.09 [0.91-1.30],0.3694801900543993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NINJ1,Ninjurin-1,22716,165,1.18 [0.95-1.47],0.1381941802199776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT1,Deaminated glutathione amidase,19613,127,0.67 [0.47-0.96],0.0299330354103589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT2,Omega-amidase NIT2,20080,128,0.96 [0.76-1.21],0.7121806742492842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN1,Neuroligin-1,19624,123,0.83 [0.60-1.14],0.2533741276701842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN2,Neuroligin-2,19511,122,0.89 [0.59-1.35],0.5986559287915592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME1,Nucleoside diphosphate kinase A,19566,122,0.78 [0.33-1.83],0.5679154851976178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME3,Nucleoside diphosphate kinase 3,23263,169,1.50 [0.89-2.52],0.1264792553206829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMI,N-myc-interactor,20011,131,1.09 [0.86-1.36],0.479138175968074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,23062,169,0.93 [0.77-1.12],0.4434385795166775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMRK2,Nicotinamide riboside kinase 2,19464,125,1.11 [0.75-1.66],0.5898567495405438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,20124,129,0.95 [0.72-1.24],0.6835467643335269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOMO1,Nodal modulator 1,23278,167,1.53 [0.86-2.74],0.1499841072363007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOP56,Nucleolar protein 56,19476,122,1.13 [0.99-1.29],0.062417277784551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",22749,164,1.49 [1.21-1.83],0.0001747975929649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS2,"Nitric oxide synthase, inducible",19476,122,0.92 [0.58-1.44],0.7045598660202336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS3,"Nitric oxide synthase, endothelial",22749,164,1.24 [0.99-1.56],0.0566795542592323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH1,Neurogenic locus notch homolog protein 1,23559,171,1.03 [0.45-2.38],0.940548021795267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH2,Neurogenic locus notch homolog protein 2,20171,128,0.82 [0.39-1.74],0.6027120787081922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH3,Neurogenic locus notch homolog protein 3,23559,171,1.16 [0.78-1.73],0.4627441447259837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPC2,NPC intracellular cholesterol transporter 2,19830,127,1.88 [1.24-2.85],0.0028217760757483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,23267,170,2.08 [1.53-2.82],3.094252770702082e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS1,Nephrin,19566,122,0.91 [0.54-1.54],0.7302645741907441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS2,Podocin,19566,122,1.18 [1.03-1.37],0.0192497815940158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPL,N-acetylneuraminate lyase,20163,130,1.35 [0.95-1.91],0.0955850470136352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPB,Natriuretic peptides B,22843,165,1.10 [1.00-1.22],0.0557698194490361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPC,C-type natriuretic peptide,23240,169,1.24 [0.98-1.58],0.0705467675878668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPR1,Atrial natriuretic peptide receptor 1,19476,122,0.75 [0.46-1.23],0.252413684440413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTN,Neuroplastin,22716,165,1.02 [0.85-1.22],0.8298487062875552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX1,Neuronal pentraxin-1,23278,167,1.14 [0.83-1.57],0.4105873192822987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX2,Neuronal pentraxin-2,20171,128,1.39 [0.84-2.29],0.1965403626887269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTXR,Neuronal pentraxin receptor,23267,170,1.10 [0.75-1.62],0.6127721793665496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPY,Pro-neuropeptide Y,23465,170,0.90 [0.73-1.11],0.3365222150099491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRCAM,Neuronal cell adhesion molecule,23267,170,1.43 [0.91-2.26],0.1241509639488558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRGN,Neurogranin,20188,130,0.96 [0.80-1.15],0.6491769645650767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRN1,Neuritin,20124,129,1.22 [0.84-1.79],0.2977828474258434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP1,Neuropilin-1,23413,171,1.73 [1.06-2.83],0.0274368435865886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP2,Neuropilin-2,23278,167,1.54 [0.98-2.42],0.0625251309417727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRTN,Neurturin,22853,166,1.03 [0.78-1.35],0.8515437666204235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRXN3,Neurexin-3,19624,123,1.04 [0.63-1.69],0.8883768316685727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NSFL1C,NSFL1 cofactor p47,23472,168,0.93 [0.75-1.15],0.4834388412647744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",20163,130,0.96 [0.76-1.20],0.7050878645237375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C1A,Cytosolic 5'-nucleotidase 1A,20115,129,1.52 [1.01-2.28],0.0462757662838003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C3A,Cytosolic 5'-nucleotidase 3A,23198,169,1.00 [0.85-1.17],0.966621291924836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5E,5'-nucleotidase,23327,169,1.18 [0.92-1.51],0.181948211385196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF3,Neurotrophin-3,23240,169,0.80 [0.54-1.19],0.2747533003315976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF4,Neurotrophin-4,22716,165,1.18 [0.87-1.60],0.2936952101965078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK2,BDNF/NT-3 growth factors receptor,23267,170,1.18 [0.69-2.01],0.5453712600921744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK3,NT-3 growth factor receptor,23472,168,0.62 [0.33-1.17],0.1397341828198673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTproBNP,N-terminal prohormone of brain natriuretic peptide,23267,170,1.17 [1.05-1.31],0.0053905580446087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUB1,NEDD8 ultimate buster 1,23240,169,1.04 [0.89-1.22],0.6124671250023513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,20093,131,1.06 [0.91-1.25],0.4477983848718001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUCB2,Nucleobindin-2,23431,170,1.64 [1.17-2.32],0.0044420775774003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDC,Nuclear migration protein nudC,23536,169,1.05 [0.84-1.30],0.679628645642924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19613,127,0.59 [0.26-1.35],0.2114487693800391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19476,122,0.80 [0.54-1.20],0.2824136005609021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT16,U8 snoRNA-decapping enzyme,20066,129,1.04 [0.86-1.26],0.6761214064858587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],23153,167,0.89 [0.69-1.14],0.3628225541184641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT5,ADP-sugar pyrophosphatase,23278,167,1.05 [0.80-1.38],0.7378188971203719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUMB,Protein numb homolog,19566,122,0.95 [0.77-1.17],0.6456796580106058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUP50,Nuclear pore complex protein Nup50,19476,122,0.47 [0.23-0.95],0.0365191504081128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPE4,NXPE family member 4,19476,122,0.83 [0.46-1.49],0.5334726185146488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH1,Neurexophilin-1,22749,164,1.24 [0.91-1.69],0.170492786686713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH3,Neurexophilin-3,19566,122,1.09 [0.61-1.94],0.7743903334562776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OBP2B,Odorant-binding protein 2b,22982,168,1.02 [0.80-1.29],0.8989181931732507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,20124,129,1.77 [1.27-2.46],0.0006820638448326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ODAM,Odontogenic ameloblast-associated protein,22707,164,0.92 [0.70-1.20],0.5327728071617903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OFD1,Oral-facial-digital syndrome 1 protein,19814,126,0.87 [0.64-1.17],0.3550042949730789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGA,Protein O-GlcNAcase,20100,129,0.98 [0.77-1.24],0.8693650106102804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGFR,Opioid growth factor receptor,23153,167,1.39 [0.92-2.09],0.1128186007944602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,23278,167,2.05 [1.55-2.70],4.67801868420571e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19814,126,1.17 [0.92-1.48],0.2089398808283634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLFM4,Olfactomedin-4,18974,119,1.05 [0.91-1.22],0.4707456500746475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLR1,Oxidized low-density lipoprotein receptor 1,23042,169,1.16 [0.94-1.43],0.1791574377860055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMD,Osteomodulin,23346,169,1.02 [0.74-1.42],0.89523054390398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMG,Oligodendrocyte-myelin glycoprotein,23153,167,0.92 [0.76-1.12],0.3873430393599549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMP,Olfactory marker protein,19511,122,0.99 [0.68-1.43],0.9477081033942696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPHN1,Oligophrenin-1,20115,129,0.95 [0.81-1.11],0.4975503902476997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPLAH,5-oxoprolinase,19613,127,0.92 [0.71-1.18],0.5059334066575337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPTC,Opticin,23153,167,1.04 [0.77-1.40],0.8183563353005604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ORM1,Alpha-1-acid glycoprotein 1,20110,127,1.05 [0.45-2.44],0.9141516874140028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSBPL2,Oxysterol-binding protein-related protein 2,20115,129,0.61 [0.34-1.10],0.1016070194240963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,23263,169,2.02 [1.37-3.00],0.0004115482946575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSM,Oncostatin-M,23128,169,1.08 [0.89-1.31],0.4261526199124653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSMR,Oncostatin-M-specific receptor subunit beta,23413,171,2.17 [1.11-4.26],0.0243710839042326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSTN,Osteocrin,19624,123,0.72 [0.44-1.19],0.2034969225460263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTOA,Otoancorin,19511,122,1.25 [0.97-1.63],0.0904265597422261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD6B,Deubiquitinase OTUD6B,20100,129,0.98 [0.74-1.31],0.9089495097504928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD7B,OTU domain-containing protein 7B,20124,129,1.08 [0.82-1.40],0.593173177381854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19613,127,0.97 [0.76-1.24],0.8170600190676831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXT,Oxytocin-neurophysin 1,23472,168,0.99 [0.90-1.08],0.7682234752822329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),P4HB,Protein disulfide-isomerase,23139,168,1.26 [0.89-1.79],0.1867248709680231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PACS2,Phosphofurin acidic cluster sorting protein 2,19476,122,0.94 [0.71-1.26],0.686665193897297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI2,Protein-arginine deiminase type-2,22853,166,1.15 [0.95-1.41],0.1566254531990581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI4,Protein-arginine deiminase type-4,22707,164,0.90 [0.74-1.09],0.2795299201515668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAEP,Glycodelin,23062,169,1.08 [0.95-1.22],0.2308710307113055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20124,129,1.15 [1.02-1.30],0.0232745117293014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19814,126,1.41 [1.05-1.88],0.0221483707046498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22843,165,1.21 [0.96-1.53],0.0984666489751658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAGR1,PAXIP1-associated glutamate-rich protein 1,19613,127,0.68 [0.43-1.06],0.0851881852874108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19430,125,1.29 [0.98-1.70],0.0727202410483304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAK4,Serine/threonine-protein kinase PAK 4,22749,164,1.23 [1.00-1.51],0.0467551110652508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALLD,Palladin,19566,122,0.67 [0.39-1.15],0.1470561060180844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM,Paralemmin-1,19987,129,1.32 [0.79-2.18],0.2884466628918117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,20115,129,1.51 [1.01-2.25],0.0435148840672929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM3,Paralemmin-3,19476,122,1.14 [0.94-1.39],0.1813812709828181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAM,Peptidyl-glycine alpha-amidating monooxygenase,23459,171,1.33 [0.81-2.18],0.2581450532610462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAMR1,Inactive serine protease PAMR1,23278,167,0.88 [0.53-1.47],0.6325673263601124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAPPA,Pappalysin-1,22853,166,0.98 [0.73-1.31],0.8675128084731784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARD3,Partitioning defective 3 homolog,19814,126,1.01 [0.81-1.27],0.9156421883138348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARK7,Parkinson disease protein 7,23278,167,0.93 [0.71-1.22],0.5907396216216139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARP1,Poly [ADP-ribose] polymerase 1,23240,169,1.00 [0.80-1.26],0.9689519110588796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAXX,Protein PAXX,19710,123,0.90 [0.61-1.32],0.5859620587235543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBK,Lymphokine-activated killer T-cell-originated protein kinase,19464,125,0.91 [0.53-1.58],0.7481947455429834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBLD,Phenazine biosynthesis-like domain-containing protein,22749,164,1.14 [0.88-1.48],0.3167171790267394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,20100,129,1.03 [0.59-1.79],0.909483337281873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCARE,Photoreceptor cilium actin regulator,19511,122,1.03 [0.84-1.26],0.8028002687924923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19671,123,1.01 [0.70-1.44],0.9643088120124572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBP2,Poly(rC)-binding protein 2,20124,129,0.97 [0.77-1.22],0.7725432327848354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH1,Protocadherin-1,23460,167,1.16 [0.62-2.20],0.6389936601836079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH12,Protocadherin-12,20124,129,1.04 [0.53-2.01],0.9179874977145582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH17,Protocadherin-17,23267,170,1.03 [0.72-1.49],0.8540081140787225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH7,Protocadherin-7,20100,129,0.95 [0.59-1.53],0.8305641149356329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH9,Protocadherin-9,20100,129,0.81 [0.51-1.30],0.3899681077820364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDHB15,Protocadherin beta-15,20093,131,0.90 [0.59-1.37],0.6165845099755963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCNA,Proliferating cell nuclear antigen,19464,125,1.18 [0.96-1.45],0.1057604189978449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK7,Proprotein convertase subtilisin/kexin type 7,20093,131,1.42 [1.10-1.83],0.0071588620966856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK9,Proprotein convertase subtilisin/kexin type 9,23559,171,1.42 [1.02-1.98],0.0402181351312866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCYT2,Ethanolamine-phosphate cytidylyltransferase,20100,129,0.99 [0.79-1.24],0.9272534869024734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDAP1,28 kDa heat- and acid-stable phosphoprotein,20163,130,1.04 [0.88-1.24],0.6263025911597987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1,Programmed cell death protein 1,23421,170,1.39 [1.03-1.88],0.0310364407030559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,23153,167,1.72 [1.15-2.57],0.0085969812053711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD5,Programmed cell death protein 5,23472,168,0.94 [0.74-1.19],0.5938248558136638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD6,Programmed cell death protein 6,23267,170,1.08 [0.88-1.32],0.4824764809322945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCL2,Phosducin-like protein 2,19464,125,1.05 [0.77-1.44],0.75781131619849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19464,125,0.87 [0.60-1.26],0.4547765122778204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19476,122,0.79 [0.55-1.13],0.1920644993571478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19710,123,0.92 [0.78-1.08],0.3014388345384053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFA,Platelet-derived growth factor subunit A,23559,171,0.97 [0.81-1.17],0.765505186231399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFB,Platelet-derived growth factor subunit B,23346,169,0.99 [0.85-1.16],0.9366745137236528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFC,Platelet-derived growth factor C,22716,165,1.12 [0.68-1.84],0.6598781534693576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRA,Platelet-derived growth factor receptor alpha,23267,170,1.51 [0.95-2.39],0.0833460142965089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRB,Platelet-derived growth factor receptor beta,23559,171,0.97 [0.66-1.42],0.8693046650404361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA2,Protein disulfide-isomerase A2,19464,125,0.91 [0.58-1.42],0.6838120052351923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA3,Protein disulfide-isomerase A3,19710,123,1.42 [0.75-2.70],0.2800007464494519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA4,Protein disulfide-isomerase A4,20171,128,1.03 [0.78-1.35],0.8457018620380553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA5,Protein disulfide-isomerase A5,19464,125,0.85 [0.63-1.16],0.3163244780533483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM5,PDZ and LIM domain protein 5,20124,129,0.98 [0.85-1.13],0.7984415217545309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM7,PDZ and LIM domain protein 7,23346,169,1.06 [0.95-1.18],0.3226182768772023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22716,165,1.32 [1.07-1.63],0.0093834893455833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDRG1,p53 and DNA damage-regulated protein 1,19624,123,0.96 [0.68-1.36],0.8144065800207496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19464,125,1.00 [0.73-1.37],0.9978189050574512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZD2,PDZ domain-containing protein 2,19476,122,1.00 [0.74-1.35],0.9764068668333564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19566,122,1.50 [1.08-2.06],0.0141599130599005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEAR1,Platelet endothelial aggregation receptor 1,23559,171,1.34 [0.74-2.42],0.3391201284756767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEBP1,Phosphatidylethanolamine-binding protein 1,23278,167,0.90 [0.70-1.15],0.3934443172808852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECAM1,Platelet endothelial cell adhesion molecule,23278,167,1.05 [0.67-1.65],0.8292626947999502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECR,Peroxisomal trans-2-enoyl-CoA reductase,19613,127,0.62 [0.31-1.21],0.1612878385881823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PENK,Proenkephalin-A,19710,123,1.37 [0.85-2.23],0.198808138881168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEPD,Xaa-Pro dipeptidase,20188,130,0.88 [0.46-1.66],0.683679091778237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PER3,Period circadian protein homolog 3,19566,122,0.96 [0.83-1.11],0.5991146917687061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PF4,Platelet factor 4,20033,127,0.99 [0.83-1.19],0.9430870335245768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN2,Prefoldin subunit 2,22749,164,0.94 [0.73-1.21],0.6402846039818499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN4,Prefoldin subunit 4,19464,125,0.97 [0.69-1.36],0.8701221928211541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN6,Prefoldin subunit 6,19624,123,0.73 [0.52-1.04],0.0830040818279004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",23118,167,1.01 [0.85-1.21],0.8805530671329614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGA4,Pepsin A-4,20188,130,0.88 [0.71-1.08],0.2174058041832398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",20163,130,1.10 [0.80-1.50],0.56514884161262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,23536,169,2.31 [1.58-3.39],1.7574431564210998e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP1,Peptidoglycan recognition protein 1,23448,171,1.33 [0.99-1.79],0.0578447983124054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19932,126,0.79 [0.44-1.40],0.4134175341870501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP4,Peptidoglycan recognition protein 4,19476,122,1.18 [0.91-1.52],0.2100329202581513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGM2,Phosphoglucomutase-2,19624,123,1.05 [0.80-1.39],0.712268189355298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGR,Progesterone receptor,19566,122,0.92 [0.75-1.12],0.4013334996860302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHACTR2,Phosphatase and actin regulator 2,20124,129,0.98 [0.85-1.14],0.815152020353755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB1,Pleckstrin homology-like domain family B member 1,20100,129,0.99 [0.72-1.36],0.9406482981684504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB2,Pleckstrin homology-like domain family B member 2,19464,125,0.96 [0.78-1.17],0.652452057164473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,23062,169,2.05 [1.30-3.22],0.0019330064004933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19710,123,0.96 [0.64-1.45],0.8472049357999253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI16,Peptidase inhibitor 16,20188,130,1.22 [0.61-2.44],0.5658185668265209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,22970,167,1.43 [1.16-1.77],0.0007367120670389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",20124,129,0.97 [0.78-1.21],0.7764003531398926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,22974,165,1.89 [1.34-2.66],0.0002514107884162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,23240,169,0.90 [0.72-1.13],0.3630834061875659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,23278,167,2.37 [1.61-3.48],1.1650600489663616e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19566,122,0.77 [0.54-1.09],0.1401266858151746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,23278,167,2.16 [1.57-2.97],2.335193028448871e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,23267,170,1.75 [1.35-2.26],2.0638735017746687e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19710,123,1.23 [0.95-1.59],0.1086429550347635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PITHD1,PITH domain-containing protein 1,19430,125,1.09 [0.89-1.34],0.4018005573269709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD1,Polycystin-1,20163,130,1.49 [0.80-2.81],0.2109555475732593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD2,Polycystin-2,19476,122,0.88 [0.65-1.21],0.4447477637044523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKLR,Pyruvate kinase PKLR,23265,169,0.84 [0.68-1.04],0.108869230984559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKN3,Serine/threonine-protein kinase N3,19814,126,0.98 [0.78-1.24],0.8963576676258539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G10,Group 10 secretory phospholipase A2,23062,169,1.20 [0.95-1.52],0.1198996043640008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,23327,169,1.86 [1.17-2.96],0.0090172589674633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G1B,Phospholipase A2,23525,170,0.88 [0.65-1.18],0.385301109756536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G2A,"Phospholipase A2, membrane associated",23251,164,1.25 [1.01-1.55],0.0414543301341851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G4A,Cytosolic phospholipase A2,23346,169,1.05 [0.90-1.23],0.5038994055996837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G7,Platelet-activating factor acetylhydrolase,23278,167,0.61 [0.41-0.91],0.0141176602043686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAT,Tissue-type plasminogen activator,23483,171,1.05 [0.81-1.37],0.6981721404570715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAU,Urokinase-type plasminogen activator,23278,167,1.14 [0.73-1.78],0.5656689006722326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,23073,169,3.12 [2.06-4.73],8.110007976142903e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLB1,"Phospholipase B1, membrane-associated",20115,129,0.74 [0.56-0.98],0.0336175997069964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19566,122,0.79 [0.49-1.27],0.3330761062767158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",20115,129,0.98 [0.82-1.16],0.7824082197917733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLEKHO1,Pleckstrin homology domain-containing family O member 1,20115,129,0.90 [0.71-1.15],0.4023321506993442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLG,Plasminogen,19685,125,1.65 [0.77-3.53],0.2013247058637878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN1,Perilipin-1,22749,164,1.27 [0.89-1.82],0.1945801673895406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN3,Perilipin-3,23267,170,1.14 [0.83-1.55],0.4250348003852359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLPBP,Pyridoxal phosphate homeostasis protein,23267,170,0.94 [0.77-1.16],0.5755970221581839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLSCR3,Phospholipid scramblase 3,20071,128,1.11 [0.83-1.49],0.4782394594619032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLTP,Phospholipid transfer protein,23491,171,0.86 [0.61-1.23],0.4114948158597992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC1,Plexin domain-containing protein 1,22716,165,0.90 [0.58-1.41],0.654891692571903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC2,Plexin domain-containing protein 2,20115,129,1.20 [0.67-2.15],0.5336900951620953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNA4,Plexin-A4,23240,169,1.03 [0.87-1.22],0.7048113360148095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,23445,171,2.38 [1.45-3.92],0.0006585916189157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB3,Plexin-B3,23191,170,1.05 [0.79-1.39],0.7514054433233525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,23165,170,1.01 [0.94-1.09],0.7384096220454751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMCH,Pro-MCH,19476,122,0.97 [0.78-1.22],0.8091614864107031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMM2,Phosphomannomutase 2,19476,122,0.87 [0.64-1.17],0.3537785986996283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMS1,PMS1 protein homolog 1,19624,123,0.76 [0.51-1.11],0.1573307643848744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMVK,Phosphomevalonate kinase,22713,164,0.99 [0.87-1.12],0.889377480367217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIP,Pancreatic triacylglycerol lipase,20188,130,0.74 [0.58-0.95],0.0199002766672601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP1,Inactive pancreatic lipase-related protein 1,20115,129,0.92 [0.75-1.12],0.3981731163577131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP2,Pancreatic lipase-related protein 2,23227,169,1.01 [0.96-1.06],0.6731228019960104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA1,Paraneoplastic antigen Ma1,19613,127,0.89 [0.66-1.22],0.4794092216468617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA2,Paraneoplastic antigen Ma2,19511,122,0.87 [0.57-1.31],0.4942143336925698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22853,166,1.07 [0.95-1.19],0.2517800974783304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL,Podocalyxin,23153,167,0.48 [0.20-1.16],0.1015307964735346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL2,Podocalyxin-like protein 2,23327,169,1.00 [0.62-1.61],0.9959868604928638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POF1B,Protein POF1B,19566,122,1.32 [0.95-1.83],0.101684032490239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2A,DNA-directed RNA polymerase II subunit RPB1,19566,122,0.80 [0.43-1.50],0.4943697467367283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",23153,167,1.43 [1.07-1.90],0.0150427662990995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POMC,Pro-opiomelanocortin,19613,127,0.80 [0.63-1.02],0.0714541954911119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON1,Serum paraoxonase/arylesterase 1,20188,130,0.52 [0.31-0.90],0.0180673617943913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON2,Serum paraoxonase/arylesterase 2,22843,165,1.14 [0.78-1.69],0.4949344959566135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON3,Serum paraoxonase/lactonase 3,23346,169,0.70 [0.50-0.98],0.0371623356831148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POSTN,Periostin,20171,128,1.32 [0.85-2.06],0.2154850066508073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPBP,Platelet basic protein,20032,126,1.00 [0.81-1.22],0.961998853984306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPCDC,Phosphopantothenoylcysteine decarboxylase,23472,168,0.82 [0.61-1.11],0.1996286652771378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIB,Peptidyl-prolyl cis-trans isomerase B,23296,170,1.06 [0.92-1.23],0.3994971771521726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIE,Peptidyl-prolyl cis-trans isomerase E,19814,126,1.09 [0.85-1.41],0.5061077411556238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",20171,128,0.98 [0.74-1.28],0.8543557762354048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPL,Periplakin,19566,122,1.01 [0.58-1.73],0.982123409192737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1A,Protein phosphatase 1A,22716,165,1.04 [0.69-1.59],0.8382962224432174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1B,Protein phosphatase 1B,19566,122,0.75 [0.52-1.10],0.1384200443139161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1F,Protein phosphatase 1F,20163,130,0.94 [0.69-1.29],0.7049245597096412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPME1,Protein phosphatase methylesterase 1,23153,167,0.90 [0.72-1.14],0.3832643435577147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,20093,131,1.00 [0.82-1.22],0.9954063667240478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,23327,169,1.10 [0.95-1.26],0.1956228065124098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19814,126,1.15 [0.93-1.41],0.2064425719429037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,20124,129,1.02 [0.82-1.26],0.8655316598528867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,20124,129,0.93 [0.59-1.45],0.7472617407833058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R2,Protein phosphatase inhibitor 2,23267,170,1.05 [0.89-1.24],0.5583818306067326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R9B,Neurabin-2,23536,169,1.08 [0.94-1.25],0.2668915963986785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,20100,129,1.08 [0.94-1.24],0.287291403189321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP3R1,Calcineurin subunit B type 1,23062,169,1.60 [1.16-2.22],0.0040413812251449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPT1,Palmitoyl-protein thioesterase 1,19624,123,1.16 [0.96-1.40],0.120315237574486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPY,Pancreatic prohormone,23198,166,0.97 [0.85-1.11],0.690860265896797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PQBP1,Polyglutamine-binding protein 1,22716,165,1.11 [0.90-1.37],0.3404897191592587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAME,Melanoma antigen preferentially expressed in tumors,19464,125,0.70 [0.35-1.41],0.3171787658818355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAP1,Proline-rich acidic protein 1,20171,128,1.21 [0.78-1.89],0.3912582474146409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRC1,Protein regulator of cytokinesis 1,20093,131,1.03 [0.70-1.50],0.8848475849545475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRCP,Lysosomal Pro-X carboxypeptidase,23409,169,1.34 [0.89-2.01],0.163949694850063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX1,Peroxiredoxin-1,22574,168,0.96 [0.82-1.12],0.6241010994325831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX2,Peroxiredoxin-2,19846,128,0.67 [0.50-0.90],0.0073450396178637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22853,166,1.16 [0.97-1.40],0.112070122154383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX5,"Peroxiredoxin-5, mitochondrial",23536,169,1.07 [0.86-1.32],0.5557132997886431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX6,Peroxiredoxin-6,23465,170,0.91 [0.73-1.14],0.4020409350152854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,22853,166,1.89 [1.33-2.69],0.0003597800811023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRELP,Prolargin,23227,169,2.19 [1.22-3.95],0.0090590968226565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG2,Bone marrow proteoglycan,20171,128,1.22 [0.88-1.68],0.2285758296364488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG3,Proteoglycan 3,20171,128,1.03 [0.73-1.44],0.8727938346782792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22853,166,1.15 [0.90-1.47],0.254198272063274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19624,123,0.95 [0.54-1.68],0.8696961893055861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,23267,170,1.03 [0.87-1.21],0.7289216792930842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,20071,129,0.91 [0.74-1.14],0.417251839467826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKCQ,Protein kinase C theta type,22853,166,1.01 [0.73-1.40],0.9472640564967127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKD2,Serine/threonine-protein kinase D2,19476,122,0.95 [0.62-1.46],0.819264777953689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKG1,cGMP-dependent protein kinase 1,19710,123,1.01 [0.88-1.16],0.9141071297046062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22716,165,1.03 [0.84-1.27],0.7570110754848862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRL,Prolactin,23472,168,1.27 [1.07-1.50],0.0053651375487317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRND,Prion-like protein doppel,20115,129,1.03 [0.73-1.44],0.8737459141685278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROC,Vitamin K-dependent protein C,23341,171,0.80 [0.48-1.35],0.4101543537291702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROCR,Endothelial protein C receptor,19476,122,0.97 [0.57-1.65],0.9201424767051338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROK1,Prokineticin-1,23240,169,1.24 [0.96-1.61],0.1039893311374078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROS1,Vitamin K-dependent protein S,20185,128,0.40 [0.22-0.75],0.0043749039637153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR4,Proline-rich protein 4,19559,123,0.97 [0.76-1.24],0.8072263511769722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR5,Proline-rich protein 5,19566,122,1.34 [0.98-1.83],0.0670632965052761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRRT3,Proline-rich transmembrane protein 3,19613,127,1.01 [0.65-1.56],0.9756942936148358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS2,Trypsin-2,23375,171,1.13 [0.90-1.41],0.3026903109334865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS22,Brain-specific serine protease 4,19566,122,1.20 [0.77-1.85],0.4180038319494908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS27,Serine protease 27,23192,170,1.35 [0.97-1.89],0.0783643337803009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS53,Serine protease 53,20115,129,1.38 [0.91-2.08],0.1291403312364934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,23153,169,1.56 [1.14-2.12],0.0049162490387436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22749,164,1.02 [0.90-1.15],0.8124428023396513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTG,Protogenin,23465,170,1.05 [0.61-1.82],0.85323233058784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTN3,Myeloblastin,22710,163,1.08 [0.82-1.41],0.5927723293434222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRUNE2,Protein prune homolog 2,19814,126,0.84 [0.45-1.56],0.5820130610827112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAP,Prosaposin,19984,127,1.69 [1.01-2.83],0.0454995096921195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAPL1,Proactivator polypeptide-like 1,20100,129,1.03 [0.74-1.44],0.8472984348812261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSCA,Prostate stem cell antigen,20100,129,0.97 [0.91-1.03],0.3150585337174884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSG1,Pregnancy-specific beta-1-glycoprotein 1,23062,169,1.25 [1.08-1.43],0.0020440765904369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSIP1,PC4 and SFRS1-interacting protein,23240,169,1.05 [0.86-1.28],0.6309797037261736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMA1,Proteasome subunit alpha type-1,22716,165,1.03 [0.76-1.39],0.8487920177258854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMC3,26S proteasome regulatory subunit 6A,19464,125,1.45 [0.85-2.47],0.1715645014627002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD1,26S proteasome non-ATPase regulatory subunit 1,20124,129,0.71 [0.49-1.02],0.061036282464711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD5,26S proteasome non-ATPase regulatory subunit 5,19624,123,0.84 [0.58-1.23],0.3766621617624015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD9,26S proteasome non-ATPase regulatory subunit 9,23153,167,0.78 [0.60-1.01],0.0612374639976833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME1,Proteasome activator complex subunit 1,23018,169,0.85 [0.59-1.24],0.4106994890984017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME2,Proteasome activator complex subunit 2,22959,169,0.89 [0.61-1.31],0.5582341697598378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG3,Proteasome assembly chaperone 3,23240,169,0.81 [0.62-1.07],0.1341134298948442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG4,Proteasome assembly chaperone 4,19566,122,0.79 [0.57-1.10],0.1596444272538651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSPN,Persephin,23240,169,1.15 [0.98-1.34],0.0825008429830449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSRC1,Proline/serine-rich coiled-coil protein 1,22716,165,1.35 [1.11-1.65],0.0029975126785056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,19022,120,0.99 [0.84-1.17],0.942634794989263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22749,164,1.20 [0.76-1.90],0.4238584934549388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,23112,170,2.06 [1.46-2.92],4.54123020338046e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGES2,Prostaglandin E synthase 2,19431,122,1.26 [0.92-1.71],0.1438523361076933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGR1,Prostaglandin reductase 1,20163,130,1.16 [0.96-1.41],0.1197176778400203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH,Parathyroid hormone,19624,123,1.20 [0.98-1.46],0.0765267116629438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,23240,169,1.37 [1.04-1.79],0.0227089908208088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTK7,Inactive tyrosine-protein kinase 7,22749,164,1.47 [1.02-2.12],0.0387732463870171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTN,Pleiotrophin,22843,165,1.42 [1.09-1.84],0.0085504089511551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTP4A3,Protein tyrosine phosphatase type IVA 3,19566,122,0.80 [0.55-1.17],0.2471899755405575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,23062,169,1.08 [0.91-1.28],0.3728182201040018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,23310,169,1.03 [0.88-1.20],0.7082318750006726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19534,122,1.02 [0.66-1.58],0.9364707965062972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRB,Receptor-type tyrosine-protein phosphatase beta,20163,130,0.67 [0.38-1.18],0.1674621286830668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRC,Receptor-type tyrosine-protein phosphatase C,20171,128,2.18 [1.16-4.09],0.0155635338162066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRF,Receptor-type tyrosine-protein phosphatase F,23559,171,1.25 [0.79-2.00],0.3436807733638027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRH,Receptor-type tyrosine-protein phosphatase H,20100,129,0.98 [0.70-1.39],0.931238166794051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,20100,129,1.79 [0.99-3.22],0.0522919197427702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRM,Receptor-type tyrosine-protein phosphatase mu,23202,168,1.14 [0.65-1.98],0.6553578857400748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22988,169,1.78 [1.22-2.60],0.0025716713713596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRR,Receptor-type tyrosine-protein phosphatase R,20115,129,1.17 [0.76-1.79],0.4835294092578014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRS,Receptor-type tyrosine-protein phosphatase S,23559,171,1.50 [0.89-2.51],0.128832961743964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20163,130,1.33 [0.78-2.26],0.29802473494996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19710,123,0.87 [0.65-1.17],0.3546194573913317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTS,6-pyruvoyl tetrahydrobiopterin synthase,22634,164,1.00 [0.78-1.28],0.9954765688857252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTTG1,Securin,19814,126,1.00 [0.66-1.51],0.9909511709125468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTX3,Pentraxin-related protein PTX3,23240,169,1.17 [0.87-1.56],0.2932053575617362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVALB,Parvalbumin alpha,23367,170,0.97 [0.87-1.10],0.6660238928476148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVR,Poliovirus receptor,23472,168,1.04 [0.73-1.49],0.830230932527281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXDNL,Peroxidasin-like protein,20093,131,1.00 [0.75-1.34],0.9774074942188508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXN,Paxillin,22749,164,1.18 [0.92-1.50],0.1891958811467012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYDC1,Pyrin domain-containing protein 1,19613,127,0.87 [0.56-1.35],0.5345457026472158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYY,Peptide YY,19476,122,1.08 [0.91-1.28],0.3711689724572663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PZP,Pregnancy zone protein,20185,128,0.97 [0.59-1.58],0.8890494995201816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QDPR,Dihydropteridine reductase,23151,170,0.87 [0.63-1.21],0.4184408481672341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QPCT,Glutaminyl-peptide cyclotransferase,23287,167,2.18 [1.34-3.55],0.001628400056254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QSOX1,Sulfhydryl oxidase 1,19780,127,1.24 [0.89-1.72],0.200599041559171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB10,Ras-related protein Rab-10,20163,130,0.89 [0.65-1.22],0.469197428899308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB11FIP3,Rab11 family-interacting protein 3,20163,130,0.97 [0.83-1.13],0.6898202290754084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB27B,Ras-related protein Rab-27B,20163,130,0.92 [0.76-1.12],0.4241825173455611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB2B,Ras-related protein Rab-2B,20093,131,1.04 [0.79-1.36],0.7951686466509208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB33A,Ras-related protein Rab-33A,19476,122,0.89 [0.68-1.16],0.3774689027135144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB37,Ras-related protein Rab-37,22853,166,1.10 [0.94-1.28],0.243997286643877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB39B,Ras-related protein Rab-39B,19476,122,1.09 [0.93-1.29],0.3001807823283281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19511,122,1.19 [0.94-1.51],0.1386801269446891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB44,Ras-related protein Rab-44,20093,131,1.04 [0.74-1.46],0.8373767506381634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6A,Ras-related protein Rab-6A,23240,169,1.02 [0.76-1.38],0.8916765110917373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6B,Ras-related protein Rab-6B,22749,164,1.10 [0.83-1.45],0.5093391925857405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEP1,Rab GTPase-binding effector protein 1,19710,123,0.89 [0.71-1.13],0.3405063852230751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEPK,Rab9 effector protein with kelch motifs,22716,165,1.21 [0.98-1.49],0.0756382538155193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABGAP1L,Rab GTPase-activating protein 1-like,22853,166,0.98 [0.78-1.23],0.8697345063682431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAC3,Ras-related C3 botulinum toxin substrate 3,19624,123,1.20 [0.98-1.48],0.0805592674852002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD23B,UV excision repair protein RAD23 homolog B,22716,165,0.97 [0.72-1.31],0.8451575167340841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD51,DNA repair protein RAD51 homolog 1,19814,126,1.03 [0.76-1.40],0.8393855158256522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALB,Ras-related protein Ral-B,19566,122,1.06 [0.59-1.90],0.8563425957724288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALY,RNA-binding protein Raly,20093,131,1.10 [0.80-1.50],0.564612538328481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP1,Ran-specific GTPase-activating protein,19613,127,0.80 [0.57-1.12],0.1925316772742101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP2,E3 SUMO-protein ligase RanBP2,19511,122,1.18 [0.71-1.96],0.5351793421829394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANGAP1,Ran GTPase-activating protein 1,22716,165,1.14 [0.87-1.50],0.3512404483430138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAP1A,Ras-related protein Rap-1A,19566,122,0.85 [0.63-1.15],0.3026339410092258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAPGEF2,Rap guanine nucleotide exchange factor 2,19814,126,1.13 [0.83-1.54],0.4442358837082347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES1,Retinoic acid receptor responder protein 1,22716,165,1.24 [0.87-1.77],0.2278582717076686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,23413,171,1.44 [1.13-1.82],0.002944546443647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASA1,Ras GTPase-activating protein 1,22749,164,1.51 [1.06-2.15],0.0222853909353749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19464,125,0.65 [0.43-0.99],0.0444531081172582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASSF2,Ras association domain-containing protein 2,22716,165,1.02 [0.81-1.28],0.867313859416057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,20124,129,1.76 [1.31-2.38],0.0002096324431473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBKS,Ribokinase,22718,166,0.75 [0.59-0.95],0.0176901986686116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM17,Splicing factor 45,20124,129,0.98 [0.78-1.22],0.835778986378072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM19,Probable RNA-binding protein 19,19476,122,0.61 [0.37-0.99],0.04401741044093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM25,RNA-binding protein 25,19464,125,1.06 [0.73-1.54],0.7622489466778986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP1,Retinol-binding protein 1,19624,123,1.18 [0.96-1.45],0.1218742553133929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP2,Retinol-binding protein 2,23153,167,1.27 [1.07-1.50],0.0058443812547972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP5,Retinol-binding protein 5,23153,167,1.33 [1.05-1.68],0.0158476894000401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP7,Retinoid-binding protein 7,20100,129,1.10 [0.85-1.41],0.475867513683029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS,RNA-binding protein with multiple splicing,19566,122,1.09 [0.85-1.40],0.4742411863949638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS2,RNA-binding protein with multiple splicing 2,19613,127,0.97 [0.82-1.15],0.7104276851139089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCC1,Regulator of chromosome condensation,20093,131,1.26 [0.97-1.65],0.082647535108826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCOR1,REST corepressor 1,22843,165,1.03 [0.75-1.42],0.8406317151329552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19613,127,0.71 [0.32-1.57],0.4018018404982053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REEP4,Receptor expression-enhancing protein 4,20124,129,0.91 [0.69-1.21],0.5214012638788639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,23148,170,1.59 [1.27-1.99],4.951340887577055e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,23559,171,1.47 [1.20-1.79],0.0001540759995651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,23559,171,1.46 [1.22-1.76],5.374153362737629e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3G,Regenerating islet-derived protein 3-gamma,20093,131,0.97 [0.64-1.49],0.9008467056565728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,23263,169,1.67 [1.31-2.12],2.9494028165155933e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELB,Transcription factor RelB,19566,122,1.03 [0.72-1.48],0.8703254129035232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,23278,167,2.27 [1.53-3.37],4.259587895693196e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,23267,170,1.34 [1.16-1.54],5.382897962931476e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REPS1,RalBP1-associated Eps domain-containing protein 1,19566,122,0.98 [0.62-1.54],0.914586726264273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REST,RE1-silencing transcription factor,19464,125,0.87 [0.52-1.45],0.5868071074529151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,23153,167,1.04 [0.72-1.50],0.8195975255567193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RETN,Resistin,23223,170,1.38 [1.03-1.84],0.0289286567767393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REXO2,"Oligoribonuclease, mitochondrial",19476,122,0.98 [0.67-1.42],0.8969754400651943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RFC4,Replication factor C subunit 4,20093,131,1.24 [0.60-2.55],0.5597167774612908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGCC,Regulator of cell cycle RGCC,20124,129,0.98 [0.78-1.22],0.8371810474531628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19814,126,1.14 [0.91-1.44],0.250807061539789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMA,Repulsive guidance molecule A,23472,168,1.14 [0.75-1.74],0.5350671856158351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMB,RGM domain family member B,23472,168,1.44 [0.91-2.31],0.1230431363620856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS10,Regulator of G-protein signaling 10,20124,129,1.03 [0.78-1.36],0.8446033967443057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS8,Regulator of G-protein signaling 8,22853,166,0.86 [0.67-1.09],0.2133311659445615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RHOC,Rho-related GTP-binding protein RhoC,22941,167,1.04 [0.93-1.17],0.505768109874243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RICTOR,Rapamycin-insensitive companion of mTOR,19566,122,1.02 [0.71-1.48],0.9017772845702487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19710,123,0.97 [0.69-1.37],0.8609809454489428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILP,Rab-interacting lysosomal protein,23404,170,1.00 [0.79-1.25],0.976698022783118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILPL2,RILP-like protein 2,20163,130,1.01 [0.85-1.20],0.8994198012979153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19476,122,1.24 [1.00-1.53],0.0509206339625491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN1,Prorelaxin H1,20124,129,1.15 [0.83-1.58],0.4064753063670786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN2,Prorelaxin H2,19674,122,1.12 [0.81-1.54],0.4998712979357133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE1,Ribonuclease pancreatic,20188,130,2.04 [1.22-3.41],0.0066458748402752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE10,Inactive ribonuclease-like protein 10,19613,127,1.13 [0.80-1.59],0.4937304672007128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE3,Eosinophil cationic protein,23155,169,1.02 [0.91-1.14],0.7695433844492484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE4,Ribonuclease 4,19531,126,1.59 [0.91-2.77],0.1040477658901358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,20053,130,1.81 [1.36-2.40],4.9897434642816814e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASEH2A,Ribonuclease H2 subunit A,20124,129,0.93 [0.64-1.34],0.6961323030383221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,23447,169,2.19 [1.38-3.46],0.0008310822722265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF149,E3 ubiquitin-protein ligase RNF149,19613,127,1.68 [1.02-2.78],0.0429942754577487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF168,E3 ubiquitin-protein ligase RNF168,19566,122,0.92 [0.59-1.45],0.7318525303702954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF31,E3 ubiquitin-protein ligase RNF31,19566,122,1.03 [0.65-1.65],0.8909419902579084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF4,E3 ubiquitin-protein ligase RNF4,19814,126,1.00 [0.77-1.30],0.98699526686316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF41,E3 ubiquitin-protein ligase NRDP1,22716,165,1.02 [0.83-1.26],0.8363352245711033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF43,E3 ubiquitin-protein ligase RNF43,19814,126,1.17 [0.91-1.49],0.2125844356452561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF5,E3 ubiquitin-protein ligase RNF5,19613,127,0.92 [0.73-1.16],0.4631105645325443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO1,Roundabout homolog 1,23263,169,2.19 [1.30-3.68],0.0032483503265885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO2,Roundabout homolog 2,23472,168,1.00 [0.55-1.81],0.9879759342219034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO4,Roundabout homolog 4,19613,127,0.44 [0.17-1.14],0.09202274723059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23267,170,1.54 [1.02-2.32],0.0400628041840922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RP2,Protein XRP2,23153,167,1.21 [0.89-1.63],0.2221210452772445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPA2,Replication protein A 32 kDa subunit,19566,122,1.12 [0.65-1.91],0.6927302737417215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPE,Ribulose-phosphate 3-epimerase,19814,126,1.08 [0.85-1.36],0.5384255208438056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPGR,X-linked retinitis pigmentosa GTPase regulator,19624,123,0.93 [0.59-1.45],0.7432114286373286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPL14,60S ribosomal protein L14,19613,127,1.03 [0.67-1.59],0.877030855333115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPS10,40S ribosomal protein S10,19476,122,0.96 [0.62-1.47],0.8457443762224659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRAS,Ras-related protein R-Ras,19624,123,1.03 [0.90-1.18],0.6308644171397939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2,Ribonucleoside-diphosphate reductase subunit M2,22716,165,1.16 [0.90-1.51],0.2468230877208687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22716,165,1.00 [0.81-1.23],0.9970637523120875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRP15,RRP15-like protein,19511,122,1.01 [0.83-1.22],0.9319575514828484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO1,R-spondin-1,23062,169,1.46 [0.99-2.15],0.0535217401881909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,23465,170,2.13 [1.39-3.27],0.0005625095403625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTBDN,Retbindin,23153,167,1.16 [0.75-1.80],0.5019281896494894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTKN2,Rhotekin-2,19476,122,1.03 [0.73-1.45],0.8519214169457334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",20124,129,1.03 [0.86-1.23],0.7580114143242791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4R,Reticulon-4 receptor,23465,170,1.32 [0.90-1.94],0.1538318418178301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RUVBL1,RuvB-like 1,22716,165,1.09 [0.96-1.24],0.1895652585528657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RWDD1,RWD domain-containing protein 1,23472,168,1.01 [0.81-1.26],0.9133968527426028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RYR1,Ryanodine receptor 1,19476,122,0.86 [0.50-1.49],0.6017542823698387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A11,Protein S100-A11,23090,168,1.02 [0.78-1.35],0.8635208103245874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A12,Protein S100-A12,22919,167,0.87 [0.72-1.05],0.1573139856071249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A13,Protein S100-A13,19566,122,1.05 [0.65-1.71],0.8327424165937551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A14,Protein S100-A14,20124,129,1.16 [0.86-1.58],0.3333117948805307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A16,Protein S100-A16,22707,164,1.06 [0.85-1.33],0.6155200373867762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A3,Protein S100-A3,20093,131,1.02 [0.70-1.47],0.933338057882668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A4,Protein S100-A4,23327,169,0.74 [0.58-0.94],0.0133851020597176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100G,Protein S100-G,20124,129,1.12 [0.81-1.55],0.4824407567667653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100P,Protein S100-P,22843,165,1.14 [0.91-1.43],0.2397579622558396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAA4,Serum amyloid A-4 protein,20185,128,0.68 [0.30-1.55],0.3525535656757753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAFB2,Scaffold attachment factor B2,20124,129,1.56 [0.96-2.52],0.0698822826783413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAG,S-arrestin,19511,122,1.30 [0.97-1.74],0.0798502315754414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAMD9L,Sterile alpha motif domain-containing protein 9-like,23240,169,0.98 [0.81-1.18],0.8328507780791061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAP18,Histone deacetylase complex subunit SAP18,19814,126,1.00 [0.79-1.26],0.9907828050524669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SARG,Specifically androgen-regulated gene protein,20090,130,1.00 [0.86-1.16],0.9897439536006244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SART1,U4/U6.U5 tri-snRNP-associated protein 1,19476,122,0.85 [0.51-1.41],0.5205546486523179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT1,Diamine acetyltransferase 1,19476,122,1.26 [0.93-1.71],0.135478853846908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT2,Thialysine N-epsilon-acetyltransferase,19814,126,1.12 [0.89-1.42],0.3181651199190012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SATB1,DNA-binding protein SATB1,20124,129,1.29 [0.78-2.15],0.3211713571873634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SBSN,Suprabasin,20135,128,0.88 [0.55-1.42],0.6086836635281319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCAMP3,Secretory carrier-associated membrane protein 3,23153,167,1.13 [0.97-1.33],0.1233462143548812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,23472,168,2.48 [1.63-3.77],2.0384887072885e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB1,Scavenger receptor class B member 1,22749,164,1.28 [1.06-1.55],0.0109532651044239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,22603,168,2.34 [1.70-3.22],1.8318801245366066e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF1,Scavenger receptor class F member 1,23559,171,1.19 [0.87-1.63],0.2815362262212789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,23472,168,2.10 [1.33-3.30],0.0013969364486474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG2,Secretogranin-2,23370,170,1.50 [1.01-2.22],0.0453907942595139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG3,Secretogranin-3,23263,169,1.29 [0.86-1.93],0.2183666819239336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB1A1,Uteroglobin,23268,169,1.07 [0.83-1.37],0.600518765917196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB2A2,Mammaglobin-A,19476,122,0.91 [0.50-1.67],0.7650479302586465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A1,Secretoglobin family 3A member 1,19710,123,0.80 [0.41-1.57],0.5213417280945802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A2,Secretoglobin family 3A member 2,23310,169,1.04 [0.88-1.23],0.661159657027275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGN,Secretagogin,22853,166,1.36 [1.02-1.81],0.036685370893628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCIN,Adseverin,19511,122,1.05 [0.83-1.32],0.6913999301842206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCLY,Selenocysteine lyase,23404,170,1.15 [0.87-1.51],0.3396401368944841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2A,Sodium channel protein type 2 subunit alpha,19511,122,0.90 [0.61-1.33],0.6060592476111031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2B,Sodium channel subunit beta-2,19624,123,0.67 [0.34-1.30],0.2349677450384095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3A,Sodium channel protein type 3 subunit alpha,19624,123,1.03 [0.63-1.67],0.920382818954462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3B,Sodium channel subunit beta-3,19511,122,0.95 [0.65-1.38],0.7701387993451636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN4B,Sodium channel subunit beta-4,19613,127,0.91 [0.62-1.35],0.6476877528312244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCP2,Non-specific lipid-transfer protein,22716,165,1.13 [0.96-1.34],0.1435894056961027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCPEP1,Retinoid-inducible serine carboxypeptidase,19548,127,1.15 [0.83-1.61],0.397319645359906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRG1,Scrapie-responsive protein 1,20163,130,1.40 [0.81-2.41],0.226619316434246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRIB,Protein scribble homolog,19613,127,0.98 [0.80-1.19],0.8115048752007937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRN1,Secernin-1,23240,169,1.07 [0.84-1.36],0.601024976494045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCT,Secretin,19624,123,0.75 [0.51-1.08],0.1251325879234476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,23267,170,1.39 [1.01-1.92],0.0432562410751641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC4,Syndecan-4,23267,170,0.99 [0.74-1.32],0.9419543362405188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDCCAG8,Serologically defined colon cancer antigen 8,20093,131,0.92 [0.79-1.07],0.2602971944740931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDHB,Succinate dehydrogenase,20100,129,1.26 [1.00-1.59],0.0467093552350955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDK2,Protein sidekick-2,19710,123,0.95 [0.60-1.50],0.8167263425231136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEC31A,Protein transport protein Sec31A,19613,127,0.95 [0.76-1.18],0.6302542021253561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEL1L,Protein sel-1 homolog 1,19613,127,1.23 [0.77-1.95],0.3878430317825957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELE,E-selectin,23559,171,1.06 [0.81-1.38],0.6618961092722291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELENOP,Selenoprotein P,20185,128,0.47 [0.27-0.83],0.0087650218034165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELL,L-selectin,20185,128,1.17 [0.56-2.42],0.6804369483906594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELP,P-selectin,23375,171,1.00 [0.78-1.27],0.9898982032101318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELPLG,P-selectin glycoprotein ligand 1,23240,169,1.05 [0.64-1.72],0.8450335007745926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3F,Semaphorin-3F,23267,170,1.70 [1.04-2.80],0.0358377234880717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3G,Semaphorin-3G,19710,123,0.97 [0.66-1.43],0.8743209134446762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4C,Semaphorin-4C,23153,167,1.17 [0.75-1.83],0.4823222230256099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4D,Semaphorin-4D,23472,168,1.38 [0.87-2.18],0.1691712598256822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA6C,Semaphorin-6C,19566,122,1.37 [0.76-2.48],0.2941412067682883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA7A,Semaphorin-7A,23483,171,1.37 [0.88-2.12],0.165208855281076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN3,Neuronal-specific septin-3,20124,129,1.08 [0.88-1.33],0.4544084452053135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN7,Septin-7,19814,126,0.92 [0.65-1.30],0.6370803519441839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN8,Septin-8,20077,128,1.24 [0.76-2.02],0.4001855886325426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN9,Septin-9,23153,167,1.15 [0.73-1.80],0.5463779285443406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA1,Alpha-1-antitrypsin,19815,126,2.02 [0.30-13.67],0.4731897408134596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA11,Serpin A11,23559,171,1.18 [0.85-1.63],0.3247369202412807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA12,Serpin A12,22603,165,1.09 [0.97-1.22],0.1579977859959069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA3,Alpha-1-antichymotrypsin,20122,128,1.47 [0.53-4.08],0.4621804202754652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA4,Kallistatin,19825,127,0.58 [0.28-1.18],0.1305698264876735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA5,Plasma serine protease inhibitor,19893,126,0.99 [0.56-1.74],0.9750829738969584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA6,Corticosteroid-binding globulin,20185,128,2.40 [0.84-6.88],0.1020180544665903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA7,Thyroxine-binding globulin,20185,128,1.01 [0.41-2.51],0.9798010668354704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA9,Serpin A9,23057,166,1.00 [0.83-1.21],0.9958878737100502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB1,Leukocyte elastase inhibitor,23197,167,0.97 [0.83-1.13],0.7155525987100575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB5,Serpin B5,22843,165,0.96 [0.72-1.28],0.7686396637411235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB6,Serpin B6,23393,168,1.11 [0.88-1.40],0.3876458174049281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB8,Serpin B8,23536,169,1.04 [0.84-1.29],0.6930045787870088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB9,Serpin B9,23062,169,1.07 [0.70-1.63],0.7633418193707269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINC1,Antithrombin-III,20152,127,0.75 [0.24-2.36],0.6180036415553559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPIND1,Heparin cofactor 2,20152,127,1.36 [0.75-2.43],0.3085503115442368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE1,Plasminogen activator inhibitor 1,23559,171,1.01 [0.83-1.24],0.9073617731031584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE2,Glia-derived nexin,20163,130,1.12 [0.87-1.45],0.3665796378327705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF1,Pigment epithelium-derived factor,19878,126,0.89 [0.47-1.71],0.7294615590983475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF2,Alpha-2-antiplasmin,19811,126,0.43 [0.17-1.08],0.0727487734203404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPING1,Plasma protease C1 inhibitor,20152,127,1.31 [0.53-3.27],0.5602510609659443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINH1,Serpin H1,19814,126,1.05 [0.92-1.20],0.4856935218471738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI1,Neuroserpin,19678,123,1.38 [0.78-2.44],0.2655815166752934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI2,Serpin I2,20100,129,0.78 [0.57-1.06],0.1078268881705631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22749,164,1.11 [0.90-1.38],0.3185418617534746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SETMAR,Histone-lysine N-methyltransferase SETMAR,22978,168,1.02 [0.65-1.61],0.923368846025716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6,Seizure protein 6 homolog,19624,123,1.17 [0.68-2.00],0.5669035172078203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L,Seizure 6-like protein,23327,169,1.11 [0.68-1.81],0.6762731230843368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L2,Seizure 6-like protein 2,23153,167,1.48 [0.85-2.57],0.1639277953990309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SF3B4,Splicing factor 3B subunit 4,23153,167,1.09 [0.91-1.30],0.3726440661299313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,22980,168,1.58 [1.22-2.05],0.0005283882429613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP4,Secreted frizzled-related protein 4,19710,123,1.06 [0.69-1.64],0.7943331897182043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA1,Pulmonary surfactant-associated protein A1,22716,165,1.04 [0.81-1.32],0.7738118963486031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA2,Pulmonary surfactant-associated protein A2,22716,165,1.10 [0.85-1.42],0.4539413050525847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPD,Pulmonary surfactant-associated protein D,23267,170,0.86 [0.71-1.06],0.1539802186318214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SGSH,N-sulphoglucosamine sulphohydrolase,19840,130,1.00 [0.74-1.35],0.9983771623462876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2B3,SH2B adapter protein 3,22716,165,1.04 [0.90-1.20],0.6071963406674756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2D1A,SH2 domain-containing protein 1A,23240,169,1.10 [0.89-1.36],0.3666877607218695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19511,122,1.27 [1.03-1.58],0.0277132006734137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BP1,SH3 domain-binding protein 1,20100,129,1.14 [0.84-1.55],0.3874405747692206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GL3,Endophilin-A3,19696,126,0.93 [0.76-1.13],0.4432093223510244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GLB2,Endophilin-B2,20115,129,0.85 [0.66-1.09],0.1951935165277318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHBG,Sex hormone-binding globulin,20188,130,1.28 [0.89-1.84],0.1903273673636875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHC1,SHC-transforming protein 1,19464,125,0.95 [0.81-1.11],0.4955761845629848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHD,SH2 domain-containing adapter protein D,19444,122,1.06 [0.88-1.28],0.5226882187724328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHH,Sonic hedgehog protein,19566,122,1.06 [0.71-1.58],0.7669372200271491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHISA5,Protein shisa-5,20171,128,1.78 [1.10-2.87],0.0184774877454128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHMT1,"Serine hydroxymethyltransferase, cytosolic",23310,169,0.92 [0.78-1.08],0.2896782064345382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHPK,Sedoheptulokinase,19814,126,0.88 [0.55-1.38],0.5684447396502145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIAE,Sialate O-acetylesterase,23286,169,1.18 [0.88-1.58],0.2588576990193672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,23346,169,2.10 [1.57-2.80],4.621053487853609e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC10,Sialic acid-binding Ig-like lectin 10,23240,169,1.70 [1.22-2.38],0.0019656245615965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC15,Sialic acid-binding Ig-like lectin 15,22749,164,1.02 [0.85-1.23],0.8135311852190676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC5,Sialic acid-binding Ig-like lectin 5,23278,167,1.30 [1.12-1.51],0.0007109327714099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC6,Sialic acid-binding Ig-like lectin 6,23465,170,1.32 [0.89-1.96],0.1720613102318698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC7,Sialic acid-binding Ig-like lectin 7,23267,170,2.03 [1.28-3.23],0.002835606365996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC8,Sialic acid-binding Ig-like lectin 8,19613,127,1.44 [1.01-2.07],0.0453863797935003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC9,Sialic acid-binding Ig-like lectin 9,23430,170,1.89 [1.21-2.94],0.0050719715469413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIL1,Nucleotide exchange factor SIL1,19613,127,0.86 [0.47-1.56],0.6161272433448319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,23333,171,1.30 [1.01-1.67],0.0421718955637141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPB1,Signal-regulatory protein beta-1,23182,169,1.52 [1.15-2.00],0.0029488206766876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT1,NAD-dependent protein deacetylase sirtuin-1,19566,122,0.92 [0.73-1.16],0.5051958988328247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT2,NAD-dependent protein deacetylase sirtuin-2,23153,167,1.08 [0.92-1.26],0.3663211187447706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22749,164,1.03 [0.80-1.33],0.8061620104345051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIT1,Signaling threshold-regulating transmembrane adapter 1,22853,166,1.26 [0.99-1.61],0.0615282352471848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP1,Src kinase-associated phosphoprotein 1,23029,169,1.05 [0.87-1.26],0.6181155578719635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP2,Src kinase-associated phosphoprotein 2,23346,169,1.05 [0.92-1.20],0.4572529006378096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKIV2L,Helicase SKI2W,19476,122,0.74 [0.44-1.23],0.2427005700405447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLA2,Src-like-adapter 2,20124,129,0.96 [0.82-1.12],0.6132491202920127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,22853,166,1.37 [1.09-1.73],0.0074073126372137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF6,SLAM family member 6,22716,165,1.15 [0.80-1.64],0.4439307976484455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF7,SLAM family member 7,23240,169,1.37 [1.11-1.70],0.0039574761023996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF8,SLAM family member 8,22716,165,1.43 [1.10-1.87],0.0076427380126079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC12A2,Solute carrier family 12 member 2,19476,122,0.96 [0.49-1.86],0.8940296370350003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC13A1,Solute carrier family 13 member 1,20093,131,1.02 [0.77-1.35],0.8866460569407928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC16A1,Monocarboxylate transporter 1,22749,164,1.31 [1.06-1.61],0.0107569114504958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC1A4,Neutral amino acid transporter A,19624,123,1.15 [0.84-1.58],0.3761279580680585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC27A4,Long-chain fatty acid transport protein 4,22749,164,1.29 [1.09-1.52],0.002681666482085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC28A1,Sodium/nucleoside cotransporter 1,19464,125,1.15 [0.90-1.49],0.2683679260431391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC34A3,Sodium-dependent phosphate transport protein 2C,19464,125,0.69 [0.44-1.06],0.0878447139784327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A14,Zinc transporter ZIP14,22749,164,1.53 [1.10-2.15],0.012789181862786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A5,Zinc transporter ZIP5,23240,169,0.95 [0.73-1.24],0.7034252971352529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC44A4,Choline transporter-like protein 4,19624,123,1.00 [0.77-1.30],0.9921149953065592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC4A1,Band 3 anion transport protein,20171,128,0.67 [0.46-0.97],0.0333728888089676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC51B,Organic solute transporter subunit beta,19476,122,1.04 [0.82-1.32],0.7316729532049506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19710,123,1.03 [0.84-1.26],0.7996459599437987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,20100,129,1.27 [0.99-1.64],0.0634691711980042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19464,125,1.22 [0.96-1.57],0.1058436096295948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIT2,Slit homolog 2 protein,22749,164,1.16 [0.91-1.47],0.2269726281708771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK1,SLIT and NTRK-like protein 1,19566,122,0.63 [0.37-1.07],0.0894243645255166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK2,SLIT and NTRK-like protein 2,23465,170,1.19 [0.85-1.65],0.3147600301308172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK6,SLIT and NTRK-like protein 6,22843,165,1.17 [0.80-1.73],0.4141337061343594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLK,STE20-like serine/threonine-protein kinase,19814,126,0.97 [0.76-1.22],0.7783920652947994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLMAP,Sarcolemmal membrane-associated protein,20100,129,1.00 [0.82-1.23],0.964758947160127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLURP1,Secreted Ly-6/uPAR-related protein 1,20032,128,1.12 [0.72-1.74],0.6262620437227844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD1,Mothers against decapentaplegic homolog 1,22716,165,1.09 [0.93-1.29],0.2743421894040326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD2,Mothers against decapentaplegic homolog 2,20093,131,0.99 [0.78-1.26],0.9475831209825916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD3,Mothers against decapentaplegic homolog 3,20093,131,0.96 [0.70-1.33],0.8229873369156904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD5,Mothers against decapentaplegic homolog 5,23153,167,1.56 [0.76-3.19],0.2235870771609888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMARCA2,Probable global transcription activator SNF2L2,22749,164,1.01 [0.83-1.23],0.9070499019164878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMC3,Structural maintenance of chromosomes protein 3,19464,125,1.02 [0.74-1.42],0.888298956807289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMNDC1,Survival of motor neuron-related-splicing factor 30,20100,129,0.96 [0.73-1.26],0.7683046559650426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC1,SPARC-related modular calcium-binding protein 1,23465,170,1.44 [0.97-2.15],0.0684317879524693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC2,SPARC-related modular calcium-binding protein 2,23346,169,1.35 [0.96-1.90],0.0802272621401688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD1,Sphingomyelin phosphodiesterase,23357,168,0.95 [0.73-1.24],0.7083595034185897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD3,Sphingomyelin phosphodiesterase 3,19566,122,0.89 [0.63-1.26],0.5136550725942182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,23301,169,0.84 [0.69-1.03],0.0872389437769461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,20093,131,1.11 [0.91-1.34],0.306121399252631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMS,Spermine synthase,19511,122,0.94 [0.71-1.25],0.6769265440358785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMTN,Smoothelin,20073,129,0.86 [0.71-1.05],0.1286343555648457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP23,Synaptosomal-associated protein 23,23267,170,0.99 [0.85-1.16],0.8881570272262347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP25,Synaptosomal-associated protein 25,19511,122,1.17 [0.82-1.67],0.3858936087077768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP29,Synaptosomal-associated protein 29,23327,169,1.06 [0.91-1.23],0.4646245455335789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAPIN,SNARE-associated protein Snapin,20124,129,0.84 [0.63-1.14],0.2621774503992036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCA,Alpha-synuclein,19710,123,0.96 [0.83-1.11],0.5643893182919473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCG,Gamma-synuclein,23062,169,1.11 [0.90-1.36],0.3266644586933578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19613,127,1.04 [0.60-1.78],0.8971798972000298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNRPB2,U2 small nuclear ribonucleoprotein B'',20115,129,0.91 [0.61-1.36],0.6512625109841441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNU13,NHP2-like protein 1,19476,122,1.01 [0.77-1.33],0.915984439486174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX15,Sorting nexin-15,19710,123,0.81 [0.59-1.12],0.2075242895584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX18,Sorting nexin-18,20100,129,1.24 [0.88-1.74],0.2195716493011753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX2,Sorting nexin-2,20093,131,1.06 [0.88-1.29],0.5134728888353002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX5,Sorting nexin-5,19613,127,0.77 [0.42-1.42],0.4035546379293164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX9,Sorting nexin-9,23267,170,1.07 [0.88-1.30],0.5091132646904253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD1,Superoxide dismutase [Cu-Zn],22823,168,0.84 [0.63-1.12],0.2366948432572991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD2,"Superoxide dismutase [Mn], mitochondrial",23278,167,1.25 [0.89-1.75],0.2041945386432968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD3,Extracellular superoxide dismutase,20188,130,0.90 [0.66-1.23],0.515430018499053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORBS1,Sorbin and SH3 domain-containing protein 1,20124,129,1.12 [0.76-1.67],0.5636319288126306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,22716,165,2.05 [1.47-2.87],2.705539201904873e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORD,Sorbitol dehydrogenase,23365,169,0.90 [0.74-1.10],0.2991700866480081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORT1,Sortilin,23237,170,1.08 [0.76-1.54],0.6751324365159057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOST,Sclerostin,23237,170,1.05 [0.74-1.48],0.7870168956036191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19624,123,1.21 [0.90-1.61],0.2039778686874701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX2,Transcription factor SOX-2,20084,129,0.64 [0.30-1.34],0.2329184529734683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX9,Transcription factor SOX-9,19624,123,0.94 [0.49-1.79],0.8526058609711913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,20124,129,1.11 [0.65-1.89],0.6973815661328093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPAG1,Sperm-associated antigen 1,20124,129,1.04 [0.79-1.37],0.7860045398557478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARC,SPARC,23327,169,0.96 [0.80-1.16],0.6941245724850347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARCL1,SPARC-like protein 1,23293,171,0.86 [0.52-1.41],0.5426613709179788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPART,Spartin,19710,123,0.90 [0.71-1.13],0.3498919558148282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPESP1,Sperm equatorial segment protein 1,20163,130,0.95 [0.58-1.56],0.8506373597768283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,23278,167,1.71 [1.28-2.27],0.000223829023474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK2,Serine protease inhibitor Kazal-type 2,19710,123,1.53 [0.99-2.37],0.0535992845346002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK4,Serine protease inhibitor Kazal-type 4,23240,169,1.21 [1.00-1.47],0.0559836867512522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK5,Serine protease inhibitor Kazal-type 5,23278,167,1.30 [0.89-1.90],0.1723882230485915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK6,Serine protease inhibitor Kazal-type 6,23465,170,1.46 [1.12-1.90],0.0048356247051653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK8,Serine protease inhibitor Kazal-type 8,19476,122,1.02 [0.63-1.67],0.9210267326514604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,23190,167,2.16 [1.39-3.36],0.0006084507975147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT2,Kunitz-type protease inhibitor 2,23346,169,1.29 [0.92-1.82],0.1439349718275954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT3,Kunitz-type protease inhibitor 3,20100,129,0.99 [0.89-1.09],0.817795136335863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPOCK1,Testican-1,23062,169,1.17 [0.70-1.96],0.5506683245686734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,23263,169,1.88 [1.34-2.66],0.0003113565631735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,23156,170,2.57 [1.79-3.68],2.8890564872911664e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,23524,171,1.50 [1.12-2.00],0.006264214073115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19566,122,0.77 [0.50-1.20],0.2556668812827558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRING1,SREBP regulating gene protein,19464,125,1.05 [0.80-1.39],0.732921464143393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR1B,Cornifin-B,19814,126,1.02 [0.83-1.25],0.8430979722194349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR3,Small proline-rich protein 3,20115,129,1.06 [0.81-1.38],0.6585291370411057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRY2,Protein sprouty homolog 2,22853,166,1.06 [0.91-1.22],0.4603860282128047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19511,122,0.82 [0.45-1.49],0.5150754121398504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTLC1,Serine palmitoyltransferase 1,20115,129,1.24 [0.86-1.79],0.2503200969446602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRC,Proto-oncogene tyrosine-protein kinase Src,23289,169,1.03 [0.92-1.16],0.5612492484848475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRP14,Signal recognition particle 14 kDa protein,23153,167,1.07 [0.86-1.33],0.5536695232635322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPK2,SRSF protein kinase 2,23240,169,1.07 [0.91-1.25],0.4210637705635107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,20163,130,1.84 [1.18-2.87],0.0070914187884601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSB,Lupus La protein,22749,164,0.92 [0.71-1.19],0.5035825836183574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19566,122,1.19 [0.75-1.89],0.4477227526445405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,23237,170,0.95 [0.85-1.06],0.3243579523331064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23375,171,0.94 [0.69-1.29],0.7030859666827053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSH3,Protein phosphatase Slingshot homolog 3,19464,125,0.56 [0.29-1.09],0.0868305961244203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSNA1,Sjoegren syndrome nuclear autoantigen 1,20100,129,1.06 [0.77-1.46],0.737479532480522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST13,Hsc70-interacting protein,19710,123,0.74 [0.54-1.01],0.0600941256683118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",23153,167,1.25 [0.94-1.66],0.1251695438600572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23559,171,1.83 [1.30-2.58],0.0005044379010136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19566,122,1.05 [0.75-1.47],0.7803674179867209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAB2,Stabilin-2,20171,128,1.09 [0.59-2.01],0.7797357356391235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAM,Signal transducing adapter molecule 1,20093,131,0.77 [0.47-1.27],0.3121818498428802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAMBP,STAM-binding protein,23029,169,1.04 [0.84-1.29],0.7124557453706087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT2,Signal transducer and activator of transcription 2,19566,122,1.01 [0.81-1.27],0.9332030986554336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT5B,Signal transducer and activator of transcription 5B,23153,167,1.00 [0.90-1.11],0.9975680888701752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19464,125,1.22 [0.98-1.53],0.0801996677819762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC1,Stanniocalcin-1,23472,168,1.33 [1.01-1.75],0.0449148518813945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC2,Stanniocalcin-2,23248,167,0.97 [0.55-1.70],0.9047134634676308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STEAP4,Metalloreductase STEAP4,19511,122,0.90 [0.69-1.18],0.4603682733008915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STIP1,Stress-induced-phosphoprotein 1,23232,167,0.97 [0.79-1.21],0.8150975296944967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK11,Serine/threonine-protein kinase STK11,22843,165,1.00 [0.83-1.21],0.9936366535432714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK24,Serine/threonine-protein kinase 24,22749,164,1.08 [0.86-1.35],0.4923001504461405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK4,Serine/threonine-protein kinase 4,23267,170,1.11 [0.95-1.30],0.1709876847559305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STOML2,"Stomatin-like protein 2, mitochondrial",19464,125,1.07 [0.90-1.28],0.4388011705410983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX16,Syntaxin-16,22716,165,1.11 [0.88-1.40],0.3780429341969749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX1B,Syntaxin-1B,19624,123,0.59 [0.34-1.03],0.0631757360053726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX3,Syntaxin-3,20115,129,0.83 [0.51-1.38],0.4803358841717841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX4,Syntaxin-4,23153,167,1.18 [0.96-1.44],0.1110032358877167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX5,Syntaxin-5,19566,122,0.98 [0.63-1.52],0.933213852528773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX6,Syntaxin-6,22716,165,1.17 [0.97-1.42],0.1064346119331606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX7,Syntaxin-7,19566,122,0.78 [0.54-1.11],0.1708717118575234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX8,Syntaxin-8,23240,169,0.98 [0.73-1.30],0.8636932723352342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP1,Syntaxin-binding protein 1,20124,129,0.91 [0.73-1.13],0.3810562991821918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP3,Syntaxin-binding protein 3,22716,165,1.07 [0.78-1.46],0.6778166304273551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGP1,SURP and G-patch domain-containing protein 1,20100,129,0.98 [0.64-1.48],0.9064501507793354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGT1,Protein SGT1 homolog,22716,165,1.05 [0.88-1.25],0.6113118757788366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT1A1,Sulfotransferase 1A1,23472,168,1.05 [0.95-1.17],0.3389082392514472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT2A1,Bile salt sulfotransferase,23240,169,1.20 [0.98-1.47],0.0824551407200186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF1,Formylglycine-generating enzyme,19566,122,1.16 [0.93-1.45],0.1958296637547572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,23472,168,1.23 [0.94-1.60],0.1353289574794106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUOX,"Sulfite oxidase, mitochondrial",20124,129,1.07 [0.82-1.39],0.6154372280792195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD1,Sushi domain-containing protein 1,22843,165,1.07 [0.80-1.42],0.6573895171965054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD2,Sushi domain-containing protein 2,23278,167,1.01 [0.62-1.62],0.9836833014964078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD4,Sushi domain-containing protein 4,20093,131,1.10 [0.73-1.66],0.6477891020300399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD5,Sushi domain-containing protein 5,19610,123,0.88 [0.53-1.45],0.6058816641572076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SV2A,Synaptic vesicle glycoprotein 2A,19624,123,1.14 [0.88-1.47],0.3344456774995054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SWAP70,Switch-associated protein 70,20100,129,1.13 [0.72-1.76],0.5898000714404479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYAP1,Synapse-associated protein 1,19710,123,0.99 [0.74-1.34],0.9619422857923388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19511,122,1.12 [0.85-1.48],0.4114403806345285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYT1,Synaptotagmin-1,20115,129,1.03 [0.68-1.55],0.9007966147872728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYTL4,Synaptotagmin-like protein 4,20163,130,0.97 [0.77-1.23],0.8109229048646378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19814,126,0.95 [0.80-1.12],0.52408285850745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACC3,Transforming acidic coiled-coil-containing protein 3,23153,167,0.99 [0.88-1.11],0.8098121489112771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACSTD2,Tumor-associated calcium signal transducer 2,20601,152,1.04 [0.63-1.71],0.8917355338359716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TADA3,Transcriptional adapter 3,20093,131,0.94 [0.62-1.44],0.7903393545451111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,23153,167,1.96 [1.42-2.71],4.201811525466447e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAGLN3,Transgelin-3,19464,125,0.79 [0.59-1.07],0.1240372851340694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TALDO1,Transaldolase,20102,128,0.88 [0.59-1.30],0.5199216071521907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TANK,TRAF family member-associated NF-kappa-B activator,22853,166,1.11 [0.91-1.35],0.2956229045249444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAP1,Antigen peptide transporter 1,19814,126,1.13 [0.87-1.46],0.3571044576187906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARBP2,RISC-loading complex subunit TARBP2,22749,164,1.09 [0.91-1.29],0.3579438714533413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19624,123,0.91 [0.71-1.17],0.4589010850041409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",20093,131,1.10 [0.71-1.71],0.6723618121026023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAX1BP1,Tax1-binding protein 1,20115,129,0.79 [0.59-1.06],0.117616640731598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D17,TBC1 domain family member 17,22749,164,1.14 [0.84-1.54],0.4127985936812613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D23,TBC1 domain family member 23,23153,167,1.07 [0.92-1.24],0.3920497762592635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D5,TBC1 domain family member 5,23240,169,0.87 [0.73-1.05],0.1381502431586692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCA,Tubulin-specific chaperone A,19710,123,0.94 [0.76-1.16],0.5438747200066526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCB,Tubulin-folding cofactor B,23062,169,1.03 [0.90-1.18],0.6796514361610269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCC,Tubulin-specific chaperone C,23062,169,1.07 [0.90-1.27],0.435101651304739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBL1X,F-box-like/WD repeat-containing protein TBL1X,22716,165,1.09 [0.93-1.29],0.2784099439641068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBR1,T-box brain protein 1,19624,123,1.18 [0.87-1.59],0.2833751373213346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1A,T-cell leukemia/lymphoma protein 1A,23033,169,0.97 [0.85-1.11],0.6549177136106028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1B,T-cell leukemia/lymphoma protein 1B,22843,165,0.99 [0.83-1.18],0.8979333519544371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN1,Transcobalamin-1,19792,128,1.34 [0.89-2.02],0.1619885406413397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,23524,171,1.95 [1.34-2.85],0.0005414584683443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCOF1,Treacle protein,20163,130,0.87 [0.51-1.51],0.626936055011913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCP11,T-complex protein 11 homolog,19814,126,1.13 [0.87-1.46],0.3466502835144474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCTN3,Tectonic-3,20163,130,1.08 [0.63-1.86],0.7851979267339668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDGF1,Teratocarcinoma-derived growth factor 1,22749,164,1.05 [0.96-1.16],0.2587114597272658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDO2,"Tryptophan 2,3-dioxygenase",19624,123,1.02 [0.66-1.58],0.9330845493400112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDP1,Tyrosyl-DNA phosphodiesterase 1,20093,131,1.03 [0.82-1.30],0.776563324903218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDRKH,Tudor and KH domain-containing protein,22749,164,1.20 [1.03-1.40],0.0207054535754896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEF,Thyrotroph embryonic factor,19476,122,0.85 [0.55-1.30],0.4477892608589322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEK,Angiopoietin-1 receptor,23327,169,1.02 [0.55-1.89],0.9499195683491088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TERF1,Telomeric repeat-binding factor 1,19566,122,1.21 [0.68-2.17],0.5187907136586578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TET2,Methylcytosine dioxygenase TET2,19778,126,1.21 [1.07-1.37],0.0023719756779456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX101,Testis-expressed protein 101,19624,123,1.29 [0.99-1.69],0.0586630858657136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX33,Testis-expressed protein 33,19814,126,1.21 [0.84-1.76],0.3025865563922824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TF,Serotransferrin,20185,128,1.04 [0.48-2.26],0.9247858279672952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFAP2A,Transcription factor AP-2-alpha,19511,122,0.88 [0.64-1.21],0.4327189144456667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,23166,166,1.24 [1.07-1.45],0.0053303178534376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,23310,169,1.41 [1.14-1.75],0.0015452392927151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,23259,170,1.67 [1.35-2.06],2.396063065309094e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI,Tissue factor pathway inhibitor,23227,170,0.81 [0.52-1.27],0.3665494161438509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI2,Tissue factor pathway inhibitor 2,23265,169,1.18 [0.89-1.56],0.248082117973011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFRC,Transferrin receptor protein 1,23369,171,0.94 [0.66-1.34],0.7299442990643772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TG,Thyroglobulin,20093,131,1.12 [0.97-1.30],0.1280851529987477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,23240,169,1.69 [1.31-2.18],5.478713016969592e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB1,Transforming growth factor beta-1 proprotein,23498,168,1.29 [0.93-1.80],0.1306005727116206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB2,Transforming growth factor beta-2 proprotein,20093,131,1.04 [0.76-1.43],0.7945911095649169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBI,Transforming growth factor-beta-induced protein ig-h3,23153,170,0.76 [0.46-1.26],0.2900220663267742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR1,TGF-beta receptor type-1,19566,122,1.05 [0.48-2.29],0.9012688562549932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,23327,169,1.68 [1.20-2.34],0.0024980179109002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR3,Transforming growth factor beta receptor type 3,23559,171,1.61 [1.04-2.51],0.0333103612586763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGM2,Protein-glutamine gamma-glutamyltransferase 2,23227,170,0.85 [0.71-1.02],0.084995658891785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGOLN2,Trans-Golgi network integral membrane protein 2,20188,130,1.54 [0.84-2.83],0.1618006842261401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THAP12,52 kDa repressor of the inhibitor of the protein kinase,19430,125,0.89 [0.71-1.12],0.3289796002288677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBD,Thrombomodulin,23267,170,1.67 [1.10-2.54],0.015949007928201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,23278,167,1.52 [1.11-2.09],0.0097669058579345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS4,Thrombospondin-4,23303,170,1.19 [0.89-1.60],0.2377903842863275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THOP1,Thimet oligopeptidase,23157,170,0.84 [0.54-1.29],0.4210081643595286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THPO,Thrombopoietin,22843,165,1.28 [0.91-1.81],0.1593423671793759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THRAP3,Thyroid hormone receptor-associated protein 3,19476,122,1.20 [1.06-1.36],0.0050312816152313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THSD1,Thrombospondin type-1 domain-containing protein 1,19429,122,0.78 [0.46-1.33],0.3606344558964636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THTPA,Thiamine-triphosphatase,20046,131,0.96 [0.79-1.16],0.6423350691507467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THY1,Thy-1 membrane glycoprotein,23472,168,1.95 [1.25-3.04],0.0032557199226979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIA1,Nucleolysin TIA-1 isoform p40,22591,164,1.02 [0.91-1.14],0.7365434923772634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIE1,Tyrosine-protein kinase receptor Tie-1,23559,171,1.28 [0.89-1.83],0.1805589857085942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22716,164,1.20 [0.91-1.59],0.1964054268335478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19814,126,1.35 [0.92-1.96],0.1226536024437821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,23375,171,1.15 [0.84-1.57],0.3783064565712117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,20163,130,1.11 [0.74-1.67],0.6230279964271603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,20115,129,0.97 [0.79-1.18],0.7421920696346405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,23037,169,1.75 [1.14-2.69],0.0101374126774956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP2,Metalloproteinase inhibitor 2,20163,130,1.02 [0.56-1.88],0.9426142664606676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP3,Metalloproteinase inhibitor 3,23346,169,1.10 [1.00-1.22],0.0602801680798909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,23278,167,1.70 [1.25-2.31],0.0006871113326633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TINAGL1,Tubulointerstitial nephritis antigen-like,23201,170,1.92 [1.05-3.51],0.0335310899126949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJAP1,Tight junction-associated protein 1,23327,169,0.98 [0.83-1.15],0.793833116213717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJP3,Tight junction protein ZO-3,19511,122,1.03 [0.68-1.56],0.876420770280826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TK1,"Thymidine kinase, cytosolic",19814,126,0.99 [0.67-1.45],0.9420659996851511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR1,Toll-like receptor 1,19566,122,2.05 [1.15-3.68],0.0157258166244411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR2,Toll-like receptor 2,19814,126,2.15 [1.15-4.01],0.0162814209802595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR3,Toll-like receptor 3,23536,169,1.02 [0.82-1.27],0.8680258128026066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR4,Toll-like receptor 4,19566,122,0.78 [0.41-1.47],0.4469769314143922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19624,123,1.25 [0.94-1.66],0.1284955044946408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED1,Transmembrane emp24 domain-containing protein 1,19814,126,0.56 [0.39-0.82],0.0030808015703273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED10,Transmembrane emp24 domain-containing protein 10,19476,122,0.91 [0.60-1.39],0.667148711349824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED4,Transmembrane emp24 domain-containing protein 4,19476,122,0.66 [0.44-0.99],0.046092330019848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED8,Protein TMED8,20100,129,0.99 [0.84-1.17],0.9371406159722154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM106A,Transmembrane protein 106A,20093,131,1.04 [0.83-1.31],0.7251941382740245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM132A,Transmembrane protein 132A,19613,127,1.18 [0.90-1.53],0.2269270174729805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM25,Transmembrane protein 25,20124,129,0.98 [0.68-1.41],0.906308057176451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMOD4,Tropomodulin-4,19464,125,0.92 [0.59-1.43],0.7088850165287448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11B,Transmembrane protease serine 11B,19511,122,0.80 [0.61-1.06],0.122277565202272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11D,Transmembrane protease serine 11D,20077,128,1.45 [0.99-2.13],0.0588066804184849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS15,Enteropeptidase,23153,167,1.03 [0.88-1.20],0.7536151420481081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS5,Transmembrane protease serine 5,22949,167,1.87 [1.32-2.66],0.0004723427812654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMSB10,Thymosin beta-10,23278,167,1.22 [1.02-1.46],0.0270897428005323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNC,Tenascin,23375,171,1.25 [0.95-1.64],0.1133239634480694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNF,Tumor necrosis factor,22811,164,1.49 [1.14-1.96],0.00374933283974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,20100,129,1.01 [0.72-1.42],0.9490545485974772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22853,166,1.11 [0.77-1.60],0.5719562184681899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19710,123,0.95 [0.72-1.26],0.7341643280820485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,23062,169,1.92 [1.42-2.60],2.2772986895911348e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,23062,169,1.36 [1.16-1.60],0.0002044554214013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,23341,171,1.05 [0.79-1.39],0.7401698732361033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23536,169,2.00 [1.50-2.68],3.002993425937958e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,23227,169,2.02 [1.33-3.07],0.0010170488348133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23327,169,2.00 [1.45-2.76],2.819694739190365e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23263,169,1.83 [1.42-2.35],2.940375987921701e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22853,166,1.24 [0.91-1.68],0.1769807379737696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23263,169,2.31 [1.60-3.33],8.057694648738202e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19710,123,1.44 [0.96-2.17],0.0781121919734907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23465,170,2.09 [1.52-2.88],6.503027616670147e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,23278,167,2.73 [1.92-3.88],2.283974369562565e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,23278,167,1.78 [1.46-2.17],1.2086271490466783e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23472,168,1.89 [1.21-2.97],0.0052230404829259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23498,168,2.02 [1.49-2.73],5.698678206185693e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,23062,169,1.62 [1.34-1.96],8.282814695706891e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23472,168,1.36 [1.03-1.81],0.0325205387221164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,23062,169,1.73 [1.38-2.15],1.4940161761081007e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF10,Tumor necrosis factor ligand superfamily member 10,23536,169,1.07 [0.63-1.81],0.803545453334502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF11,Tumor necrosis factor ligand superfamily member 11,23240,169,1.01 [0.81-1.26],0.9464220792492528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF12,Tumor necrosis factor ligand superfamily member 12,23536,169,0.58 [0.35-0.94],0.0257336455963449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,23346,169,2.53 [1.60-4.01],7.505586389539338e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23524,171,2.21 [1.46-3.34],0.0001604491474882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF14,Tumor necrosis factor ligand superfamily member 14,23062,169,1.03 [0.82-1.30],0.7931066364044359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF8,Tumor necrosis factor ligand superfamily member 8,20171,128,1.86 [1.23-2.82],0.0034015098199436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNIP1,TNFAIP3-interacting protein 1,20115,129,0.82 [0.67-1.00],0.0452232997770719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNN,Tenascin-N,20171,128,1.17 [0.79-1.74],0.4199712764900368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNNI3,"Troponin I, cardiac muscle",22843,165,0.93 [0.80-1.09],0.3973775706070083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNPO1,Transportin-1,19814,126,0.89 [0.54-1.45],0.6367963661431892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNR,Tenascin-R,23062,169,0.94 [0.68-1.29],0.6911567539017671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNXB,Tenascin-X,23278,167,1.34 [0.79-2.26],0.2752824597090761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,20163,130,1.05 [0.85-1.30],0.6494447469266474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1,DNA topoisomerase 1,20100,129,0.99 [0.86-1.14],0.8942539517389313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1MT,"DNA topoisomerase I, mitochondrial",19464,125,0.92 [0.63-1.34],0.6487526561705204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP2B,DNA topoisomerase 2-beta,19566,122,0.88 [0.70-1.10],0.2693306148923764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOR1AIP1,Torsin-1A-interacting protein 1,19613,127,0.88 [0.63-1.24],0.467536181154676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53,Cellular tumor antigen p53,22716,165,1.20 [0.88-1.62],0.2422777328421891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53BP1,TP53-binding protein 1,19566,122,1.05 [0.85-1.29],0.6445272184774011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53I3,Quinone oxidoreductase PIG3,19281,121,0.88 [0.63-1.24],0.4678581768592371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53INP1,Tumor protein p53-inducible nuclear protein 1,22843,165,1.06 [0.68-1.65],0.8100093506272321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP73,Tumor protein p73,19624,123,1.11 [0.67-1.86],0.6772716669729213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPBGL,Trophoblast glycoprotein-like,19624,123,0.75 [0.46-1.21],0.2340142327895148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPD52L2,Tumor protein D54,19710,123,0.98 [0.84-1.15],0.8101922673147024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPK1,Thiamin pyrophosphokinase 1,20163,130,1.51 [0.84-2.73],0.1662584543674599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPM3,Tropomyosin alpha-3 chain,19476,122,0.96 [0.65-1.41],0.8383111734288151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPMT,Thiopurine S-methyltransferase,22716,165,0.81 [0.66-0.99],0.037107934517847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPP1,Tripeptidyl-peptidase 1,23073,169,1.25 [0.96-1.64],0.0951373489462033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP2,Tubulin polymerization-promoting protein family member 2,19814,126,1.04 [0.83-1.29],0.7524384261744774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP3,Tubulin polymerization-promoting protein family member 3,22749,164,0.89 [0.60-1.31],0.54998957188799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPR,Nucleoprotein TPR,19476,122,0.94 [0.65-1.36],0.7378212962674546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPRKB,EKC/KEOPS complex subunit TPRKB,19464,125,1.13 [0.90-1.41],0.3068740428942696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSAB1,Tryptase alpha/beta-1,23498,169,1.36 [1.05-1.77],0.0213534805676312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSD1,Tryptase delta,20124,129,1.22 [0.82-1.82],0.3307035033789607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSG1,Tryptase gamma,19566,122,0.97 [0.51-1.87],0.936309356381892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPT1,Translationally-controlled tumor protein,22853,166,0.96 [0.77-1.20],0.7368937774945943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF2,TNF receptor-associated factor 2,23240,169,0.88 [0.72-1.08],0.2213993123010516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3,"TNF receptor-associated factor 3, Isoform 2",19566,122,0.98 [0.62-1.56],0.9291021319144118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19476,122,0.96 [0.66-1.40],0.8271926270165353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19814,126,0.90 [0.72-1.11],0.3077136649845772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREH,Trehalase,20171,128,0.91 [0.73-1.13],0.3985063877787355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,23227,169,1.44 [1.14-1.83],0.0021164297797546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML1,Trem-like transcript 1 protein,20188,130,1.07 [0.78-1.46],0.6852510794018507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,23278,167,1.85 [1.29-2.64],0.0007556564012281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIAP1,TP53-regulated inhibitor of apoptosis 1,23465,170,1.25 [1.01-1.55],0.0372647570835765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM21,E3 ubiquitin-protein ligase TRIM21,23240,169,0.94 [0.78-1.13],0.5168415688136291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM24,Transcription intermediary factor 1-alpha,19779,126,1.17 [0.91-1.49],0.2213340989793369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,20100,129,0.97 [0.83-1.13],0.6955957059189075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM26,Tripartite motif-containing protein 26,19464,125,0.89 [0.64-1.24],0.4970264430450228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM40,E3 ubiquitin ligase TRIM40,19624,123,1.14 [0.91-1.43],0.2462826953488879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM5,Tripartite motif-containing protein 5,23240,169,1.00 [0.85-1.17],0.975900598117576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM58,E3 ubiquitin-protein ligase TRIM58,20093,131,0.99 [0.82-1.20],0.9134340832095884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRPV3,Transient receptor potential cation channel subfamily V member 3,19476,122,0.62 [0.41-0.96],0.0299334717371705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC1,Hamartin,19566,122,0.54 [0.37-0.80],0.0020415918793338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC22D1,TSC22 domain family protein 1,20124,129,1.00 [0.77-1.29],0.9844986525190424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSHB,Thyrotropin subunit beta,23267,170,0.85 [0.70-1.03],0.1031370640609316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSLP,Thymic stromal lymphopoietin,22843,165,1.04 [0.83-1.30],0.7327009310184995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSNAX,Translin-associated protein X,19476,122,0.67 [0.42-1.06],0.0876876033933826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN1,Tetraspanin-1,22843,165,0.98 [0.83-1.17],0.8439771561593983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN15,Tetraspanin-15,19476,122,1.08 [0.79-1.49],0.6252348141456048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN7,Tetraspanin-7,19511,122,0.89 [0.72-1.10],0.2742271792995975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN8,Tetraspanin-8,20100,129,1.23 [1.03-1.46],0.0227933850551832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPYL1,Testis-specific Y-encoded-like protein 1,19566,122,0.93 [0.59-1.45],0.7338501194785056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TST,Thiosulfate sulfurtransferase,22713,164,1.12 [0.93-1.34],0.2372873174276337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTF2,Transcription termination factor 2,19624,123,1.03 [0.73-1.47],0.8475052398050866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTN,Titin,19476,122,1.21 [0.96-1.51],0.0996393567952686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTR,Transthyretin,19970,127,0.49 [0.26-0.94],0.0328026585311237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TUBB3,Tubulin beta-3 chain,19511,122,1.39 [0.79-2.45],0.2576170348058819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TWF2,Twinfilin-2,20171,128,0.97 [0.80-1.19],0.7972073824580412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXK,Tyrosine-protein kinase TXK,19814,126,1.03 [0.82-1.29],0.8234607438083765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXLNA,Alpha-taxilin,23062,169,1.05 [0.90-1.23],0.5484518100699198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXN,Thioredoxin,19865,128,0.83 [0.55-1.26],0.3797969631745104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC15,Thioredoxin domain-containing protein 15,23327,169,1.44 [0.89-2.33],0.1359338843566379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC5,Thioredoxin domain-containing protein 5,23472,168,1.28 [1.06-1.55],0.011597034975908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC9,Thioredoxin domain-containing protein 9,20115,129,1.08 [0.79-1.48],0.6230786482330345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNL1,Thioredoxin-like protein 1,19477,122,1.08 [0.92-1.27],0.3519723747741782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",23278,167,0.96 [0.71-1.29],0.7904887223087661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYMP,Thymidine phosphorylase,23120,170,1.17 [0.96-1.44],0.1264871321544347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRO3,Tyrosine-protein kinase receptor TYRO3,23267,170,1.08 [0.67-1.74],0.758751952071666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19566,122,0.99 [0.75-1.31],0.9542948681157548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBAC1,Ubiquitin-associated domain-containing protein 1,23153,167,0.70 [0.46-1.05],0.0860749159562008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2B,Ubiquitin-conjugating enzyme E2 B,20093,131,1.20 [0.68-2.09],0.531903980823524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,20163,130,1.07 [0.81-1.40],0.6437210884933349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19566,122,0.89 [0.64-1.22],0.4594076153308583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBQLN3,Ubiquilin-3,19476,122,1.25 [0.98-1.60],0.0665883161284443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBXN1,UBX domain-containing protein 1,19710,123,0.86 [0.66-1.12],0.2647850150117827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,20100,129,1.02 [0.90-1.15],0.7782290266176832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UGDH,UDP-glucose 6-dehydrogenase,19476,122,1.16 [1.01-1.34],0.0365725525759334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UHRF2,E3 ubiquitin-protein ligase UHRF2,19476,122,0.68 [0.37-1.23],0.2020767684550376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,23062,169,1.84 [1.34-2.52],0.0001414259322579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UMOD,Uromodulin,23478,171,0.71 [0.57-0.90],0.0042757020881375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC5D,Netrin receptor UNC5D,19566,122,0.97 [0.50-1.88],0.9205196333730048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC79,Protein unc-79 homolog,19464,125,0.90 [0.65-1.25],0.5265692188607967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNG,Uracil-DNA glycosylase,20093,131,1.09 [0.69-1.74],0.7068049241063998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPB1,Beta-ureidopropionase,20163,130,1.02 [0.85-1.23],0.7953490040425132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3A,Uroplakin-3a,19511,122,1.37 [1.00-1.87],0.0521399460721351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3BL1,Uroplakin-3b-like protein 1,19774,126,0.83 [0.56-1.23],0.3481763859293872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROD,Uroporphyrinogen decarboxylase,19710,123,0.80 [0.61-1.04],0.0908988102382411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROS,Uroporphyrinogen-III synthase,19624,123,0.74 [0.55-0.99],0.0428040845377337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USO1,General vesicular transport factor p115,23153,167,1.10 [0.94-1.29],0.2167206697967142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP25,Ubiquitin carboxyl-terminal hydrolase 25,20093,131,0.96 [0.76-1.21],0.7364804933049975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP28,Ubiquitin carboxyl-terminal hydrolase 28,20115,129,1.24 [0.82-1.86],0.3082411316065809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP47,Ubiquitin carboxyl-terminal hydrolase 47,19476,122,0.84 [0.67-1.06],0.135457168787887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP8,Ubiquitin carboxyl-terminal hydrolase 8,22843,165,1.07 [0.93-1.24],0.3638170704315704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UXS1,UDP-glucuronic acid decarboxylase 1,22716,165,0.91 [0.69-1.21],0.5292386614347856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP5,Vesicle-associated membrane protein 5,22843,165,1.33 [1.08-1.63],0.0071683626033157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP8,Vesicle-associated membrane protein 8,19566,122,1.07 [0.88-1.30],0.5056384911326856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASH1,Tubulinyl-Tyr carboxypeptidase 1,23240,169,1.08 [0.91-1.27],0.3824516313856873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASN,Vasorin,22920,168,1.44 [0.88-2.35],0.1449029061360121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASP,Vasodilator-stimulated phosphoprotein,20188,130,1.01 [0.80-1.27],0.9405107753585388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,23153,167,1.24 [0.62-2.48],0.5422596397584176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAV3,Guanine nucleotide exchange factor VAV3,19511,122,0.99 [0.83-1.18],0.9030071939965308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,23341,171,2.18 [1.39-3.41],0.0006924777096373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAN,Versican core protein,23472,168,1.88 [1.22-2.90],0.0045167728410446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCPKMT,Protein-lysine methyltransferase METTL21D,19464,125,1.11 [0.94-1.32],0.2274594597168088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFA,Vascular endothelial growth factor A,23462,169,1.01 [0.79-1.28],0.9488615367070538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFB,Vascular endothelial growth factor B,19566,122,1.54 [0.86-2.75],0.1484569047857726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFC,Vascular endothelial growth factor C,23327,169,1.03 [0.81-1.31],0.8062778697228818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFD,Vascular endothelial growth factor D,23502,169,1.24 [0.87-1.76],0.2407120920818148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VGF,Neurosecretory protein VGF,20124,129,1.18 [0.69-2.04],0.5470329991973125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIM,Vimentin,22843,165,0.97 [0.87-1.09],0.6504580963738775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIPR1,Vasoactive intestinal polypeptide receptor 1,19613,127,0.48 [0.22-1.07],0.0734898358976671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIT,Vitrin,20163,130,1.50 [0.97-2.31],0.068040938268916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VMO1,Vitelline membrane outer layer protein 1 homolog,23153,167,1.10 [0.90-1.36],0.3436156065540194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN1,Pantetheinase,20188,130,1.01 [0.80-1.27],0.9235921254599366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN2,Vascular non-inflammatory molecule 2,23153,167,1.24 [0.91-1.67],0.1678108572462859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS28,Vacuolar protein sorting-associated protein 28 homolog,19814,126,1.15 [0.90-1.48],0.2590113772249299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS37A,Vacuolar protein sorting-associated protein 37A,23153,167,1.03 [0.87-1.22],0.7328418557337876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS4B,Vacuolar protein sorting-associated protein 4B,20093,131,1.06 [0.89-1.26],0.5214044460789495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS53,Vacuolar protein sorting-associated protein 53 homolog,23153,167,1.12 [0.94-1.32],0.2106494489156347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10,V-set and immunoglobulin domain-containing protein 10,20093,131,1.49 [1.03-2.17],0.0360387684572917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19476,122,1.32 [0.83-2.11],0.2439761617037683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG2,V-set and immunoglobulin domain-containing protein 2,20093,131,1.32 [1.04-1.66],0.0206088035819605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,23248,167,2.93 [2.26-3.82],9.91802248892269e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,23230,169,1.20 [0.98-1.48],0.0799101666563322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSNL1,Visinin-like protein 1,20115,129,1.04 [0.68-1.59],0.8582311506040389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM1,V-set and transmembrane domain-containing protein 1,22749,164,1.31 [1.03-1.68],0.0302229410737678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2B,V-set and transmembrane domain-containing protein 2B,19814,126,0.73 [0.44-1.21],0.2197907683497384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22843,165,1.17 [0.94-1.44],0.1563065778949599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,23472,168,1.06 [0.87-1.28],0.5850263414790313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTCN1,V-set domain-containing T-cell activation inhibitor 1,22716,165,1.61 [1.08-2.41],0.0194915049379166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19710,123,0.89 [0.65-1.22],0.4778556142758804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA1,von Willebrand factor A domain-containing protein 1,23439,170,1.52 [1.11-2.08],0.0083912930182016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA5A,von Willebrand factor A domain-containing protein 5A,19464,125,1.08 [0.88-1.32],0.468770044931497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,22988,168,2.16 [1.57-2.97],2.3314857850810484e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2L,von Willebrand factor C domain-containing protein 2-like,20124,129,1.14 [0.82-1.60],0.4350214746614391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWF,von Willebrand factor,23559,171,1.07 [0.90-1.29],0.446016423183425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WARS,"Tryptophan--tRNA ligase, cytoplasmic",23278,167,1.40 [0.97-2.00],0.0690053922015859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WAS,Wiskott-Aldrich syndrome protein,22853,166,1.07 [0.87-1.31],0.5277132022316122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF1,Wiskott-Aldrich syndrome protein family member 1,22843,165,1.08 [0.93-1.24],0.3150057884762118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF3,Wiskott-Aldrich syndrome protein family member 3,22749,164,1.08 [0.92-1.28],0.3324091590992413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASHC3,WASH complex subunit 3,20115,129,0.91 [0.72-1.15],0.4337977627807767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASL,Neural Wiskott-Aldrich syndrome protein,19566,122,0.92 [0.67-1.27],0.6224003784697858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WDR46,WD repeat-containing protein 46,20093,131,1.05 [0.68-1.64],0.8157571251024531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC1,WAP four-disulfide core domain protein 1,19675,128,1.05 [0.77-1.41],0.7721441101274774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC12,WAP four-disulfide core domain protein 12,23418,170,1.23 [1.00-1.51],0.0518567165845639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,22096,160,2.08 [1.60-2.70],3.188639739652933e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22978,168,0.66 [0.47-0.93],0.0166791515944163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",23263,169,1.07 [0.71-1.61],0.756132757387415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WIF1,Wnt inhibitory factor 1,23465,170,1.25 [0.84-1.84],0.2690229816436273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,22853,166,2.39 [1.68-3.42],1.5919743109260191e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,23062,169,1.04 [0.80-1.35],0.755699658177617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XCL1,Lymphotactin,23465,170,1.46 [1.20-1.78],0.0002091638240954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XG,Glycoprotein Xg,23453,169,1.76 [1.22-2.54],0.0023229121837396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XIAP,E3 ubiquitin-protein ligase XIAP,19566,122,0.91 [0.67-1.24],0.5451455690409746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XPNPEP2,Xaa-Pro aminopeptidase 2,23327,169,0.96 [0.85-1.08],0.5123290546640134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XRCC4,DNA repair protein XRCC4,22749,164,1.09 [0.76-1.57],0.6442772172839931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YAP1,Transcriptional coactivator YAP1,20115,129,1.54 [0.89-2.68],0.1228987753983665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",20100,129,1.04 [0.92-1.17],0.5368192294884356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YES1,Tyrosine-protein kinase Yes,23153,167,1.06 [0.94-1.19],0.3610949531867636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YJU2,Splicing factor YJU2,20093,131,0.98 [0.59-1.63],0.9388808427304586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YOD1,Ubiquitin thioesterase OTU1,19476,122,0.64 [0.48-0.85],0.0019179657834404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YTHDF3,YTH domain-containing family protein 3,22853,166,1.13 [0.97-1.33],0.1210163936789267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YWHAQ,14-3-3 protein theta,19710,123,0.99 [0.78-1.26],0.9543066784918712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YY1,Transcriptional repressor protein YY1,19566,122,0.89 [0.47-1.67],0.7169837135858645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBP1,Z-DNA-binding protein 1,19566,122,0.94 [0.60-1.47],0.7855292636093187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB16,Zinc finger and BTB domain-containing protein 16,22716,165,1.07 [0.89-1.29],0.4815325410183046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB17,Zinc finger and BTB domain-containing protein 17,22843,165,1.17 [0.88-1.56],0.2719170875484287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZCCHC8,Zinc finger CCHC domain-containing protein 8,19476,122,1.05 [0.80-1.39],0.7084089370771947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZFYVE19,Abscission/NoCut checkpoint regulator,20100,129,1.02 [0.85-1.23],0.8310660594597604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZHX2,Zinc fingers and homeoboxes protein 2,20115,129,0.79 [0.44-1.41],0.4236092837821353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF174,Zinc finger protein 174,19566,122,0.92 [0.55-1.52],0.7339628859892906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF75D,Zinc finger protein 75D,19814,126,0.87 [0.64-1.18],0.3727477069801671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF830,Zinc finger protein 830,20093,131,1.08 [0.88-1.32],0.47338070331222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRD2,Protein ZNRD2,20100,129,0.85 [0.66-1.09],0.1954423246227141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,20093,131,1.06 [0.78-1.43],0.7203366933419808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP3,Zona pellucida sperm-binding protein 3,19613,127,1.03 [0.96-1.10],0.4471552050049374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP4,Zona pellucida sperm-binding protein 4,19464,125,1.46 [1.01-2.11],0.0431625892012073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZPR1,Zinc finger protein ZPR1,19511,122,1.07 [0.91-1.27],0.4172167190079517
